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      “Tuberculosis, perhaps more than any other disease, is a lens through which society can be viewed (…) Responses reflect how society views those on the margins, from the homeless, drug users, and the HIV infected, to immigrants and felons” (Coker, 2000, p.16).  
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Abstract 
Tuberculosis (TB) is an infectious disease which causes about two million deaths 
each year. In 1993, the World Health Organization (WHO) declared TB to be a 
“Global Emergency” due to an increasing number of TB cases and a rise in multi-
drug resistant cases in the developed world. Treatment interruption was considered 
one of the major challenges. WHO introduced the current TB control program 
DOTS (directly observed treatment, short course) as the tool to control the disease. 
To prevent further development of resistance against anti-TB drugs it was decided 
to observe each patient taking their daily dose of medication. The overall aim of 
this thesis is to explore how patients and health workers perceive and manage TB 
symptoms and treatment in a high-endemic and a low-endemic setting in the era of 
DOT(S). The data is based on fieldwork, including in-depth interviews and focus 
groups with TB patients and health workers, in Addis Ababa, Ethiopia (2001-
2002) and in Oslo/Akershus, Norway (2007-2008).  
We found that people’s interpretation and management of TB symptoms is 
influenced by cultural, social and economic factors. TB was, in both contexts, associated 
with poverty, and subsequently with a disease that affects certain countries or certain 
segments of a population. TB was viewed as a severe disease in both contexts, but there 
was variation between individuals to what extent one considered oneself as a likely 
victim. In the absence of circumstantial causes, such as poverty, patients in a low-
endemic setting like Norway, found it difficult to understand why they had developed 
the disease. There was scarce knowledge about the fact that the disease could be latent. 
Awareness of early symptoms, such as persistent cough, was low in both contexts. 
Perceptions of vulnerability, together with the presence or absence of socio-economic 
barriers or enablers influenced at what time patients would seek help.  
The study suggests that health personnel lacked awareness or misinterpreted early 
symptoms of TB. In Ethiopia, lay categorizations of early TB symptoms converged with 
diagnostic practices in parts of the professional health sector. The diagnostic process 
could endure for many months after patients’ first contact with the health services. 
Similarly, in Norway, we found that patients’ interpretations of early symptoms often 
were confirmed in the meeting with health personnel. The consequences were prolonged 
diagnostic processes.   
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The study shows that patients’ ability to manage TB treatment is a product of 
dynamic processes, in which social and economic costs and other burdens interplay over 
time. A decision to interrupt treatment can be shaped by past struggles and accrued 
costs; in which seems financially, socially or emotionally unbearable at the moment of 
treatment interruption. The burdens related to DOT could also be significant, in patients 
who did not interrupt treatment. Patients in both Ethiopia and Norway experienced an 
authoritarian and rigid practice of DOT, which made it difficult to simultaneously attend 
to demands related to treatment and demands related to other areas of life. The most 
vulnerable patients, such as those without permanent jobs, suffered from high economic, 
social and emotional costs.  
In conclusion, health personal need more knowledge about typical and atypical 
symptoms of TB. In low-endemic settings doctors need to be trained to adjust their level 
of suspicion to the migration history of the patient. In high-endemic settings one should 
be aware that health personnel may understand and manage TB within a traditional 
perspective. Patients in both high- and low-endemic contexts need concrete information 
about the cause of TB, how it is transmitted, how symptoms can be manifested, how the 
disease can progress and how it can be cured. The study indicates that inequalities that 
predispose for TB may be reinforced in the patient’s interaction with the health services 
due to a rigid, disempowering practice of DOT. Subsequently, DOT per se may add to 
the chain of structural barriers that patients have to overcome to access and complete 
treatment. To ensure that TB patients complete treatment one must address the 
coexisting and interacting crises that follow a TB diagnosis. This would require TB 
programs to adopt a more holistic approach. Measures that secure early diagnosis may 
reduce some of the physical, psycho-social and economic costs patients face while 
undergoing treatment. Measures that empower patients to participate in their own health 
care may avoid disempowering and humiliating practices.  
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Sammendrag (abstract in Norwegian) 
Tuberkulose (TB) er en infeksjonssykdom som forårsaker rundt to millioner 
dødsfall hvert år. Verdens helseorganisasjon (WHO) karakteriserte i 1993 
økningen i TB som en ”global krise”, da det ble observert en økning i antall TB 
tilfeller, samt en økning i antall multiresistente tilfeller i industrialiserte land. For å 
få kontroll over sykdommen introduserte WHO behandlingsprogrammet DOTS 
(directly observed treatment, short course). Avbrutt behandling ble ansett som en 
av hovedutfordringene, og for å forebygge videre utvikling av resistens mot anti-
tuberkulose medikamenter, ble det bestemt at daglig inntak av medikamenter 
skulle observeres av helsepersonell. Avhandlingens mål er å utforske hvordan 
pasienter og helsepersonell oppfatter og håndterer symptomer på TB og 
påfølgende behandling; i en høy-endemisk og i en lav-endemisk kontekst. Dataene 
er basert på et feltarbeid, som inkluderte dybdeintervjuer og fokusgrupper med TB 
pasienter og helsepersonell, i Addis Ababa, Etiopia (2001-2002) og et feltarbeid i 
Oslo/Akershus, Norge (2007-2008). 
 Vi fant at fortolkning og håndtering av TB symptomer er påvirket av 
kulturelle, sosiale og økonomiske faktorer. TB var, i begge kontekster, assosiert 
med fattigdom og derav med en sykdom som er vanlig i visse land og i visse 
segmenter av en befolkning. TB ble sett på som en alvorlig sykdom i begge 
kontekster, men det var variasjon mellom individer i forhold til i hvilken grad de 
anså seg selv som utsatt for å få sykdommen. I fravær av årsaker betinget av ytre 
omstendigheter, slik som fattigdom, var det vanskelig for pasienter i en lav-
endemisk kontekst som Norge å forstå hvorfor de var rammet av TB. Det var lite 
kunnskap om at sykdommen kunne ligge latent i kroppen. Det var lav bevissthet 
rundt tidlige symptomer på TB, slik som vedvarende hoste, i begge kontekster. 
Forståelse av egen sårbarhet, i kombinasjon med tilstedeværelse eller fravær av 
sosioøkonomiske barrierer, påvirket på hvilket tidspunkt pasienter søkte 
helsehjelp.  
 Vi fant at helsepersonell var lite bevisste eller feiltolket tidlige symptomer 
på TB. I Etiopia var det samsvar mellom lekfolks fortolkninger av tidlige 
symptomer og diagnostiske praksiser i deler av den profesjonelle delen av 
helsesystemet. Den diagnostiske prosessen kunne vedvare i mange måneder etter 
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pasienters første kontakt med helsevesenet. I Norge ble pasienters fortolkning av 
symptomer, på liknende måte, ofte bekreftet i møtet med helsepersonell. 
Konsekvensene av dette var langvarige diagnostiske prosesser.  
Vi fant at pasienters mulighet til å håndtere TB behandling var et produkt 
av dynamiske prosesser, hvor sosiale og økonomiske kostnader og andre byrder 
virker sammen over tid. En beslutning om å avbryte behandling kan være formet 
av tidligere strev og oppsamlede kostnader, som økonomisk, sosialt, eller 
emosjonelt oppleves som uhåndterbart på det tidspunktet behandlingen avbrytes.  
Byrder relatert til behandling kunne også være betydelige blant pasienter som ikke 
avbrøt behandling. Pasienter i både Etiopia og Norge erfarte en autoritær og rigid 
praksis av DOT, som gjorde det vanskelig og samtidig å forholde seg til krav 
relatert til behandling og krav relatert til andre områder i livet. De mest sårbare, 
som de uten fast arbeid, led under økonomiske, sosiale og emosjonelle kostnader.  
 Studien peker på behovet for mer kunnskap blant helsepersonell om typiske 
og atypiske symptomer på TB. I lav-endemiske kontekster er det behov for 
opplæring av leger slik at de vurderer muligheten for TB ut i fra pasientens 
migrasjonshistorie. I høy-endemiske kontekster bør man være oppmerksom på at 
helsepersonell kan forstå og håndtere TB innenfor et tradisjonelt perspektiv. 
Pasienter i både høy- og lav-endemiske kontekster trenger konkret informasjon om 
årsaken til TB, hvordan TB smitter, hvordan symptomer manifesteres, hvordan 
sykdommen kan utvikle seg, og hvordan man kan helbredes.  
Studien indikerer at ulikhetene som disponerer for TB kan forsterkes 
gjennom rigide og krenkende behandlingspraksiser. DOT per see kan medføre nye 
hindringer i rekken av strukturelle barrierer som pasienter møter for å få tilgang til- 
og for å kunne fullføre behandling. For å sikre at pasienter kan gjennomføre 
behandlingen må man være oppmerksom på de sameksisterende og samvirkende 
kriser som følger av at pasienter får en TB diagnose. Dette krever at TB 
programmer i større grad har en helhetlig tilnærming. Tiltak som kan sikre tidlig 
diagnose kan redusere noen av de fysiske, psykososiale og økonomiske kostnadene 
pasienter erfarer under behandling. Tiltak som søker å styrke pasienten slik at de i 
større grad kan ta ansvar for egen helse, kan forhindre praksiser som skaper 
avmakt eller er krenkende.   
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Preface 
During my undergraduate studies in social anthropology, I attended a course in medical 
anthropology, and in one of the classes patients’ compliance to medical treatment was 
discussed in the light of political, economic, social, cultural and individual factors. 
Tuberculosis was used as an example to highlight some of the research findings and to 
address the complexity involved in understanding the phenomenon of compliance. I 
realized the importance of listening to people’s own voices, and at the same time being 
able to contextualize these voices by assessing the structures that frame them. As a 
masters student I decided to pursue this interest and to focus on compliance with 
tuberculosis treatment. In October 2001, I left for fieldwork and collected data over a six 
month period in Addis Ababa, Ethiopia. This fieldwork was the basis of the master 
thesis I submitted for the degree Master of Philosophy in International Community 
Health in 2003. As a doctoral student at the Section for International Community Health, 
Faculty of Medicine, University of Oslo, these data were subject for further analysis and 
interpretation. This work culminated in the publication of two papers that constitute one 
part of this dissertation. The second part of this dissertation, and two of the papers, is 
based on fieldwork from June 2007 to June 2008 among African immigrants in Oslo, 
and the surrounding county of Akershus, Norway. Throughout this thesis I use the term 
“we” when I refer to processes were the supervisors have participated. “We” may also 
be used when describing the part of the study where I used a research assistant. I use the 
term “I” when I refer to personal reflections and experiences.     
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1.    Introduction 
Tuberculosis (TB) is an infectious disease which is caused by an acid-fast bacillus, 
which belongs to the Mycobacterium tuberculosis complex. TB transmission 
begins with a human source, most often a person with cavitary, pulmonary TB. 
When an infectious patient coughs, sneezes or talks, aerosols are formed in the 
lungs and expelled. These aerosols contain the micro-particles that carry the 
bacilli, and can be inhaled by others. The disease affects the lungs in 
approximately two thirds of cases, but almost all other organs can be the site of TB 
infection. It is estimated that about one third of the world’s population is infected 
with TB. However, the infection is contained by the immune system in about 90 % 
of those infected. The TB bacilli can lie dormant for years, being protected by a 
thick waxy coat. If the immune system is weakened, for example by an HIV 
infection or treatment with immunosuppressive agents, the chances of developing 
active TB become much higher (Comstock, 2000, p.139).  
TB differs from other diseases with high mortality rates because it has a 
highly effective treatment available. The greatest burden of TB incidence and 
mortality is found in the 15-49 age group. Therefore, the economic costs of TB, in 
terms of lost production, are considerable. Medical treatment usually enables 
people to return to an active and economically productive life, often with no 
disability or residual morbidity. By making people non-infectious through medical 
treatment, transmission can be prevented and the global burden of the disease 
considerably reduced. TB is ranked as the most cost-effective of all diseases to 
treat, and is estimated to be the cause of 26 % of all preventable adult deaths 
(Murray, Styblo, & Rouillon, 1990).   
1.1  A historical perspective on the management of TB  
In order to understand today’s management of TB, we need to see the disease in its 
historical context. TB has burdened societies since prehistoric times. 
Mycobacterium tuberculosis (M. tuberculosis), the pathogen causing TB, is 
suggested to have caused more deaths than any other microbial pathogen. Daniel 
(2006) has given an account of the history of TB, in which he demonstrates how 
TB has plagued humankind throughout known history and human prehistory.  
People suffering from TB have been pictured in early Egyptian art, and M. 
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tuberculosis DNA has been amplified from tissues of both Egyptian and Peruvian 
mummies. The disease has been described by many varying names, such as the 
ancient Hebrew word schachepheth used in biblical books, phthisis used in 
classical Greek, and consumption, wasting disease and the white plague in modern 
English. TB has surged in major epidemics and then subsided, similar to other 
infectious diseases. However, the time scale of TB challenges common 
explanations for epidemic cycles (Daniel, 2006). TB reached epidemic proportions 
in Europe and North America during the 18th and the early 19th centuries. At that 
time death rates in cities like London, Stockholm, and Hamburg approached 800-
1000 per 100 000 population per year (Daniel, 2006). A likely explanation for 
these figures is that TB transmission increased due to increased population density 
and crowded living conditions, while other risk factors, such as poor nutrition, 
increased the risk of progressing from latent to active disease (Lönnroth, Jaramillo, 
Williams, Dye, & Raviglione, 2009). In the face of an enormous TB prevalence, 
parts of society responded by romanticizing the disease. Writers and artists 
described the pallid faces and skinny bodies of the TB diseased as attractive, 
interesting and sensitive in expression (Daniel, 2006). One of the famous quotes is 
Charles Dickens’ (1812-70) description of the death of Smike in Nicholas 
Nickleby; “[As] the mortal part wastes and withers away, so the spirit grows light 
and sanguine” (Dickens, 1986, p.739).  However, TB first of all caused fear, not 
only of catching the disease, but also a fear that one would “catch” or be 
associated with the predisposing factors linked with TB; such as poverty, poor 
nutrition, alcoholism, and drug-dependency (Coker, 2000, p.6).   
 During the first meeting of specialists in internal medicine, held in Paris in 
1867, TB was found to be the most frequent disease that specialists dealt with.  
Subsequently, a series of scientific meetings and international congresses devoted 
particularly to TB were initiated. This eventually led to the establishment of the 
International Union against Tuberculosis and Lung Disease (IUATLD) in 1920  
(Enarson, 2000, p.55). Towards the end of the 19th century, after death rates from 
TB had started to decline, two historic events occurred that had a tremendous 
impact on the diagnosis and treatment of the disease: The discovery of the tubercle 
bacillus in 1882, by Robert Koch (1843-1910), and the discovery of X-rays by 
Wilhelm Konrad Röntgen (1845-1923) in 1895. These two events led to a wave of 
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research that eventually resulted in the development of the BCG vaccine in the 
1920s, as well as effective medical treatment. Some of the major breakthroughs 
were the discovery of the anti-tuberculosis drugs streptomycin in 1944, isoniazid 
in 1952, and rifampicin in 1965 (Daniel, 2006).  
1.1.1 TB - a global emergency 
Half a century after the introduction of effective therapy and 111 years after M. 
tuberculosis was identified, the World Health Organization (WHO) declared that 
TB represented a “Global Emergency”. Dr. Kochi, manager of the WHO 
Tuberculosis Programme, emphasized, in a speech in 1993, that TB was 
humanity’s greatest killer, and that the disease was out of control in many parts of 
the world. In light of all the scientific breakthroughs how was such a development 
possible? From the early and mid-19th century, at the same time as knowledge of 
TB advanced, the prevalence and mortality rates had started to decline in Europe 
and North America. Improved social and living conditions, better nutrition, and 
introduction of sanatoria, have been put forward as explanations for the decline. 
Herd immunity, due to natural selection of a genetically more resistant population, 
has also been suggested to have played a role (Daniel, 2006; Lönnroth et al., 
2009). TB was no longer considered a threat to the developed countries, and 
funding and interest for TB control and TB related research became greatly 
reduced. Loss of funding and interest in TB control caused a loss of awareness, a 
loss of clinical competence, as well as a dismantling of infrastructure related to TB 
control management (Ogden, Walt, & Lush, 2003). The discovery of the BCG 
vaccine and the development of effective therapeutic regimens would most 
probably have had a much greater impact on TB control if adequate resources had 
been available in the developing world. The opportunities given through the 
medical advancements were first of all implemented in the developed world. 
Attempts to transfer good results from industrialized countries, by using the same 
methods, were successful in only a few other countries. In the poorest countries, 
where the majority of the cases lived, infrastructure for providing services could be 
absent. Populations were scattered, and communication needed for surveillance 
and ensuring accessibility to the existing health-services was insufficient. In 
addition, economic resources were far from sufficient to deal with the disease 
burden (Enarson, 2000, p.60-61).  
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 There were other contributing problems to TB control in the developing 
part of the world. One of the earliest interventions in low-income countries, during 
the 1960’s, was the use of isoniazid alone in the treatment of TB. It was cheap, 
showed good results, was easy to apply, and received support from the executive 
director of the IUATLD and from the Director General in the WHO. This strategy 
led to the proliferation of isoniazid resistance and formed the basis for the present 
problem of multi-drug resistance (Enarson, 2000, p.61). Another strategy was 
based on the importance of active case findings. The idea was that if one obtained 
a modest level of treatment-success in a large number of cases it would be a more 
effective way of reducing the disease burden than if a high level of treatment-
success was obtained in a restricted number of cases. After recommendations from 
the WHO, most governments in low-income countries developed national TB 
control programs. After a few years with the recommended strategy, millions of 
TB cases were reported to the WHO. Regular surveys from countries in East Asia 
showed that more than half of the sources of transmission of TB were cases being 
treated, but not cured. In addition, the majority of these cases had developed 
resistant strains. The strategy had failed, and the ineffective treatment made the 
epidemiological situation far worse than if the patients had been left untreated 
(Enarson, 2000, p.61-62). 
1.1.2 Renewed interest in the developed world 
While attention to and funding for TB had vanished, the disease returned in the 
developed world. Reichman (1991) describes this as the “U-shaped curve of 
concern” by showing how changes in TB incidence are related to resource 
distribution. The interest and concern over TB increased in the mid-1980’s as a 
result of an increasing number of TB cases, as well as an alarming rise in 
multidrug resistant cases, in the developed world. Although drug resistant strains 
had long been diagnosed in high-endemic contexts, multidrug resistance was a 
new problem in the developed world. The main key to the renewed interest are 
linked to the HIV-related outbreaks of TB in New York City in the late 1980’s and 
early 1990’s. The spread of the disease from the poor and the marginalised to 
middle class Americans caused a resurgent fear of TB. The city authorities in New 
York initiated a large campaign to combat the epidemic, including the 
implementation of directly observed therapy (DOT) and incentives such as travel 
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token reimbursement, free lunches, and food coupons to encourage compliance. 
The use of detention, based on previous failures of completing treatment, also 
became a part of the strategy. The efforts showed that with sufficient attention and 
resources including individualized treatment plans, treatment offered in a variety 
of settings, food-support, and close follow-up; TB to a large extent could be 
controlled. However, the use of detention, based on judgment of previous 
behaviour, and not on assessment of whether the person actually posed a 
significant risk to others due to this behaviour, caused a debate about the grounds 
of coercive measures (Coker, 2000, p.47-119; Ogden et al., 2003).  
1.1.3 Management of TB through DOTS 
In 1991, delegates to the WHO’s 1991 World Health Assembly set two targets for 
national TB control programs; to detect at least 70 % of all new sputum smear-positive 
cases arising each year and to cure at least 85 % of them (Dye, Hosseini, & Watt, 2007). 
During the early 1990’s essential methods for TB diagnosis and treatment were 
integrated into the WHO’s TB control strategy; DOTS, became the main tool to reach 
these targets. Treatment interruption was considered one of the major challenges in TB 
control. To prevent further development of resistance against anti-TB drugs (rifampacin 
in particular), it was decided to emphasize the control of each patient taking their daily 
dose of medication. Subsequently, the WHO developed an extensive strategy that 
centered on directly observed therapy (Lienhardt & Ogden, 2004). DOTS, is still the 
internationally recommended strategy for TB control and is comprised of five 
components which emphasize:  
1. Sustained financial and political commitment,  
2. Case detection trough passive case finding using quality ensured sputum-smear 
microscopy,  
3. Standardized short-course anti-TB treatment given under direct observation,  
4. Securing of a regular, uninterrupted supply of high quality anti-TB drugs, and  
5. Standardizing recording and reporting (The World Health Organization [WHO], 
2009a). 
The introduction of DOTS led to a debate between representatives from the 
scientific community and policymakers who were eager to implement the global 
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strategy. The DOTS strategy was criticized for not including a focus on research 
and development of new vaccines and new drugs, and there was a worry that the 
implementation of DOTS would imply even less money being allocated to such 
research. Many saw DOTS as an oversimplified measure based on conventional 
methods, and expressed concerns about the effectiveness of such an approach 
(Ogden et al., 2003). Another source of debate was that directly observed 
treatment, one of the components of DOTS, was controversial from an operational 
as well as from an ethical and human rights perspective (Porter & Ogden, 1997; 
Hurtig, Porter, & Ogden, 1999). A strict and universal application of DOT was 
developed on the basis of a few controlled studies, and transferred to a variety of 
other social, economic and cultural contexts without clear guidelines for 
implementation (Lienhardt & Ogden, 2004). It has been claimed that there has 
been to little focus on whether the implementation in different settings is user-
friendly, to what degree clinics and health personnel are culturally-sensitive 
enough, and whether or not the coercive elements (enforced daily clinic-based 
treatment) are justifiable ethically (Porter & Ogden,1999; Lienhardt & Ogden, 
2004). These arguments and concerns led to a randomized controlled trial of DOT 
versus self-supervision of treatment in South Africa, which concluded that the use 
of DOT showed no benefit in terms of cure-rates (Zwarenstein, Schoeman, 
Vundule, Lombard, & Tatley, 1998). The study results were not taken into 
consideration by the WHO due to problems in the study design. Another two 
randomized controlled trials followed. One of them, conducted in Thailand, 
showed a clear benefit from DOT versus self-administration. In this setting DOT 
was being conducted by a family member and with weekly support visits from 
health personnel (Kamolratanakul et al., 1999). The other trial was conducted in 
Pakistan and showed no difference between DOT and self-administration. 
However, higher cure rates where seen in the group where DOT was provided by a 
family member compared to a health worker (Walley, Khan, Newell, & Khan, 
2001). The lessons from these three trials were inconclusive, but raised serious 
doubts about the effectiveness of TB control programs when DOT executed by 
health personnel where key elements (Lienhardt & Ogden, 2004).  
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1.2  Epidemiology of TB today 
Today, TB is still a major global public health concern. In 2008, there were an estimated 
8.9–9.9 million incident cases of TB, 9.6–13.3 million prevalent cases of TB, 1.1–1.7 
million deaths from TB among HIV-negative people and an additional 0.45–0.62 million 
TB deaths among HIV-positive people (best estimates of 9.4 million, 11.1 million, 1.3 
million and 0.52 million, respectively) (WHO, 2009b). The incidence of TB has 
gradually increased over the last 20 years, from about 6.6 million cases in 1990, to 8.3 
million cases in 2000, and 9.2 million cases in 2006. Most of the estimated cases in 2007 
were in Asia (55 %) and Africa (31 %), and only a small proportion of TB cases are 
found in the Eastern Mediterranean Region (6 %), the European Region (5 %) and the 
Region of the Americas (3 %) (WHO, 2009c). There has been a disproportionate burden 
of HIV and TB infection, disease, and death in the African region. In 2003, there were 
an estimated 8.8 million new cases and 1.7 million deaths from TB. Even though only  
11 % of the world’s population lives in Africa, 27 % of cases and 31 % of deaths 
occurred in this region. Of the 9.4 million new TB cases in 2008 an estimated 1.2-1.6 
million (13-16 %) were HIV positive (best estimate of 1.4 million). 78 % of the HIV-
positive cases were in the African region (WHO, 2009b, p.5; Corbett, Marston, 
Churchyard, & De Cock, 2006).  
 In the developed world, prevalence and mortality rates have steadily 
declined among the general population from the early 19th century. However, TB 
is becoming more prevalent among certain minority groups, as well as among the 
homeless, people with alcohol dependence, and people with drug addiction.  
Lönnroth et al. underlines that “the TB burden follows a strong socio-economic 
gradient between countries, within countries and within communities, and the 
poorest have the highest risk” (Lönnroth, Jaramillo, Williams, Dye, & Raviglione, 
2009, p.2243).  Studies that have assessed the impact of TB in vulnerable 
populations show that there is a strong association between social suffering and 
TB (Lönnroth et al., 2009). In England and Wales notifications of TB increased by 
12 % from 1988 to 1992. There was an increase of 35 % among the poorest 10th of 
the population, a 13 % increase in the next two 10ths, and no increase among the 
more affluent (70 %) part of the population (Bhatti, Law, Morris, Halliday, & 
Moore-Gillon, 1995). In the USA, the epidemics of TB in the 1980s and the 1990s 
mostly affected the socio-economically underprivileged. In the mid-1980’s, active 
23 
 
TB rates among the homeless in New York were estimated to be 968 per 100 000 
population, compared to 23 per 100 000 for the whole population of New York 
(Coker, 2000, p.51). It has been argued that a more market oriented approach to 
public health has changed both the rationale and distribution of health services and 
created an ‘ecological niche’ in certain areas, such as inner American cities, within 
which infectious diseases like TB can spread more easily (Wallace & Wallace, 
1999). Within developing countries there are large differences in the prevalence of 
TB. In the slums of Delhi and Calcutta the prevalence is found to be 50 per 1000 
compared with 3 per 1000 for non-slum areas (Ogden et al., 1999). Even if we 
observe an increase of TB among some groups in industrialized countries, the 
burden of TB is mainly carried by the developing countries, where 95 % of all TB 
cases occur (Lienhardt & Ogden, 2004). The TB afflicted has had few health 
advocates and the funding of TB control continues to be very low compared to 
infectious diseases like AIDS and Malaria (Gandy & Zumla, 2002).   
In a low-endemic, high-income setting such as Norway, with a total population of 
4.7 million people, 307 new cases of TB were reported in 2007 (Winje, Mannsåker, 
Heldal, & Dahle, 2008). Foreign-born persons accounted for 243 (79 %) of these cases. 
Among Norwegian-born individuals with TB (including second generation immigrants), 
the median age at the time of diagnosis was 74 years. The incidence of TB in Norway is 
highest among people who originate from Africa and Asia, and the rates reflect the 
epidemiological situation in the countries of origin. In 2005, the number of reported TB 
cases were highest among people with the following countries of origin; Somalia, 
Ethiopia, Vietnam and the Philippines (listed in order of number of cases) (Winje, 
Mannsåker, Heldal, Brantsæter, & Dahle, 2006b). In 2006, the number of reported TB 
cases were highest among people with the following countries of origin; Somalia, 
Ethiopia, Pakistan, Thailand, and the Philippines (listed in order of number of cases) 
(Winje, Mannsåker, Heldal, & Dahle, 2007).  
In a high-endemic, low-income setting such as Ethiopia, with a total population 
of approximately 77.1 million people (Population Reference Bureau, 2007), 314,267 
new TB cases were reported in 2007 and there was an estimated incidence rate of 378 
cases per 100,000 population. The TB case detection rate is very low compared to the 
WHO’s target of detecting 70 % of infectious TB cases; with only a 28 % detection rate 
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of new smear positive cases, and a 40 % detection rate of all cases (WHO, 2009d). 
Ethiopia ranks seventh among the world’s 22 high-burden countries (WHO, 2009b, p.5). 
1.3  The epidemiological situation in the era of DOTS  
In 2000, 148 countries, including all 22 high burden countries, which bear 80 % of the 
estimated cases, had adopted a version of DOTS. However, many countries have 
continued to show slow progress in controlling TB. There has been a slow expansion of 
control efforts and progress in case detection has remained slow. In a number of sub-
Saharan countries case rates have risen dramatically, mainly because of the AIDS 
epidemic (Raviglione, 2003). In 2005-2006, the new “Stop TB strategy” was developed 
by the WHO in response to challenges not adequately addressed in the initial DOTS 
strategy. The “Stop TB strategy” was built on the DOTS strategy, but sought to address 
sustainment, improvement and acceleration of quality DOTS expansion. The new 
strategy is also concerned with new challenges related to multi-drug resistant TB, the 
intersecting epidemics of TB and HIV, lack of involvement of private practitioners, 
challenges related to weak health systems, further involvement and empowerment of 
patients and their communities, and enabling and promoting research (WHO, 2009c). 
It has been documented that treatment according to the principles of DOTS is a 
cost effective public health intervention when evaluated with regards to disability 
adjusted life years saved (DALYs) (the sum of years of potential life lost due to 
premature mortality and the years of productive life lost due to disability) (Lönnroth et 
al., 2009). Further, cost benefit calculations have shown that curative TB control is a 
good investment in society (Lönnroth et al., 2009). The number of notified cases of TB 
in 2008 world wide was 5.7 million, equivalent to 55–67 % of all incident cases (best 
estimate of 61 %). This is 10 % less than the Global Plan milestone of a case detection 
rate of 71 % in 2008. Among patients in the 2007 cohort, 86 % were successfully 
treated. This is the first time the target of 85 % has been exceeded at a global level since 
it was set in 1991 (WHO, 2009b). However, studies investigating DOTS’ effect on TB 
incidence, treatment completion, and cure do not provide a solid assurance of the value 
of DOTS as the main strategy in TB control. The implementation of DOTS has been 
associated with a decline in TB prevalence and incidence in Peru, Cuba, China, parts of 
India and the USA. Still, in areas were there has been a significant decline it has been 
difficult to separate the effect of DOTS and the effect of general socio-economic 
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development (Lönnroth et al., 2009). Dye, Lönnroth, Jaramillo, Williams, & Raviglione 
(2009), investigated trends in TB incidence and their determinants in 134 countries. 
They found that the incidence rate declined more quickly in countries that had a higher 
human development index, greater health expenditure, lower child mortality, and 
improved sanitation. Further, incidence rates declined more quickly in high-income 
countries with lower immigration and in countries with lower HIV infection rates. 
General development measures were found to be the dominant explanatory variables 
within regions as well. A possible causal link between TB incidence and control efforts 
were found only in Latin America and the Caribbean, in which lead to the conclusion 
that TB control program’s effect on TB transmission and incidence rates is highly 
insecure (Dye et al., 2009). A systematic review assessing long term efficacy of standard 
short course regimens (6 months) found that there was a wide variation in TB recurrence 
(ranging from 0 % to 14 %) after completion of treatment. The authors conclude that 
despite standard DOTS regimens being implemented for more than a decade, few studies 
have assessed the ability of such regimens to result in a lasting cure (Cox, Morrow, & 
Deutschman, 2008). 
1.3.1 The effectiveness of DOT 
Even though the TB control programs’ effect on transmission and incidence rates 
may be insecure, there is little doubt that the different components of the DOTS 
strategy have revitalized and strengthened TB control efforts. However, the way in 
which the DOT component of DOTS contributes to the treatment and cure of TB is 
a relationship that has yet to be rigorously evaluated (Verma, Upshur, Rea, & 
Benatar, 2004). Due to the impact of DOT on patient autonomy, this is the 
component of the treatment strategy that has remained controversial. Volmink and 
Garner (2007), set out to compare DOT with self-administration of treatment or 
different DOT options. They conducted a systematic review of 11 randomized and 
quasi-randomized controlled trials that compared DOT conducted by a health 
worker, family member, or community volunteer with self administration of 
treatment at home. They found that there was no significant difference between 
DOT and self-administration in terms of cure (assessed in four trials). DOT 
provided at home compared to DOT provided at a clinic indicated a small 
advantage with home based DOT in terms of cure (assessed in three trials). No 
significant difference in clinical outcomes was found between DOT given at a 
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clinic compared to DOT given by a family member or community health worker 
(assessed in two trials), or for DOT given by a family member compared with a 
community health worker (assessed in one trail). Further, in two trials comparing 
DOT and self-administration of medication among intravenous drug users (TB 
prophylaxis), no statistically significant difference was found between DOT and 
self-administration. The authors conclude that results from low-, middle-, and 
high-income countries provide no evidence that DOT, compared with self- 
administration of TB treatment, has any quantitatively important impact on cure or 
treatment completion (Volmink & Garner, 2007). DOT has also been 
recommended to improve adherence for patients with HIV infection being treated 
with antiretroviral treatment. A systematic review and meta-analysis of 
randomized trials of DOT versus self-administrated antiretroviral treatment 
showed that DOT offered no benefit compared to self-administered treatment. The 
authors suggest that the reason why both this review and Volmink and Garner’s 
review provide no evidence that supports the use of DOT, could be linked with the 
burden associated with frequent clinic visitations, resistance caused by 
infringement of patients’ autonomy, a desire among patients to be in control of 
their own treatment, absence of the intervention, or patients adhering to the 
treatment independent of any intervention (Ford, Nachega, Engel, & Mills, 2009).     
1.4  Diagnosis and treatment of TB 
Bacteriological diagnosis of TB still relies on detection of acid fast bacilli on 
microscopic examination and on culture; routine diagnostic methods that are very 
similar to those used 100 years ago. Diagnosing drug resistant TB (TB that is resistant to 
any first line anti-tuberculosis drug) is more demanding because it needs growth on 
culture and the incorporation of anti-tuberculosis drugs takes six to eight weeks and 
requires special laboratory facilities. These are largely unavailable in high-endemic, low-
income settings (Grant, Gothard, & Thwaites, 2008). In patients with extra-pulmonary 
TB, and in patients with TB/HIV co-morbidity, the sputum smear is often negative. 
Since low-income settings have limited access to mycobacterial culture (and PCR-based 
nucleid-acid amplification tests), the most common way of diagnosing such cases in 
low-income setting are therefore through clinical diagnosis, supported by radiology . In 
2006, the WHO issued guidelines for the diagnosis of smear-negative and extra-
pulmonary TB. These were aimed at settings with high prevalence of HIV infection. 
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Case definitions for smear-negative TB have also been developed. However, studies 
from Africa show that the results vary (Maartens & Wilkinson, 2007).   
 Conventional short-course treatment for TB has been the same for decades. The 
most common treatment combination is isoniazid, rifampicin, pyrazinamide, and 
ethambutol for 2 months, followed by isoniazid and rifampicin for 4 months. This 
treatment regimen is highly effective on patients with TB, including those who are HIV 
positive, and is a part of the current DOTS strategy (Maartens & Wilkinson, 2007).   
Side-effects are common, and hepatotoxicity to isoniazid is considered a serious 
problem. Other side-effects include dermatological reactions (e.g. flushing), 
gastrointestinal intolerance (e.g. nausea, vomiting, diarrhea) hypersensitivity (e.g. rash, 
fever), neurological effects (e.g. peripheral neuropathy), hematological effects (e.g. 
thrombocytopenia, hemolytic anemia), as well as different renal diseases. Such side-
effects can lead to drug discontinuation or more serious morbidity or mortality (Forget & 
Menzies, 2006). 
 An extended variant of the DOTS strategy, DOTS plus, is used in cases with drug 
resistant TB (Maartens & Wilkinson, 2007). To be able to detect drug resistant TB, this 
part of the program recommends an additional investment in facilities for culture and 
drug susceptibility testing. Management of drug resistant TB is difficult because there is 
a lack of randomized controlled trials providing evidence related to treatment. 
Furthermore, second line drugs are expensive and weak, they can give severe side-
effects, and many patients have an advanced disease that requires extensive treatment. 
Treatment of multidrug resistant TB can also be complicated by HIV co-infection and 
interrupted provision of second line drugs (Grant et al., 2008). 
 Preventive therapy is found to reduce TB incidence in both HIV-positive and 
HIV-negative patients. Such therapy is considered a successful component of TB control 
in Europe and North-America. Problems in identifying those at risk, uncertainties related 
to the effects in high-endemic settings, and insecurity about cost-effectiveness and 
acquired drug resistance has restricted the implementation in high-endemic, low-income 
settings (Maartens & Wilkinson, 2007).    
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1.5  Challenges in contemporary TB management  
Delay in seeking treatment/delay in receiving a diagnose (patient and health care system 
delay) and interruption of treatment are two fields that both in the pre-DOTS era and in 
present time are considered as main barriers for the successful control of TB. Diagnostic 
delay leads to an increased period of infectiousness in the community and exacerbates 
the disease in affected individuals (Lienhardt, 2001). Non-adherence to treatment may 
result in prolonged infectiousness, drug resistance, relapse, and death. Treatment 
interruption thus poses a serious risk both for the individual and the community 
(Volmink & Garner, 2007). Diagnostic delay and treatment interruption have been 
described as “twin problems” due to their complex, similar and interrelated causes 
(Rubel & Garro, 1992). Furthermore, in the context of physical, geographic, economic, 
and socio-psychological barriers to treatment, early diagnosis may serve as an important 
precondition for managing a long treatment regimen (Lienhardt, 2001). Some studies 
suggest that diagnostic delay is related to how patients perceive and manage early 
symptoms (Demissie, Lindtjorn, & Berhane, 2002; Liefooghe, Baliddawa, Kipruto, 
Vermeire, & De Munynck, 1997; Watkins & Plant, 2004). Others studies have 
emphasized stigma and economic costs related to obtaining the diagnosis (Rubel & 
Garo, 1992; Sanou, Dembele, Theobald, & Macq, 2004; Johansson & Winkvist, 2002). 
A recent review of quantitative studies identified several factors associated with 
diagnostic delay, such as; HIV infection; coexisting chronic cough or lung diseases; 
negative sputum smear; extra-pulmonary TB; rural residence; poverty; poor access to 
care (geographic or socio-psychological barriers); initial visitation of a government low-
level healthcare facility, private practitioner, or traditional healer; old age; female sex; 
low awareness of TB; incomprehensive knowledge; history of immigration; low 
education level; alcoholism and substance abuse, and stigma (Storla, Yimer, & Bjune, 
2008). Other health related factors that lead to an increased risk of delay were generally 
poor health, smoking, less severe/indifferent symptoms, and an absence of hemoptysis. 
Most of the studies, independent of high or low endemic context, reported a total 
diagnostic delay within the range of 60-90 days (Storla et al., 2008). A factor that gave 
an increased risk of delay in one study could give a decreased risk in another study. This 
indicates the need to explore context specific factors. Most factors were found to 
influence both patient and health care delay, but factors such as poverty, low access to 
health care facilities, and incomprehensive knowledge of TB were more linked to patient 
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delay. Factors such as coexistence of chronic cough and/or other diseases, having extra-
pulmonary or negative sputum smear TB, less severe and indifferent symptoms, absence 
of hemoptysis, and use of traditional or private practitioners first, were more linked to 
health care system delay. Generally, many studies describe difficulties that patients have 
in reaching the local treatment unit of the national TB program due to poverty, distance 
and/or stigma associated with these clinics. Another factor of vital importance is 
repeated consultations by a patient at the same level in the health care system, without 
receiving a diagnosis (Storla et al., 2008). Such treatment patterns will evidently 
increase poverty related problems in accessing and adhering to relevant treatment.   
 Studies from both low- and high-income countries have shown that between 20- 
50 % of patients with TB do not complete their treatment regimes (Sackett & Snow, 
1979, p.14; Addington, 1979; Cuneo & Snider, 1989). In recent years, there have been a 
large number of qualitative studies conducted on TB and adherence in the developing 
world. In a systematic review of 44 qualitative studies on patient adherence to TB 
treatment, eight major themes were identified: barriers related to how treatment and care 
were organized; patients’ interpretation of illness and wellness; financial burdens related 
to treatment; knowledge, attitudes and beliefs related to treatment; law and immigration; 
personal characteristics; side-effects; and family and community support. The review 
concludes that a more patient-centered approach and more attention to structural barriers 
are needed to improve treatment adherence (Munro et al., 2007a). The intertwined 
problems of delay in seeking treatment and interruption of treatment are clearly 
demonstrated by the main findings in the literature: People's understanding of symptoms 
and treatment may affect health seeking behavior throughout the course of the disease 
from acting on the first symptoms, until treatment completion. Indirect or direct costs 
related to diagnostic procedures, loss of time, or transportation to relevant health 
services also represent major barriers. Similarly, the social stigma that is attached to TB 
seems to represent a barrier in all stages of the disease.                    
 However, the literature illustrates that treatment adherence is a complex, dynamic 
phenomenon. To understand such a phenomenon studies exploring a wide range of 
preceding, interacting, and contextual factors need to be conducted. Given the 
importance of long-term medication adherence in relation to TB, more studies are 
needed to better understand people’s experiences with TB and the long treatment 
regimen (Munro, Lewin, Swart, & Volmink, 2007b). There is a particular lack of 
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research  exploring lay understandings of TB and its treatment and how these influence 
how people act upon symptoms and continue or discontinue treatment at particular times 
(Munro et al., 2007a; Munro et al., 2007b). Few studies have, for example, used 
qualitative methods to explore patients’ perception and management of TB during 
different phases of the disease and its treatment. Patients may change their perception 
and behavior from the onset of symptoms to completion of treatment. Exploring the 
rationale behind such changes may bring us closer to an understanding which would in 
turn facilitate an improved management of patients with TB. However, Munro et al. 
(2007a) emphasize that any further research on patients’ experiences in relation to TB 
and adherence needs to include and explore the social, economic, and geographic 
contexts in which the patient is embedded. 
 DOTS have been implemented globally, including most countries in Europe 
(WHO, 2005). However, few studies have investigated TB patients’ management of 
symptoms and treatment in a low-endemic context. Further, few studies have explored 
patients’ and health workers’ experiences with DOT in low-endemic, high-income parts 
of the world. We therefore know little about whether patients face barriers similar to 
those described from low-income, high-endemic settings.  
1.5.1 Challenges related to the concepts used to develop TB control strategies              
A vast number of studies exploring reasons for diagnostic delay and patient non-
compliance have been conducted, both before and after the implementation of 
DOTS. Even though more recent studies and reviews seem to address structural 
barriers to a further extent, there has been a general trend of focusing more on the 
behavioral aspects among patients, and less on the structural barriers that may 
prevent patients from obtaining a diagnosis and complete treatment (Farmer, 
1999). When focusing on behavioral aspects, there has been a tendency to “blame” 
the patient and in particular the term “non-compliance” has been used in a 
paternalistic manner. Haynes (1979, p.3), demonstrates that “non-compliance” is 
linked with blame and sin since the first recorded incidence of human non-
compliance within the Judeo-Christian tradition was Eve eating the fruit of the tree 
of knowledge in the Garden of Eden. Even though Eve was persuaded by a snake, 
and as such her “health belief model” was changed, she, and not the snake, had to 
carry the blame. Haynes (1979, p.1-2), summarizes the common use and 
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interpretation of the concept by defining compliance as: “the extent to which a 
person’s behavior coincides with medical or health advice”. Such an interpretation 
incorporates the biomedical perspective in which patients are expected to be 
passive recipients of health personnel’s instructions (Munro et al., 2007b). 
Donovan and Blake turn to the dictionary definition where; “to obey, submit, defer 
or accede to instructions” are the corresponding synonyms (Donovan and Blake 
1992, p.507). Such definitions imply that all patients should comply with the 
instructions provided by health personnel, and subsequently that non-compliance 
is to be considered as deviant behavior.   
 Trostle (1988) has reviewed historical material about the twentieth century and 
found that what clinicians nowadays refer to as “compliance”, used to be presented as a 
matter of physician “control”. Trostle argues that medical compliance is better 
understood if viewed as an ideology; “a system of shared beliefs that legitimize 
particular behavioral norms and values at the same time that they claim and appear to be 
based on empirical truths” (Trostle, 1988, p.1300). According to Trostle, such ideologies 
facilitate transformation of power into authority and legitimate control. Trostle points to 
the inconsistent results derived from research on patient compliance, and relates it to 
how the ideology of the concept compliance has transformed theories physicians have on 
proper patient behavior into certain research questions. This in turn has produced certain 
research results. Such research questions have ignored health related behavior that 
contradicts the physicians’ view, and has resulted in potentially coercive medical 
interventions that appear to be right (Trostle, 1988). By using certain scientific concepts, 
specific agendas can be concealed. Further, by using certain concepts, those in control 
can narrow or adjust their targets in accordance with their definition of the word.       
 In line with an extensive focus on patients’ behavior, socio-demographic 
variables such as age, ethnicity, race, income and education have been thoroughly 
explored in studies on compliance with TB treatment. Sumartojo (1993) concludes that 
these factors are inconsistent or unreliable predictors of patient adherence, and argues 
that focusing on such characteristics may lead to a bias among the providers judging 
people with certain characteristics to be potential defaulters and thus limiting the 
expectations of compliance.   
 Homedes and Ugalde (1993) reviewed 37 empirical studies on compliance with 
medical treatment in developing countries. They found that most research done on 
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compliance in developing countries is carried out from a bio-medical perspective. 
Information on what type of rationality was involved in patients’ decision-making was 
limited. This made it difficult to understand the motives behind health seeking behavior 
and to address appropriate action towards higher patient compliance. Social scientists 
have, and still, argue that the language of “compliance” has failed to recognize patients’ 
active participation in their own health care, and that many of the reasoned decisions for 
being “non-compliant” may have been ignored due to such a perspective. Donovan and 
Blake (1992) argue that research shows that patients actively make choices about their 
health within the context of enablers and barriers in their lives, and so “non-compliance 
may thus not be deviance, but reasoned decision-making” (Donovan and Blake, 1992, p. 
508). Some have suggested that the concept of “adherence” should replace “compliance” 
because it includes patients’ agency in a better way (Sumartojo, 1993). Adherence refers 
to consistency in peoples own ideas and beliefs, and includes a perspective where a 
patient faithfully follows a particular set of beliefs related to how they interpret and 
manage their own disease (Sumartojo, 1993). However, to fully understand the concept 
of treatment adherence one needs to understand that different medical systems co-exist 
in different societies and that these different medical systems can be used at the same 
time by the same individual. Use of different medical systems can be related to different 
stages of a disease or be a result of separate approaches towards the treatment of 
symptoms and the treatment of cause. The variety of practices may imply adherence to 
one or several belief systems, or it can indicate lack of adherence to any particular 
system (Stoner, 1986; Helman, 1978).  
 The concept of “concordance” has also been suggested as a means to understand 
and address patient compliance from a different perspective. Concordance emphasizes 
the importance of health personnel being able to acknowledge and take into account 
patients’ decision making capabilities, and with patients being more active in stating 
their needs and constraints. Central to the use of this concept is the sharing of 
information and knowledge between the recipient and the provider of health services 
(Mullen, 1997). DOT has been criticized for moving away from promoted adherence- 
and concordance models of communication to the more traditional medical approach in 
which patients remain passive recipients of treatment. A consequence of this is that 
patients may feel forced or pushed to follow medical rules or advice, and might not 
adhere to the proposed treatment even if they do “comply” at certain or all stages. Some 
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of the supporters of DOT have argued that the effect of an intervention, such as DOT, is 
meant to go beyond the observation of medication intake, and that the use of the concept 
concordance would be a step in the right direction. By emphasizing an agreement 
between the patient and the health care workers, about whether, when, and how 
medicines are to be taken, one will, to a greater extent, promote the protection of civil 
rights and patient autonomy (Maher, Uplekar, Blanc, & Raviglione, 2003).  
 Another important and complicating issue in the debate about diagnostic 
delay and treatment compliance as the main barriers in TB control is that both 
health conditions and the delivery of health-care vary in developing countries. In 
these countries, where a large part of the population have only recently been given 
access to modern medical care, availability, accessibility, costs for patients, and 
the quality of care are all factors that may be barriers. These barriers may make it 
impossible to render or make it impractical to access and adhere to medical 
regimens, even in places were the knowledge of TB is good and the patients are 
highly motivated to seek care within the formal biomedical system. Some of these 
issues are also highly relevant in western societies. An important early study 
(Curry, 1968) in San Francisco, California, demonstrates this. Health workers 
attributed barriers to continuation of TB treatment to social and cultural 
characteristics of the patients such as lack of education, ignorance, old age, 
alcoholism and language problems. Patients on the other hand ascribed treatment 
irregularity and dropouts to problems with the organization of care and the 
interaction with the health workers. Among the barriers described by the patients 
were  rigid, repeating and time-consuming routines, lack of continuity among the 
physicians, not treating families as a unit, lack of adequate explanations related to 
the diagnosis and treatment of TB, punitive staff practices, prolonged waiting in 
overcrowded rooms, and inconvenient times and place for appointments. When 
clinical staff became aware of these viewpoints the treatment services were re-
organized and missed appointment rates fell from 26 % to 4 % in 6 years (Curry, 
1968).  
 Paul Farmer (1997), a physician and anthropologist, has argued that compliance 
is a problematic concept because it assumes that all patients are equally able to comply 
with anti-tuberculosis therapy. He argues that the focus on patients’ agency is 
exaggerated, particularly in the biomedical literature. According to Farmer, it is social 
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scientists that have insisted on the causal role of culture or personal traits when 
explaining treatment interruptions. Famer argues that such studies have failed to 
recognize the wider influences on patients’ lives such as poverty, conflicts, political 
instability, racial and gender inequalities. Treatment of TB patients needs measures that 
recognize how wider structural forces limit patients’ ability to access, maintain and 
complete therapy. This point is underlined in Farmers’ well-known quote:  “Throughout 
the world, those least likely to comply are those least able to comply…” (Farmer, 1997, 
p. 353). Farmer emphasizes that a large proportion of the patients with TB world-wide 
go undetected because of a lack of access to medical facilities, or having difficulties in 
making regular clinic appointments. Studies suggest that many of the therapy 
interruptions are due to failures or poor treatment imposed by health care workers or the 
health care system. Health workers may not comply with proper prescribing practices 
(e.g. provide suboptimal dosage, mono-therapy). Patients may be exposed to arrogant, 
humiliating or patronizing behavior. Poor communication or poor follow-up can lead to 
misunderstandings and subsequent interruptions. Treatment interruptions are often 
caused by an interrupted supply of drugs, or by demands set by the system causing 
social, practical and economic costs impossible to manage by patients. Thus, the issue of 
“compliance”, and the growth of multi-drug resistant TB, cannot be reduced to a 
discussion of different categories of patients and their degree of co-operation with health 
workers (Farmer, 1997; Gandy & Zumla, 2002).  
In 2005, 187 countries had implemented DOTS (WHO, 2005). A global 
application of DOT, to ensure patient compliance with treatment, has been 
promoted and transferred to a variety of other social, economic and cultural 
contexts. How do people living with TB in different parts of the world perceive 
and manage their symptoms and treatment in the era of DOT? Are there particular 
barriers or enablers associated with disparity in accessible resources? Are patients 
being treated by DOT in low-endemic settings experiencing barriers similar to 
those experienced in high-endemic settings? How do health personnel from 
different parts of the world interpret and manage TB treatment? Few studies have 
been conducted in low-endemic, high-income settings. By exploring views and 
experiences in a high-endemic, low-income setting versus a low-endemic, high-
income setting we may identify factors that serve as common challenges and 
potential solutions.   
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1.6  Case one: Addis Ababa, Ethiopia 
In 2001-2002, Addis Ababa had about 95 % coverage of DOTS in existing governmental 
health facilities. TB treatment involved daily clinic attendance for two months (the 
intensive phase), followed by a period of six months during which medicines were 
collected once or twice a month (the continuation phase). In 2001-2002, there had been 
few studies exploring patients or health workers perception or management of TB in 
Addis Ababa, Ethiopia. One study examining ethno-medical knowledge and practices 
related to TB in a rural community in southern Ethiopia, found that the 
symptomatological concepts coincided with biomedicine, while local explanatory 
models referred to causal factors unrelated to the TB bacilli (Vecchiato, 1997). A 
quantitative study in Addis Ababa found that diagnostic delay was associated with 
patients’ inadequate knowledge of TB symptoms and treatment (Demissie et al., 2002). 
Another quantitative study in Addis Ababa, conducted before the implementation of 
DOTS, found “social problems” and “feeling of improvement” to be important causes of 
treatment interruption (Demissie & Kebede, 1994). Quantitative studies from rural areas 
(conducted both before and after our study) have suggested that between 6 % and 20 % 
of patients interrupted treatment due to long distances to the health facilities, poor 
awareness about the disease and the treatment length, side effects, and lack of family 
support (Getahun & Aragaw, 2001; Michael, Belachew, & Jira, 2004; Shargie & 
Lindtjorn, 2007; Tekle, Mariam, & Ali, 2002).  Studies conducted both before and after 
our study found that most TB patients interrupt in their third or forth month of the 
treatment (Demissie & Kebede, 1994; Tekle et al., 2002; Shargie & Lindtjorn, 2007).  
To our knowledge, the studies on diagnostic delay and treatment interruption in 
Ethiopia have not been explored further in qualitative research. In general, few studies 
have used qualitative methods to explore TB patients’ or health workers’ views and 
experiences during different phases of the disease and the long treatment regimen. On 
the basis of the existing knowledge at the time of our study we found a need to explore, 
in-depth, how patients and health workers perceived TB and the related treatment. There 
was a need to explore the meaning of what seemed to be important quantitative variables 
(such as “social support”), how different variables were interrelated, and how and at 
what time in the treatment regimen they had a decisive influence. The WHO (2003, 
p.129) has emphasized that an important research area is identifying time points in the 
treatment that are of importance for different types of adherence strategy. 
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1.7  Case two: Oslo/Akershus, Norway 
In Norway, new regulations for TB control were introduced in 2002, and the 
corresponding national guidelines introduced five components similar to the 
components of the WHO’s DOTS strategy. DOT was implemented as a principle 
in 2003, and is to be used in all patient cases without prior selective appraisement. 
Knowledge regarding patients’ and health workers’ perception and management of 
TB in low-endemic countries is limited. Most studies on diagnostic delay and 
treatment adherence have been conducted in high-endemic countries. The only 
qualitative study on diagnostic delay from a low-endemic society (Wales) 
concluded that general practitioners (GPs) are important in diagnosing TB. Low 
clinical suspicion, lack of continuity of patient care, time constraints, suboptimal 
communication between the doctor and the patients, combined with atypical 
presentation could cause diagnostic delay (Metcalf, Davies, Wood, & Butler, 
2007). Some studies have tried to understand management (adherence) of 
treatment by examining patients’ and health workers’ experience with DOT in 
low-endemic countries. One study, from New York, examining patient satisfaction 
with the DOT program, found that even if provision of enablers and incentives 
were given only about half of the patients expressed positive views. Those that 
were positive emphasized the supportiveness from the staff, describing them as 
“caring” and “wanting to help”; indicating the importance of personal involvement 
by staff members (Davidson, Smirnoff, Klein, & Burdick, 1999). A study based on 
interviews with 19 professionals, involved in TB control from various parts of the 
world, found that many of the informants thought that the role of the DOT 
provider should transcend the actual observation of a patient swallowing the 
medication. Participants from high-income settings in particular saw DOT as a 
continuous process of negotiation with emphasis on each patient’s specific needs 
and choices (Macq, Theobald, Dick, & Dembele, 2003).   
 A quantitative study in Norway, based on data from the National TB 
Registry, clinical case notes from hospitals, and referral notes from primary health 
care providers, found a median total delay of 63 days from the onset of symptoms 
to initiation of TB treatment (Farah et al., 2006). The delay was primarily 
attributed to doctors not initiating TB specific examinations despite symptoms 
suggesting TB (Farah et al., 2006). There was little information about the causes of 
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patient delay. Another study from Norway showed that the total treatment result 
for 1996-2002 was slightly below the WHO’s defined target (85 %). Of 655 
patients treated for TB the total treatment success was 83 %. 22 patients (3 %) 
interrupted treatment, 58 patients (9 %) died and 26 (4 %) were expelled or moved 
out of the country (Farah et al., 2005). The latest published treatment results are 
from 2004 and show a completion rate of 86 %. Of 302 patients reported with TB 
in 2004, 10 (3, 3 %) interrupted treatment and 6 (2 %) patients left the country. Of 
194 patients with lung TB, 84 % completed treatment, which is similar to previous 
years (Winje, Brantsæter, Heldal, & von der Lippe, 2006a). In 2005, the 
Norwegian Directorate of Immigration, in cooperation with Norwegian health 
authorities, decided that asylum seekers diagnosed with TB are not to be sent out 
of the country as long as they are treated for TB. Thus, a structural barrier to TB 
treatment may have been eliminated.  
There has been no qualitative study exploring perception and management 
of TB symptoms, or perception and management of TB treatment, neither in the 
pre- or post DOT(S) era in Norway. On the basis of the existing knowledge we set 
out to explore patients’ experiences with the diagnostic process, and patients’ and 
health workers views’ and experiences in relation to the practice of DOT.  
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2.  Aims of the study 
The overall aim of the study is to explore how patients and health professionals perceive 
and manage TB symptoms and treatment in a high-endemic and a low-endemic setting, 
with the specific aims to:  
• Explore how symptoms of TB are perceived and managed from the onset of 
symptoms and during the course of treatment in Addis Ababa, Ethiopia. 
• Explore enablers and barriers in the management of TB treatment during the first 
five months of treatment in Addis Ababa, Ethiopia.  
• Explore experiences of being diagnosed with TB among African immigrants in 
Norway, with a view to factors associated with diagnostic delay. 
• Explore patients’ and health workers’ views and experiences with TB treatment 
(DOT) in Norway.  
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3.  Material and Methods 
3.1  Ethiopia - country profile 
Ethiopia is located on the Horn of Africa. The country constitutes a total surface area of 
1.1 million square kilometers. The population in 2006 was estimated to be about 81 
million, and consists of different ethnic groups (WHO, 2009d). The Oromo (32 per cent) 
and Amhara (30 per cent) are the largest ethnic groups, followed by the Tigre (6 per 
cent), Somali (6 per cent), Southern ethnic groups (10 per cent), and other smaller ethnic 
groups (16 per cent). The languages spoken include Amharic, Tigrinya, Oromigna, 
different Southern languages, Somali, Arabic, local dialects and English. English is the 
major foreign language taught in schools. 45 per cent of the population is Orthodox 
Christian, 40 per cent are Muslim, 10 per cent are Protestants, 4 per cent are animists, 
and 1 per cent follow other religions. The major industries are agriculture and animal 
husbandry (80 per cent), government and services, and industry and construction. 
Ethiopia is one of the poorest countries in the world, and was ranked 171 out of 182 
countries in the Human Development Report 2009 (United Nations Development 
Programmes [UNDP], 2009). Life expectancy at birth m/f (years) is 55/58.  In 2006, the 
total expenditure on health per capita was (Intl $, 2006): 22 (WHO 2009d). Recurring 
droughts, environmental degradation, insecurity related to conflict, poor access to health 
services, and persistent price hikes for staple foods make Ethiopia constantly vulnerable 
to nutritional and health crises.   
3.2  Norway - country profile 
Norway is located in northern Europe. The country constitutes a total surface area of 
385,155 square kilometers. Per 2006, the population consisted of approximately 4.7 
million people, the population density being one of the lowest in Europe (WHO, 2009e). 
Among ethnic Norwegians 90 per cent are considered Christian (Evangelical Lutheran), 
and the language spoken is either Bokmål (influenced by Danish) or Nynorsk (new 
Norwegian). Sami, spoken by an ethnic minority group, is also an official language in 
some districts. The major industries are oil and gas, fisheries, manufactured goods, 
machinery and transport. Immigrants and Norwegians-born to immigrant parents 
constituted nearly 508 200 persons (10.6 per cent) of Norway’s population in 2009. 
Additionally, 230 000 persons have one Norwegian and one foreign-born parent. Most 
immigrants and Norwegians-born to immigrant parents live in Oslo (relative and 
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absolute figures). According to Statistics Norway [SSB] (2010a), 152 100 (25 %) of 
Oslo’s 575 500 inhabitants were immigrants or Norwegians-born to immigrant parents 
in 2009. The largest immigrant groups are from Poland, Pakistan, Sweden, Iraq, 
Somalia, and Germany. Between 1990 and 2008, 377 000 non-Nordic citizens were 
granted residence in Norway. Of these, 24 % came as refugees, 24 % came as labor 
immigrants and 11 % came in order to undertake education. A large group (23 %) came 
to Norway due to family reunification, and 17 % were granted residence because they 
had established a family in Norway (SSB, 2010b). People from Somalia and people from 
Ethiopia are among the groups that have the shortest residence in Norway (SSB, 2007; 
SSB, 2010c). There were almost no Ethiopians in Norway before 1985 (SSB, 2007). The 
first refugees from Somalia came in mid-1980. After the dissolution of the Somali state 
in 1991, the number of refugees from Somalia has increased (SSB, 2010c). The structure 
of these two population groups is typical of those with short residence; a majority is 
refugees; many are young adults, and the majority is men (SSB, 2007, SSB, 2010c). 
Norway is one of the richest countries in the world, and ranked first in the Human 
Development Report 2009 (UNDP, 2009). Life expectancy at birth m/f (years) is 78/83. 
Figures from 2006 show that the total expenditure on health per capita was (Intl $): 
4,521 (WHO, 2009e). The public sector is the main source of health funding in Norway. 
In 2005, about 84 per cent of health spending was funded by public sources (SSB, 2006).  
3.3  Theoretical frameworks  
The study was initially theoretically influenced by behavioral sociologist Howard 
Becker’s work. Becker has reviewed models and theories seeking to explain 
individuals’ adherence to medical treatment. He found that different theories and 
models converge on many of the same elements. In general, these theories and 
models conclude that there will be some predisposing factors that together with 
certain enabling and supportive factors will lead patients in different directions 
when making choices about treatment (Becker & Maiman,1975; Becker,1990, p. 
5-37). Predisposing factors include (among others) health beliefs and attitudes 
towards the disease, the related treatment, and the health services. These health 
beliefs include both general health beliefs (as concern about health matters in 
general, willingness to seek and accept a certain medical direction) and specific 
health beliefs (as perceived susceptibility to the disease, belief in diagnosis, 
perceived severity of the condition). Following Becker, these factors in isolation 
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will seldom be directly responsible for the continuous use of health services, but 
may influence how motivated patients are for initiating and completing a long 
treatment-regimen. The same factors can also indicate what type of information 
and support is needed from health personnel. However, as emphasized by Becker, 
even though some patients are predisposed to use certain health services, some 
means must enable them to do so. Enabling factors such as availability of relevant 
health services, and factors related to accessibility; use of time, use of money for 
transport or treatment, long waiting hours, loss of possibility to work, difficult 
appointment-times or poor treatment by health personnel are decisive factors. 
Perceptions or experiences of social, psychological, physical or economic costs of 
the recommended behavior will, through initiation of treatment to its completion, 
be influential. This influence can be modified through support from health 
personnel, family, friends, and in some cases the neighborhood. This is particularly 
relevant if the disease is stigmatizing in nature. Social support or social pressure 
can also stimulate certain behavior in cases where the diseased person is not ready 
to take appropriate health action.  
  Following Becker and Maiman (1975), and Becker (1990), and the Health Belief 
Model (HBM), the amount of health services being utilized by a person will be a 
function of the predisposing, enabling and supportive factors present over time. The 
combination of different factors will continuously be interpreted and evaluated and the 
“sum” of perceived negative and positive aspects of treatment may lead a patient in 
different directions, making different choices, in different stages of treatment.  
Becker’s synthesized perspective views health behavior change as a rational 
appraisal of barriers and benefits associated with action. The assumption that individuals 
behave in such a rational or conscious way is the source of one, of several, critiques of 
his perspective. Another objection is that the relationship between the described 
variables is unclear; there are no definitions of the individual components and no 
formulation of rules regarding combinations. It is assumed that the different variables 
are not moderated by each other and that they have an additive effect (Munro et al., 
2007b). The HBM has also been criticized for a lack of evidence to support the belief-
behavior relationship, and that it has too much focus on individual factors compared to 
socio-economic and environmental factors. It has been suggested that the model 
encourages victim blaming because of its strong focus on the individual’s part in 
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determining behavior (Roden, 2004). In a review of health behavior theories and their 
usefulness in promoting long-term medication adherence for TB and HIV/AIDS, the 
authors, Munro et al., conclude that there is little empirical evidence on the effectiveness 
of different theories in promoting adherence (Munro et al., 2007b). However, they 
suggest that several models and theories have the potential to contribute to our 
understanding of adherence behavior. The authors encourage future research that will 
build on theories, and that to a further extent include issues over which individuals have 
no control. Another point being raised by the authors is the need to identify theories of 
health behavior change that are suited to explain adherence to long-term medication. 
Even though Becker has been criticized for a lack of focus on structural barriers, we 
have read and used Becker in the sense that we interpreted the term “enabling” factors as 
including a focus on structural barriers such as lack of availability and accessibility of 
relevant health services. There are several components within the HBM, and in 1990 
Becker added the concept “self-efficacy”, which involves expectancies of performing a 
specific behavior in a specific situation. Our study is particularly inspired by the 
components that concern perceived vulnerability to and severity of the disease as well as 
perceived benefits and costs of treatment.      
 This study was also inspired by Christensen-Szalanski and Northcrafts’ 
(1985), suggested effect of time per se on adherence behavior. Christensen-
Szalanski and Northcraft argue that treatment adherence is a dynamic process in 
which costs and benefits accrue at different rates over time. They claim that 
models commonly used to explain adherence-behavior, such as the HBM, have not 
taken into account the passage of time as a factor that can modify perceptions of 
costs and benefits associated with treatment compliance. Christensen-Szalanski 
and Northcraft point to the importance of understanding patients’ temporal 
perception of costs and benefits, and how temporal perceptions may be influenced 
by delayed benefits and accrued costs. Within this theoretical scenario, a decision 
of interrupting treatment, which may seem incomprehensible, may have been 
shaped by past struggles and accrued cost. Therefore, these decisions should not 
necessarily be understood as a response to an immediate change.  
 Kleinman’s (1980) conceptual division of health care systems has also 
influenced this study. According to Kleinman (1980, p.50-70), health care systems 
consist of three partly overlapping sectors: the popular sector (individual, family 
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and community beliefs and activities), the professional sector (the organized and 
institutional parts of health care) and the folk sector (sacred or secular types of folk 
medicine). Kleinman (1980) conceptualizes illness and disease as socially 
constructed “explanatory models” which represent patterns of thoughts that 
provide answers to questions regarding etiology, symptoms, cause, course and 
treatment. Thus, the health care system includes people’s beliefs and their 
behaviors, in which to a great extent are governed by cultural rules (Kleinman, 
1980, p.26). According to Kleinman, the beliefs and behaviors that constitute the 
different activities are influenced by particular social institutions (e.g. clinics), 
social roles (e.g. sick-role, healing role), interpersonal relationships (e.g. doctor-
patient relationships, social network relationships), interaction settings (e.g. 
doctors office), economic and political constraints (accessibility, availability) and a 
number of other factors. Illnesses and their variety of responses form different 
components of the health care system, and are systematically interconnected 
(Kleinman, 1980, p.26). Kleinman uses the term “clinical reality” to describe “the 
beliefs, expectations, norms, behaviors, and communicative transactions associated 
with sickness, health care seeking, practitioner-patient relationships, therapeutic 
activities, and evaluations of outcomes” (Kleinman, 1980, p.42). The “social 
reality” is the part of reality that expresses different clinical phenomenon, but this 
part of the reality is itself constructed by the clinical reality (Kleinman, 1980, 
p.42). 
 Individuals, as well as the various agents in the three sectors of the health 
care systems, may perceive and explain similar symptoms differently. In many 
cases explanatory frameworks may overlap. Research suggests that models that are 
traditionally invoked in the popular or folk sector may also prevail in the 
professional biomedical sector (Helman, 1978; Scheper-Hughes, 1988). Further, 
an illness may inspire different explanatory models as symptoms develop over 
time or as a response to separate approaches towards the treatment of symptoms 
and the treatment of cause (Good, 1994; Robinson, 1990). Both Kleinman (1980) 
and Good’s work (1994) represent the “meaning-centered approach” in medical 
anthropology. Kleinman (1997) has criticized his own concept (explanatory 
models) for neglecting the dimension of suffering. He points to the importance of 
acknowledging social suffering as a dimension that includes the consequences of 
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war, famine, depression, disease, suppression, and torture – all factors resulting 
from political, economic and institutional power (Kleinman, Das, & Lock, 1997). 
 This study has also been influenced by Paul Farmers work and ideas (1997; 
1999). In the same way people try to adapt to their lived world within given 
socioeconomic incentives and constraints, they will adapt and rationalize behavior 
related to the medical sphere. To be able to understand more about people’s 
movements within the different parts of the health care system, structural barriers, 
and how such barriers limit patients’ ability to access, maintain and complete 
therapy, need to be explored.   
 The study has, in its later stages, also been influenced by Foucault (1975), and 
his perspectives on how infectious diseases are being managed. Foucault argues that the 
idea of keeping everything within the borders of what is “normal” is a driving force in 
modern societies. The primary function of modern disciplinary systems is to correct 
abnormality by regulating behavior. Infectious diseases may induce fear of chaos in the 
population, and this fear is managed by imposing discipline and order. A society may 
respond to an abnormality, like an infectious disease, by declaring a “state of 
emergency” with subsequent restrictions or withdrawals of individual rights. In public 
health discourse, members of the middle class have historically been portrayed as 
possessing the valued qualities of self-denial and self-efficacy, while individuals from 
the working class are seen as lazy, dirty, immoral and incapable of resisting their urges. 
Disciplinary measures to impose order have subsequently, first of all, been directed 
toward less-privileged members of society (Foucault, 1975; Lupton, 1995; Coker, 2000).  
3.4  Addis Ababa: Participants and study design  
The empirical data in this part of the study were generated in semi-structured 
interviews and focus groups in October 2001 and March 2002, with a sample of 
participants diagnosed with TB, their relatives and a group of health personnel. A 
sample of 32 respondents; 23 TB patients, five health personnel and four relatives 
were recruited for in-depth interviews. We recruited an additional 11 participants 
for focus group discussions. Four of these had previously attended an in-depth 
interview. We included TB patients who were attending TB treatment and TB 
patients who had interrupted TB treatment. Since the study initially sought to 
explore reasons for non-adherence we considered to include only patients that had 
45 
 
interrupted treatment. However, we decided that only including patients that had 
interrupted treatment could result in a response bias. Patients that have defaulted 
from treatment might fear being labeled or stigmatized, and provide answers 
focusing on defending or “rationalizing” their actions. Additionally, data obtained 
about previous decisions and events may be influenced by recall bias. By including 
a group of regular TB patients, and following them over time, we sought to reveal 
what types of enablers and barriers were important during treatment, and in what 
way the identified factors interacted in different stages of treatment. We recruited 
10 newly diagnosed TB patients, five men and five women, aged 18 to 67 years, 
on the basis of a purposeful sampling strategy in which we sought to ensure 
variation related to educational background, gender and age (table 1). The 
participants belonged to different ethnic groups, but almost all were Orthodox 
Christians (one Muslim, one Catholic). All 10 participants had been diagnosed 
with pulmonary TB. Potential participants were approached with written 
information about the study by nurses at Woreda 23 Health Clinic; a centre for TB 
diagnosis and treatment. Two patients declined to participate because they were 
too ill.  
 We recruited 11 TB patients, six men and five women, aged 20 to 60 years, 
which had interrupted treatment. Seven of these participants had been diagnosed with 
pulmonary TB and four had been diagnosed with extra-pulmonary TB (table 1). There 
were difficulties with tracing patients who had interrupted treatment, due to lack of, or 
incorrect, addresses. St Peter’s TB Specialized Hospital Outpatient Service, a hospital 
which offered diagnostic and treatment services, and Kebele 16 Health Post, which 
provided TB treatment but was without diagnostic facilities, were included for the 
purpose of recruiting patients who had interrupted treatment. The three research sites 
where chosen based on advice from local researchers at Armauer Hansen’s Research 
Institute (AHRI) and from the WHO’s TB/Leprosy advisor at the Ministry of Health in 
Ethiopia. The sites were considered to be “typical” DOT clinics, but they were also 
chosen because they represented diversity being located in different areas of the city. We 
traced 11 patients that had been on treatment for at least two weeks, and had interrupted 
treatment for more than six consecutive weeks at the time of contact. All eleven patients 
agreed to participate in the study. The National Tuberculosis and Leprosy Control 
Program (NTLCP) restricts its definition of defaulters to patients who have attended 
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treatment for at least four weeks and have been absent for at least eight consecutive 
weeks or for a cumulative period of 12 weeks. (The definition of a defaulter, used by the 
WHO, is a patient whose treatment was interrupted for 2 consecutive months or more. 
(WHO, 2007). We considered that the strict use of the NTLCP’s definition would 
exclude the experiences of patients that, due to unknown reasons, had interrupted 
treatment within the first four weeks. By including patients from this group we were able 
to explore these patients’ experiences. Some of our participating patients in this group do 
thus not meet the formal definition of a defaulter as set by the NTLCP.  
  
To investigate treatment adherence from perspectives other than the patients, we 
included other groups of informants. Two relatives of patients that had died or 
were terminal after interrupting treatment, and two relatives that escorted severely 
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ill patients to the clinic daily, were interviewed. Two TB patients on re-treatment 
were also interviewed. In-depth interviews were additionally conducted with two 
nurses and one doctor from Woreda 23 Health Centre, one nurse from Kebele 16 
Health Post and one nurse from St Peter's TB Specialized Hospital Outpatient 
Service. These individuals were recruited because they were managing TB patients 
on a full-time basis in the same clinics where we had recruited patients.  
 At the end of the study we recruited TB patients undergoing TB treatment 
for focus group discussions. Focus group participants were recruited by the first 
author and the research assistant from all three clinics. Patients with different 
educational backgrounds were chosen, yet with adjustments to personal features 
and the group composition as a whole. One group consisted of five female TB 
patients, the other of six male TB patients. Two patients in each group were 
patients that had been interviewed earlier. These participants were considered to be 
particularly valuable informants in the sense that they had provided balanced and 
many-faceted perspectives.  
3.4.1 Interviews  
The interviews were conducted during the period from October 2001 until March 2002. 
10 TB patients that were attending treatment were interviewed three times over a period 
of five months. The first in-depth interview was conducted two weeks after diagnosis, 
the second interview two months later and the third interview five months into treatment. 
All patients, except one who died, participated in all three interviews. A single 
individual in-depth interview was conducted with each of the 11 patients who had 
interrupted treatment. All interviews took place at locations chosen by the patients, such 
as in a closed room in the clinic area, the patients’ homes, and in one case in the home of 
the researcher. The questions and answers were translated from English to Amharic or 
Oromo and vice versa by a local research assistant/interpreter that participated in all the 
interviews. The interviews lasted from two to three hours, the length being influenced by 
the continuous translation as well as minor discussions between the research assistant 
and the researcher about the meaning of different words and statements and how to 
proceed with the interview. My interview approach was inspired by Kvale’s principles 
for qualitative research interviewing (Kvale, 1996, p.131-135). I used various strategies 
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and types of questions to structure the interview, such as introducing questions, follow-
up questions, probing questions, specifying questions, and interpreting questions.  
My point of departure was an interview guide that was developed as a result of a 
thorough literature review. The interview guide also drew inspiration from Becker’s 
review (Becker & Maiman,1975; Becker,1990) to find factors associated with 
adherence, and Kleinman’s (1980) theories on the use of different health care systems. 
The development of the interview guide also drew on Christensen-Szalanski and 
Northcrafts’ (1985) suggested effect of time per se on adherence behavior. Lastly, the 
interview guide drew inspiration from a debate in the research community, in particular 
between Barnhoorn and Farmer (Barnhoorn & van der Gest, 1997; Farmer, 1997), about 
which factors were most relevant in understanding the phenomenon “non-compliance”. 
The discussion centered on to what degree themes related to patients’ “health beliefs” 
were important in understanding non-compliance. Farmer argued that these approaches 
are overemphasized and that studies fail to recognize the wider influences on patients’ 
lives such as poverty, conflict, political instability, racial and gender inequalities, all 
factors beyond the control of the individual.  
We decided to develop the interview guide as a response to all main 
perspectives identified in the literature, and it was structured to cover four broad 
themes: 1) Symptom understanding/understanding of own vulnerability, and health 
related behaviour; 2) Interaction with health personnel; 3) Social support factors 
and; 4) Structural/socio-economic barriers (Appendix A; Appendix B).  
Many of the questions in the guide were influenced by the interview guide 
used by Barnhoorn and Adriaanse’s (1992) in their study: “In search of factors 
responsible for noncompliance among tuberculosis patients in Wardha District, 
India”, which at that time was available on the internet. The aim was to explore 
which factors were more important from the patients’ view, in what way different 
factors were interrelated, and whether the influence and interrelation of different 
factors changed during treatment. Questions in the interview guide were open-
ended and developed to enable patients to respond to introductory questions 
related to all the main themes. Several suggested follow-up questions and probing 
questions were included. After each interview emerging themes and hypotheses 
from earlier interviews were included and explored in subsequent interviews. In 
the interview-guide used for the patients that were interviewed three times, each 
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interview generated personal questions that were to be pursued in the second and 
third interview.   
  The interviews conducted with the patients that had interrupted treatment 
gradually took a narrative form. The narrative method was used because we found that 
allowing people to tell their stories gave us more insight into the cultural framework 
within which the participants made sense of their actions. By the use of a narrative 
approach we experienced that we allowed the participants to set the agenda, to select the 
aspects that were important to them; and to order these aspects, in their own language, 
into a non-fragmented whole (Elliot, 2005, p.1-36). We began with an open question 
asking the patient to describe the period when s/he first felt ill, and if the answer 
spontaneously took form as a story we sought not to interrupt. Narrative probing was 
used when narrative fragments were unclear or not exhausted. The interview guide was 
used to check that topics where covered, sometimes leading to the inclusions of specific 
questions at the end of the interview. Patients who attended treatment and patients who 
had interrupted treatment were in general interviewed about the same themes. Part of the 
validation process involved identifying intersects between findings in the different 
groups. The interview guide that was used in the interviews with health personnel was 
based on the same themes as the interview guide used for patients (Appendix C). It was 
designed as a thematic guide and sought to explore health workers’ views and 
experiences on topics such as barriers and enablers faced by TB patients.    
3.4.2 Focus groups 
Two focus groups with TB patients undergoing treatment were arranged after the in-
depth interviews were completed. The focus group discussions lasted for about two 
hours, and were held in a room in one of the clinics. The focus groups were moderated 
by the research assistant, who was trained in focus group techniques and in qualitative 
methodology. The development of focus group questions was a result of a thorough 
review of all the earlier collected material. The first author was present and introduced 
topics related to common, discrepant or particularly interesting findings from the in-
depth interviews for further exploration and validation. The research assistant had been 
involved in all stages of the research; enabling him to improvise; introduce new 
questions or adjust to subjects as they were raised. Notes were taken, and the discussions 
were tape-recorded and transcribed.  
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3.4.3 Observations 
Observation was not formally included as part of the methodology and not described in 
the methodology section in either of the papers from Ethiopia. However, I gained 
valuable insight into communication and interaction patterns between health workers 
and patients due to considerable time observing at the clinics. The observations were not 
planned, but took place while sitting on a bench in the clinic area waiting to meet a 
patient, health personnel or my research assistant that was often late due to unpredictable 
public transport schedules. The DOT procedure was conducted either outside or partly 
outside the clinics (patients moving in and out of an open door) and the interaction 
between the nurses and the patients were easily observed. Interaction and behavioral 
patterns described by the patients that were attending daily treatment were often 
illustrated and confirmed during these observations. When my research assistant was 
present we would discuss and negotiate what we saw and he provided valuable insight 
into the non-verbal language in the light of the specific cultural context.  
3.5  Oslo/Akershus: Participants and study design  
The empirical data in this part of the study were generated in semi-structured interviews 
with a sample of 42 participants, of which 22 were TB patients and 20 were health 
personnel working with TB patients. Data collection took place between June 1st 2007 
and June 30th 2008 in the city of Oslo, and the surrounding county of Akershus, in 
Norway. Participants were recruited through the primary health care services and from 
six hospitals: Ullevål University Hospital, Aker University Hospital, Akershus 
University Hospital, Asker and Bærum Hospital, and Lovisenberg Diakonale Hospital. 
Written information was sent to hospitals in Oslo/Akershus and a variety of primary 
health care districts. Health personnel in leading positions were subsequently contacted 
by the first author by phone, in order to come into contact with doctors or nurses in key 
positions. Some of the health personnel were recruited by snowball sampling, as 
participants were asked to identify potential participants who could provide relevant 
information. The final sample of health personnel consisted of eight men and twelve 
women, of whom eight were doctors (specialists in either lung diseases or infectious 
diseases), five were TB coordinators, two were community nurses, and five were nurses 
from home based services. Some of the TB coordinators and nurses that were recruited 
later helped us in informing and recruiting patients. We recruited a purposeful sample of 
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10 male and 12 female TB patients, aged 19-42, who originated from Somalia and 
Ethiopia (table 2). 
Table 2.  Characteristics of patients (n = 22) 
 
The decision to include respondents who were born in these countries was based on the 
epidemiological situation when the study was planned. Data from the Norwegian 
Surveillance System for Communicable Diseases (MSIS) showed that the number of 
reported TB cases in 2005 and 2006 were highest among people who originated from 
Somalia and Ethiopia (Winje et al., 2006b; Winje et al., 2007). We therefore considered 
these groups to be of particular interest to policymakers and health professionals. It was 
also of interest to compare perceptions and experiences within the same group 
(Ethiopians) in two very different contexts.  
The participants that were recruited had all been notified to one of the local TB 
coordinators, after they had been diagnosed in a hospital and TB treatment had been 
initiated. During the data collection period, a total of 10 persons originating from 
Ethiopia and a total of 30 persons originating from Somalia were diagnosed with TB in 
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Oslo/Akershus. Each time a new TB patient from Somalia and Ethiopia was notified, the 
TB coordinator or nurse would inform me (MS). We recruited 22 participants on the 
basis of a purposeful sampling strategy in which we sought to ensure variation related to 
educational background, gender and age. Potential participants were approached with 
written information about the study by a TB coordinator or a nurse. Participants then 
contacted the researcher by phone, or the researcher contacted patients if they had given 
their consent. Two patients declined to participate stating they did not want to share their 
experiences with those other than family. The sample size of 22 patients was a result of 
saturation in the data, as we found that additional interviews yielded little new 
information. Most of the participants from Ethiopia were Orthodox Christians, and all 
the participants from Somalia were Muslim. The duration of stay in Norway varied from 
six months to 16 years (mean stay was seven years). Half of the participants (11 patients) 
had been diagnosed with pulmonary TB and the other half (11 patients) with extra-
pulmonary TB. At the time of the interviews, 16 patients were undergoing TB treatment. 
Five patients had recently completed treatment. One patient had interrupted treatment. 
All participants gave their written consent to participate in the study. 
3.5.1 Interviews  
The interviews took place between June 1st 2007 and June 30th 2008. All the in-depth 
interviews were carried out by me (MS). The patient interviews lasted from one to three 
hours and were tape-recorded. They took place in locations chosen by the patient, such 
as in the patient’s home or in a suitable room in one of the university buildings. Most 
interviews were conducted in Norwegian. Some interviews with patients were conducted 
in English, depending on the patients’ language skills and preferences. One patient was 
interviewed with the assistance of an interpreter. Eight patients were interviewed twice, 
in order to assess whether their perspectives or experiences had changed throughout 
treatment, and to explore themes that appeared to be unclear or ambiguous. The health 
personnel interviews lasted from one to two hours and were tape-recorded. They took 
place either at the locality where the participant worked or in a room in one of the 
university buildings.  
 My interview approach was inspired by Kvale’s principles for qualitative 
research interviewing (Kvale 1996, p.131-135). I used various strategies and types of 
questions to structure the interview, such as introducing questions, follow-up questions, 
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probing questions, indirect questions, silence, and interpreting questions. My point of 
departure was an interview guide that was developed as a result of a thorough literature 
review and experiences, inspiration sources and findings in previous research (paper I 
and paper II). The interview guide for patients covered five major themes: (1) Symptom 
understanding/understanding of own vulnerability, and health related behavior; (2) 
interaction with health personnel; experiences related to the diagnostic process; (3) 
information and understanding of the disease; 4) social support factors and 5) 
perceptions and experiences related to treatment (DOT) (Appendix D). Questions in the 
interview guides were broad and open-ended and formulated with the intention to enable 
participants to describe and emphasize what they considered to be significant. I did not 
follow the interview guide strictly, but aimed at creating an atmosphere where the 
participants were encouraged to talk freely about their views and experiences. In some 
interviews participants started to answer the first question (“Can you tell me about the 
period when you first felt ill?”) by telling their stories, and whenever a participant 
preferred to express himself trough a full story s/he would rarely be interrupted. 
Structuring questions were sometimes used to interrupt long reflections on parts that 
were irrelevant to the topic of the investigation (Kvale, 1996, p.134). The interview 
guide was used to check that the main topics were covered. In addition, themes that 
emerged during the data collection were systematically written down and explored in 
subsequent interviews. Socio-demographic data was taken at the end of the interview.  
 The interview guide for health personnel covered three broad themes: (1) 
experiences and reflections concerning TB related work and strategies on a system level; 
(2) experiences and reflections concerning TB related work on an individual level; (3) 
reflections concerning ethical aspects of the treatment system (DOT) (Appendix E). 
Even if there were some predetermined themes that were to be covered, the interviews 
with the health personnel often took form as an informal conversational interview 
adjusting to the immediate context and the experiences of the different professions (Ulin, 
Robinson, & Tolley, 2005). Relevant themes that emerged during the data collection 
were systematically written down and explored, when relevant, in subsequent 
interviews. 
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3.6 Differences in sample and methods  
There were differences in the sample and the methods employed in the two cases 
included in this study. In both Ethiopia and Norway we recruited patients through 
health workers. In both studies we included participants from different 
clinics/hospitals and we interviewed both patients and health workers. The total 
sample of participants in the Ethiopian study was 39 (including the new 
participants in the focus groups), while the total number of participants in Norway 
was 42. The number of health workers included from Norway exceeded the 
number of health workers included from Ethiopia. Including a higher number of 
health personnel gave a broader and more thorough exploration of this group’s 
views and experiences. Data provided by health workers became an important 
source of validating and exploring some of the data provided trough the interviews 
with the patients. In Ethiopia, we included different types of participants, such as 
patients’ relatives, and different types of patient groups (patients on regular 
treatment, patients on re-treatment, and patients that had interrupted treatment). 
The inclusion of different participants provided a deep and many-faceted insight 
into the perspectives and experiences expressed by patients. The use of focus 
groups towards the end of the study gave us an opportunity to explore and validate 
important findings even further.  
The most important methodical difference between the two cases is that the 
sample of patients in Norway only included one patient that had interrupted 
treatment. In Ethiopia we managed to include 11 patients that had interrupted 
treatment, and subsequently this group’s experiences were explored more in-depth. 
The Norwegian data provides insight into the burdens of TB treatment, whereas 
the Ethiopian material provides insight into the actual causes of treatment 
interruption. The data provided by the patients that had interrupted treatment were 
to some extent also validated by the data provided by patients that were 
interviewed three times over a period of five months. Each of these interviews 
explored what types of barriers and enablers were perceived as particularly 
relevant in a specific period of treatment. Thus, these data provided insight into 
factors that can help explain adherence to long-term medication.  
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3.7  Interviewer’s role, background and perspectives 
3.7.1 Case one: Addis Ababa, Ethiopia. 
In the interview setting I was particularly conscious to create an atmosphere where 
the participants would be encouraged to speak freely about their views and 
experiences. I presented myself as a “researcher with an interest in how 
tuberculosis patients perceive their disease and the medical treatment”. In the 
consent form I informed participants that I was a nurse and that the study was part 
of a masters degree in international community health at the University of Oslo, 
Norway.  I presented my research assistant as my interpreter and assistant, and 
informed the participants of his background as a sociology student at Addis Ababa 
University. I explained the aim of the study and said that the information they gave 
me could be helpful in improving TB related health services. I intentionally 
emphasized the interest in TB from a social science perspective to remove the 
focus from my role as a health worker and to encourage patients to reflect on their 
disease and treatment beyond a medical perspective. I underlined that the 
information they gave me and my assistant would be treated confidentially. Even 
though I sought to under communicate my role as a health worker, many patients 
asked questions related to the disease and treatment. In such cases I emphasized 
that I was not an expert on the disease or the medication and encouraged them to 
contact a nurse or doctor. In certain cases, such as when patients told me about 
severe side effects, I facilitated direct contact with one of the health workers.   
 On the basis of readings and discussions with local students and researchers 
I learned that there is (for different reasons) a general fear of authority among 
many Ethiopians. Health personnel in particular are highly respected and many 
patients expressed that they did not dare approach a health worker to ask 
questions. In my role as a foreign researcher I decided to communicate the 
differences I represented. For example, when patients greeted me in a very polite 
form (by holding their left arm on upper right arm while bowing) I would great 
them in the same way. Most participants did not seem to expect me to greet them 
this way and many started to laugh when I adapted the same approach. This 
situation gave me the opportunity to explain to them that I was used to greeting 
everyone in the same way, and to consider people as equals. The approach felt 
honest and right and it enabled me to define myself in a way that was different and 
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surprising for the participants. To reduce the distance between myself, the research 
assistant and the participants we were always careful in our non verbal 
communication such as the way we dressed, talked and behaved. Entering the 
clinic by foot or public transport was one such means.  
 Due to the presumed power imbalance in the interview situation, I was 
concerned that participants would seek to tell me what they thought I wanted to 
hear. During the interviews I emphasized that I was interested in their point of 
view. Over time, in particular with the group of participants that were interviewed 
three times, my experiences reassured me that participants felt safe enough to 
express what they felt was important. Those that expressed tension or insecurity in 
the first interview became increasingly relaxed and open throughout the 
subsequent interviews. Even in cases where participants were introduced to direct, 
and to some extent, leading questions, they would often redirect the question, 
argue why, and often answer the opposite of what I expected. Some of the 
participants told us that they had shared issues they had never shared with anyone 
before. Some of the women told us that they were surprised finding themselves 
talking openly to a man (the assistant) about sensitive issues like sexuality.   
 An important reflection, however, is how and to what degree my presence 
influenced the views and behavior of the participants. This is a difficult question to 
answer, because many unknown mechanisms may have been in play. What 
sometimes seemed clear was that the participants, through my questions and 
probes, were introduced to certain values and perspectives, and the relevance of 
these values and perspectives may have been redefined for them. An example of 
this were the questions about when and how patients got information about TB, 
and whether or why they had not asked questions about their disease and 
treatment. Some patients told me in the second or third interview, that as a result of 
the meeting with me, they had approached the health personnel asking some of the 
questions they had wanted to ask for a long time. In this way, not only 
participants’ views may have been affected, but also their behavior.  
 Working with an interpreter was the challenge I was most concerned about 
before entering the field. I systematically worked to prevent errors or biases due to 
misinterpretations or misunderstandings. The interview guide was translated back 
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and forth three times with different results. The final result was a negotiated 
version based on an agreement between the research assistant and myself. Before 
we started the data collection the research assistant and I discussed the protocol, 
relevant literature, and simulated interviews. During this process we thoroughly 
discussed the aim of the study, the questions that were to be answered through the 
study, and important words and concepts that were to be used (internal validity). 
We spent time together in local museums, the university area, and in the city 
surroundings. I was introduced to important historical and political events, cultural 
norms and features, relevant books and articles, all important parts of the context 
in which the data was to be interpreted. As a result of the time we spent together, 
we became increasingly familiar with each others preconceptions, enabling us, to a 
further extent, to understand and contextualize our immediate interpretations and 
responses.  
 My motive for engaging in this research project was an interest in 
understanding more about patients’ and health workers’ views and experiences of 
TB and management of the disease. Malinowski argues that ”preconceived ideas 
are pernicious in any scientific work, but foreshadowed problems are the main 
endowment of the scientific thinker” (Malinowski, 1922, p.8-9). Foreshadowed 
problems are statements of specific research questions or problems that provide a 
focus for the research. Foreshadowed problems help identify what factors to 
consider without specifying anticipated results. My professional background is 
nursing with an academic degree in anthropology, and a master’s degree in 
international health. Due to this diversity, I brought with me a variety of 
preconceptions and “foreshadowed problems”. I was inspired by different works in 
medical anthropology (Kleinman, 1980; Farmer, 1999), social psychology (Becker 
& Maiman, 1975; Becker, 1990), epidemiology (Reichman & Hershfield, 2000) 
and by interdisciplinary approaches to TB (Porter & Grange, 1999). My aim was 
to bridge different perspectives and theories and I assumed that a comprehensive 
understanding could help facilitate a better management of TB patients at the 
clinical, or even the global level. 
My research assistant, a local man aged 22, with a middle-class 
background, holding a bachelor in sociology, also brought with him a variety of 
preconceptions. He was inspired by his sociology studies, knowledge from a recent 
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participation in a local study on HIV/AIDS, and from voluntary work nursing 
patients in public hospitals. He was strongly engaged in the society he lived in, and 
he was a politically active student. It is obvious that his way of understanding the 
society and the culture we were part of influenced me to a great extent. The views 
and experiences that we sought to interpret and understand became a reflected and 
negotiated version of two people’s frames of reference.      
3.7.2 Case two: Oslo/Akershus, Norway 
In this part of the study I was also conscious to create an atmosphere where the 
participants would be encouraged to speak freely about their views and experiences. I 
presented myself as a “researcher with an interest in how tuberculosis patients perceive 
their disease and the long medical treatment”. In the consent form I informed 
participants that I was a nurse and that the study was part of a PhD program at the 
University of Oslo, Norway. I told the participants that I had conducted a similar study 
in Ethiopia. This was a good way of “breaking the ice” when meeting participants from 
Ethiopia. I explained the aim of the study and said that the information they gave me 
could be helpful in improving TB related health services in Norway. As with the 
previous study I intentionally emphasized the interest in TB from a social science 
perspective to remove the focus from my role as a health worker. I underlined that the 
information they gave me would be treated confidentially. Even though I sought not to 
focus on my role as a health worker, some patients asked questions related to the disease 
and treatment. In such cases I emphasized that I was not an expert on the disease or the 
medication, but if I felt able I answered some questions at the end of the interview. 
Otherwise, I encouraged them to contact the TB coordinator or the hospital doctor.  
 I entered the second part of this study with changed preconceptions due to 
the experiences and knowledge gained from the study in Ethiopia. One of the 
insights I brought with me from Ethiopia, was that the implementation and practice 
of DOT involved many challenges for patients. Acquiring this knowledge inspired 
a more nuanced view of the existing TB treatment system, and the analysis of the 
Norwegian data was done with a more critical view than during the first part of the 
study.   
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 3.8  Analysis  
3.8.1 Case one: Addis Ababa, Ethiopia 
To reduce sources of misunderstandings and misinterpretations, key words, broader 
concepts and units of meaning were constantly discussed before, during, and after the 
data collection. After each interview the research assistant and I listened to the tape-
recorded interview and thoroughly discussed and clarified the content. I took notes while 
listening, capturing the main essence of the answers provided by each of the participants. 
In collaboration with the assistant, the cultural content was “decoded” and 
contextualized, clarifying notes were added and main themes and issues to be explored 
in subsequent interviews or focus groups were systematically written down. Personal 
issues, and unclear or ambiguous issues, were systematically written down to be pursued 
in the second and third interview. Conceptual maps were used to visualize associations 
between potential categories and concepts. The research assistant transcribed and 
translated (close to verbatim) each interview and focus group discussion after we had 
discussed and negotiated the content. After the transcription the interview was read by 
me, which encouraged minor discussions and clarifications.  
 All transcriptions were manually coded within a defined coding frame. The 
coding frame was developed on the basis of four broad themes identified by the 
literature, but was informed by themes and issues emerging from the material. For 
example, themes like religion and sexuality, initially not included as questions or probes, 
developed to be important themes throughout the study. Data concerning different 
factors related to how patients and health personnel perceive and manage TB were used 
for systematic text condensation in accordance with the principles of Giorgi’s 
phenomenological analysis (Giorgi, 1985), as modified by Malterud (Malterud, 1993). 
The analysis followed these steps: (i) reading all the material to get an overall 
impression; (ii) identifying units of meaning that represent different factors related to 
how patients and health personnel perceive and manage TB and coding for these; (iii) 
condensing and summarizing the content of each of the coded groups; and (iv) 
integrating the insights from the condensed meaning units into generalized descriptions 
that reflect apparently significant factors.  
The findings and analysis were summarized and accounted for in an analysis 
document that was used as a basis for writing and revision of the two first manuscripts 
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(paper I-II). I wrote a memorandum which included demographic information on each 
participant, observations and reflections from each interview, and a description of main 
issues that emerged in each interview. These memorandums were helpful tools during 
the analysis and I consulted them if I needed any contextual information about excerpts 
or quotes used as illustrations. Further, the memorandum enabled my supervisors to read 
about each of the participants referred to in the paper. 
3.8.2 Case two: Oslo/Akershus, Norway 
In the Norwegian part of the study I transcribed the tape-recorded interviews verbatim. 
Most of the transcriptions were done immediately after the interview. During the process 
of transcribing the interviews I wrote a memorandum which included demographic 
information on each participant, observations and reflections from each interview, and a 
description of the main issues that emerged in each of the interviews. Main issues were 
transferred to a separate word document suggesting potential codes and categories. As in 
the previous study, the memorandums were helpful tools during the analysis and I 
consulted them if I needed any contextual information about excerpts or quotes used as 
illustrations. The qualitative software NVivo 7 was used to organize the material (QSR 
International, 2009). My main supervisor and I independently read half of the transcripts 
and developed a coding frame for the analysis. I coded all the transcripts, while both my 
supervisors contributed in the analysis. Data regarding views and experiences related to 
TB and treatment (DOT) were identified among patients and health personnel and were 
used for systematic text condensation in accordance with the principles of Giorgi’s 
phenomenological analysis (Giorgi, 1985), as modified by Malterud (Malterud, 1993). 
The analysis followed these steps: (i) reading all the material to get an overall 
impression; (ii) identifying units of meaning about views and experiences concerning 
how patients and health personnel perceive and manage TB and coding for these; (iii) 
condensing and summarizing the content of each of the coded groups; and (iv) 
integrating the insights from the condensed meaning units into generalized descriptions 
that reflected significant factors. The findings and analysis were summarized and 
accounted for in an analysis document that was used as a basis for writing and revision 
of the third and fourth manuscripts (paper III-IV). Quotes from the interviews were 
translated from Norwegian to English by me (MS) in the process of writing the articles.  
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3.9  Ethical considerations 
Ethical approval for the Ethiopian part of the study was obtained from the Regional 
Committee for Medical Research Ethics, Region West, Norway (reference: 071.01), and 
the National Ethical Clearance Committee in Ethiopia (reference: RDHE/43-42/2001). 
All participants were informed about the purpose of the study, and that they could 
withdraw from the interview and the study at any time without giving a reason and 
without penalty to their treatment. Informed, oral or written consent was sought in all 
cases. De-identification and confidentiality were ensured by using numbers and fictitious 
names to describe and identify patients.  
 There is an inevitable power imbalance between health personnel and patients, 
and the use of health personnel to help recruit patients to research may cause patients to 
feel pressured to participate due to a feeling of duty or because they depend on the good 
will of the health personnel (Richards & Schwartz, 2002). This inter-relationship and 
power imbalance between health personnel and patients has been discussed earlier. We 
sought to prevent such pressure by instructing the nurses in a way that would ensure 
ethical concerns during recruitment of patients. At each interview we thoroughly went 
through the consent form, repeating the aim of the study, that the information they 
provided would be confidential, and that they could withdraw at any time. In this way 
we considered the consent as an ongoing process instead of a one-off event (Richards & 
Schwartz, 2002). 
 Qualitative interviews, which allow people to speak in their own terms, can 
potentially be therapeutic. However, the interview can also lead to exploitation and 
harm. The researcher can be tempted to inappropriately ask sensitive questions and 
participants may reveal more information than they had foreseen (Richards & Schwartz, 
2002). I paid attention to interviewees’ emotional responses during the interview, but 
due to tremendous physical, social and mental strains faced by many of these patients it 
was difficult to define any clear limit of where to close the interview. Participants 
carried stories of social exclusion, abuse, loss of family members, impoverishment, 
anxiety, chronic hunger and hopelessness. All these factors were directly or indirectly 
linked with being ill with TB. Many cried during the interviews, but often they would 
express gratefulness that someone was listening. In one case a young participant became 
aggressive and threatening, accusing me of being callous listening to his suffering 
without helping him. At that time we had met three times, and he defined the 
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relationship we had as a relationship between humans, not as a relationship between a 
researcher and a participant. Even if this was the only time I was confronted about such 
an issue, I constantly felt a conflict between preserving a neutral role as a researcher, or 
taking on an advocate role as well as preserving my role as a fellow human being.      
 The analysis of qualitative data is influenced by theoretical frameworks, previous 
studies, personal characteristics, and preconceptions introduced by the researcher(s). 
Qualitative research has an interpretive nature, and the presented findings will only be a 
version of the “truth”. Subsequently, the trustworthiness of the findings must be 
evaluated in relation to the care with which the data was handled (Richards & Schwartz, 
2002). I believe we limited misrepresentation of the findings due the systematic, 
dynamic and negotiated approach we took to the emerging data. By interviewing half of 
the patients three times, and by conducting two focus groups at the end of the study, we 
managed to validate and explore further most of the important themes.  
 The inconvenience and opportunity costs involved in qualitative research can be 
underestimated (Richards & Schwartz, 2002). In this part of the study participants 
participated in interviews for 2-3 hours, many of them 3 times and some of them being 
severely ill. Based on advice from local researchers we decided to compensate for 
inconvenience and opportunity costs by giving each patient 20 birr (at that time 
equivalent with 2.3 US dollar) after the interview. The concrete sum was never 
mentioned in advance, but the consent form informed that any related costs for 
participating in the interviews (like transportation costs), would be compensated. I did 
not experience that this compensation influenced the recruitment or ongoing 
participation in the study. I cannot, however, exclude the possibility that it might have 
served as a minor incentive among the participants that were interviewed three times.   
  Ethical approval for the Norwegian part of the study was obtained from the 
Regional Committee for Medical Research Ethics, Region South, Norway (reference: S-
07186a). Norwegian Social Science Data Services granted us permission to make a 
temporary register of participants of the study (reference: 16619/LT). All participants 
were informed about the purpose of the study, and that they could withdraw from the 
interview and the study at any time without giving a reason and without penalty to their 
treatment. Written consent was sought in all cases. De-identification and confidentiality 
were ensured by using numbers to describe and identify patients.  
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 As described above, there is an inevitable power imbalance between health 
personnel and patients, and the use of health personnel to help recruit patients to 
research may cause patients to feel pressured to participate (Richards & Schwartz, 
2002). We sought to prevent such pressure by instructing the TB coordinators and the 
nurses in a way that would ensure that patients did not feel pressured to participate. 
Potential participants were approached with written information about the study by a TB 
coordinator or a nurse. The written information was provided in Norwegian, English, 
Somali and Amharic. The study and its terms were explained, and if the patient agreed to 
participate s/he could decide between contacting the researcher by phone, or to allow the 
researcher to contact them by phone. During the phone call the aim of the study and its 
terms were repeated and the participant would confirm whether or not they wanted to 
participate. In the interview setting we went through the consent form, repeated all the 
information about the study, and also emphasized that the participant could withdraw 
from the interview without any repercussions. As in the study in Ethiopia, we considered 
the consent as an ongoing process instead of a one-off event (Richards & Schwartz, 
2002). At the end of the interview the participants were asked if the researcher could 
make contact to clarify issues, or for a second interview.  
 As described previously, the interpretive nature of qualitative research implies 
that the findings that are presented only represent a version of the “truth”. Thus, the 
trustworthiness of the findings must be evaluated in relation to the care with which the 
data was handled (Richards & Schwartz, 2002). Many of the participants’ had limited 
language skills in both Norwegian and English. Some of these patients were offered an 
interpreter, but refused due to many different and personal reasons. To avoid 
misrepresentation of the findings due to language barriers or general misunderstandings 
we decided to interview patients that had given unclear, ambiguous or incomplete 
answers twice. By interviewing these patients a second time we managed to clarify and 
validate the findings from previous interviews. Misrepresentation was also limited by 
interviewing health personnel about many of the same issues.  
 There are less than 300 cases of TB each year in Norway. Therefore, there is a 
clear risk of identification of the participants. It is not always easy to foresee which data 
may lead to identification (Richards & Schwartz, 2002), but we have intentionally used 
as few identifiable factors as possible when presenting cases and illustrating quotes.     
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4.  Summary of results 
 
4.1 Paper I 
 
Sagbakken, M., Frich, J.C., Bjune, GA.  
Barriers and enablers in the management of tuberculosis treatment in Addis 
Ababa, Ethiopia: a qualitative study.  
BMC Public Health, 2008; 8: 11. 
 
The aim of this paper is to explore enablers and barriers in the management of TB 
treatment during the first five months of treatment in Addis Ababa, Ethiopia.  
We found that daily treatment was time-consuming and physically demanding, 
and rigid routines at health clinics reinforced many of the emerging problems. Patients 
with limited access to financial or practical help from relatives or friends experienced 
that the total costs of attending treatment exceeded their available resources. One group 
of patients still managed to continue treatment, mainly because relatives or community 
members provided food, encouragement and sometimes money for transportation. Lack 
of income over time, combined with daily accumulating costs and other struggles, made 
patients vulnerable to interruption during the later stages of treatment. Patients who were 
poor due to illness or slow progression, and who did not manage to restore their health 
and social status, were particularly vulnerable. Such patients lost access to essential 
financial and practical support over time, often because relatives and friends were 
financially and socially exhausted by supporting them.  
   We conclude that patients’ ability to manage TB treatment is the product of 
dynamic processes, in which social and economic costs and other burdens change and 
interplay over time. Interventions to facilitate adherence to TB treatment need to address 
both time-specific and local factors. 
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4.2 Paper II 
 
Sagbakken, M., Frich, J.C., Bjune, GA.  
Perception and management of tuberculosis symptoms in Addis Ababa, Ethiopia.  
Qual Health Res, 2008; 18: 1356-66.  
 
The aim of this paper was to explore how symptoms of TB are perceived and managed 
from the onset of symptoms and during the course of treatment, in Addis Ababa, 
Ethiopia.  
 We found that patient’s perceptions and self-treatment of early symptoms could 
cause diagnostic delay. Stigma associated with TB and public health services made 
many patients approach private clinics, causing further delay. Both private and public 
clinics often labeled and managed symptoms according to lay explanatory models. Lack 
of adequate knowledge concerning TB’s etiology and cure caused patients to continue 
relating to symptoms by reference to their own understanding. This impacted patients’ 
ability to manage TB and its treatment. 
 We conclude that addressing diagnostic delay will require simultaneous efforts to 
be directed at patients’ communities and the health sector. Campaigns to destigmatize 
public TB services and make them more user-friendly are other important efforts.  
Reducing diagnostic delay could reduce some of the physical, psychological, social and 
financial burdens patients face during the long treatment regimen.  
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4.3 Paper III 
 
Sagbakken, M., Bjune, G.A., Frich, J.C.  
Experiences of being diagnosed with tuberculosis among immigrants in Norway – 
Factors associated with diagnostic delay: A qualitative study.  
Scand J Public Health, 2010 (E-published ahead of print),  
doi: 10.1177/1403494809357101 
 
The aim of this paper was to explore experiences of being diagnosed with tuberculosis 
among immigrants in Norway, with a view to factors associated with diagnostic delay.  
 We found that one third of the participants reported less than two months from 
onset of symptoms to treatment initiation. The factors associated with little delay 
included a medical history that gave suspicion of TB, presenting with typical TB 
symptoms, or being screened for TB at arrival. Two thirds of the participants told about 
extensive diagnostic processes. Factors that could delay a patient’s first initiative to seek 
help were persistent cough not accompanied by symptoms such as weight loss and 
weakness; mild, diffuse, atypical and/or intermittent symptoms; and a sense of not being 
a likely victim of TB. Participants experienced that the diagnostic process in the health 
services could endure for months, even years. The diagnosis could be difficult to 
confirm, but health professionals appeared to have difficulties associating their 
symptoms with TB. 
 We conclude that public health efforts to increase awareness about how TB is 
transmitted, it’s diversity in manifestations, and that TB can progress from latent to 
active disease, may decrease patient delay. An increased awareness among health 
professionals about typical and atypical symptoms of TB, aspects of the patient’s 
history, and being aware and sensitive to patients’ own interpretation of symptoms may 
reduce diagnostic delay in the health services.  
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4.4 Paper IV 
 
Sagbakken, M., Bjune, G.A., Frich, J.C.  
Patients’ and health professionals' views and experiences with tuberculosis 
treatment in Norway.  
(submitted manuscript).  
 
The aim of this paper is to explore patients’ and health professionals’ views and 
experiences regarding the practice of directly observed treatment (DOT) in Norway.  
 We found that one group of patients experienced DOT as rigid and inflexible and 
felt that they had no power to influence their own situation. Those who had jobs or that 
attended school experienced that this lack of flexibility and unpredictability in how the 
treatment was organized had high social costs. Men in particular described DOT as 
humiliating and discriminating, while some of the women saw DOT as an expression of 
care and thorough follow-up. Those with positive experiences emphasized continuity 
among the health workers and the possibility to negotiate flexible treatment 
arrangements. We found that health professionals had divergent views about DOT. 
While one group argued that all patients should be treated equally and follow the rule of 
DOT throughout treatment, another group argued that DOT interfered too much in 
people’s lives, and that one should aim for an individualized and flexible approach.  
 We conclude that in order to avoid disempowering and humiliating practices, 
care and treatment of TB patients should be organized in ways that create structures and 
decision-making processes that allow fully informed patients to express their views and 
negotiate their needs throughout treatment. To enforce profound changes, preservation 
of patient autonomy, empowerment and dignity must be part of the knowledge practice 
upon which DOT is based.     
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5.  Discussion 
 
5.1 Methodological considerations 
5.1.1 Reflexivity 
I started out with a general interest in exploring the social and cultural dimensions of a 
disease like TB through qualitative methodology. By engaging in the field I developed 
an interest in exploring how patients with TB perceive and manage symptoms and 
treatment of TB. I also developed an interest in exploring health personnel’s views and 
experiences with TB and the related treatment. I chose to focus on how patients and 
health personnel interpret and manage symptoms in a low-endemic and a high-endemic 
context (paper II and III). I also chose to focus on how patients and health personnel 
view and experience TB treatment in the same two parts of the world (paper I and IV). 
By comparing views and experiences in two such different contexts, I sought to identify 
similarities and differences within and beyond specific contexts – and come closer to an 
understanding of challenges related to manage TB. 
 During my first fieldwork, in Addis Ababa, I set out to explore factors associated 
with adherence to TB treatment. During the study I found that diagnostic delay, 
indirectly, was one of the main reasons why TB patients were not able to adhere to their 
treatment. By the time patients had reached the clinics that provided TB treatment, many 
were too ill to cope with the demands of daily clinic attendance. In order to understand 
the phenomenon of adherence, I therefore found it necessary to explore patients’ 
perceptions and management of early symptoms. What surprised me in this stage of the 
research was that the organization of the treatment (DOT) seemed to serve as a reason 
why some patients interrupted treatment. When I set out to conduct the study, I 
perceived DOT(S) as a program that would facilitate adherence; few studies had at that 
time documented barriers experienced by patients due to the implementation of DOT.  
 During the first interviews, religious and cultural interpretations of practicing sex 
(and related “sinful” behaviors) spontaneously emerged in participants’ accounts, as 
relevant to adherence. This was another unexpected finding and in the beginning I did 
not understand the relevance enough to probe sufficiently. Due to thorough discussions 
of each interview, and vital inputs and initiatives provided by my research-assistant, we 
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included themes that otherwise could have been overlooked. Sexuality and sinful 
behavior turned out to be of overall importance to understand the phenomenon of 
adherence in this particular context.  
 In general, what I expected to be one of the main challenges in the study, the use 
of an interpreter, turned out to be one of the main assets. By continuously using the 
interpreter to broaden my understanding of the local culture, he served as a key 
informant. Through the eyes of the interpreter I was able to identify themes relevant in 
this particular culture and contextualize subsequent findings. Through my own 
observations I was able to question the unspoken; knowledge, values and norms taken 
for granted within the same culture. Trough continuous discussions all the findings 
became a product of a thorough, transparent and negotiated understanding of what two 
people with different frames of references had seen and heard. Early in the research 
process I acknowledged that both the interpreter and I were co-producers of given 
accounts, and instead of working “through” him I decided to work “with” him (Wallin & 
Ahlström, 2006). Working “with” my interpreter also implied him playing an active role 
during the interviews by suggesting probes and initiating follow-up questions. In this 
way the interpreter and I became a close team which to an invaluable extent increased 
the trustworthiness of the data.   
 My preconceived ideas about potential findings from the Norwegian setting were 
few, since there was little literature on patients and health workers perceptions and 
management of TB in low-endemic contexts. Due to my findings from Ethiopia I had 
developed a more critical view about how DOT affected patients’ lives and their ability 
to manage their disease. However, most of the barriers that were experienced by patients 
in Ethiopia were poverty-related. I was therefore surprised to find that patients in 
Norway faced socio-economic consequences due to the organization of their TB 
treatment (DOT). What I did expect to find was that living in a society highly influenced 
by the bio-medical perspective would affect how people perceived and acted upon their 
symptoms. As suspected, people’s interpretations of symptoms had changed due to the 
new circumstances, but I was surprised to find that so few related to the lay categories 
that were used to describe symptoms of TB by patients in Ethiopia. However, when 
prompted, patients seemed shy to talk about interpretations other then the biomedical of 
TB. Sometimes I had the feeling that they did relate to other explanatory models, but due 
to the common use and acceptance of biomedical perspectives in Norway, patients were 
70 
 
reluctant to bring these ideas and concepts forward. Another possible interpretation, as 
suggested by my findings, is that a relatively consistent use of bacteria as part of the 
health workers’ way of explaining TB, may have facilitated an another understanding 
and subsequent stronger adherence to the bio-medical perspective.  
 Religion (sinful activities) and its potential relation to healing was another theme 
that seldom emerged spontaneously among the Norwegian participants. There could be 
different reasons for this, but among the Muslim participants, sin and disease did not 
seem to have the same strong correlation as among Christian participants in Ethiopia, 
nor among some of the Christian participants in Norway. Another possible cause of the 
absence of lay, non-biomedical explanatory models is that patients in Ethiopia 
experienced much insecurity related to the etiology of the disease, and poor progress 
without adequate explanations seemed to facilitate a parallel use of different explanatory 
models – both among patients and health workers. Yet another possibility is that a large 
group of the participants in Ethiopia were interviewed tree times, encouraging a level of 
trust and intimacy that I might not have managed to establish in one, or two, interviews 
with the participants in Norway.  
 Though I managed to talk with the participants in either Norwegian or English, 
without the potential disturbance of an interpreter, I found that working alone with the 
data caused a greater sense of insecurity. I missed the dynamic of having a partner to 
discuss each interview with; someone that could challenge my preliminary 
interpretations and vice versa. Some of the participants spoke limited Norwegian and 
English, but for different reasons they did not want to use an interpreter. Subsequently, 
the content of statements could sometimes be unclear or ambiguous. I sought to avoid 
such unclearities by transcribing the interviews immediately afterwards. Sometimes I 
called patients for clarifications, and eight of the patients were interviewed twice. In the 
process of analyzing the material, about half of the transcripts were read independently 
by me and my main supervisor, compensating to some extent for not having an assistant 
to discuss alternative interpretations with.  
 I was influenced by different theories, which may have inspired a broad approach 
to the questions this study seeks to explore. A debate taking place while being in the 
planning stage of the first part of the study revealed disagreement on the value of 
exploring culturally specific meanings and norms to understand a phenomenon such as 
adherence (Barnhoorn & van der Gest, 1997; Farmer, 1997). Farmer in particular argued 
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that “cultural variables” were overemphasized, and that the main answers in explaining 
adherence behavior were to be found by focusing on structural barriers. This debate 
inspired me to integrate different views in relation to the assumed importance and 
validity of which questions were to be asked. I believe that my findings have managed to 
illustrate that to understand how people perceive and manage TB these viewpoints are 
(to some extent) supplementary.    
5.1.2 Trustworthiness and internal validity 
In qualitative research, validity is related to the degree to which a method explores what 
it is intended to explore, and to what extent our data actually represent the phenomenon 
of interest (Kvale, 1996, p. 238). Kvale suggests that “to validate is to question” and 
recommends that critical questions are asked in all stages of the research process. By 
leaving these questions open to insight the reader may, to a further extent, be able to 
judge whether the study is internally valid. In this thesis, the methods chapter has met 
some of these requirements, but some additional points will be included and elaborated 
on here.  
 Participants in the Ethiopian part of the study (paper I & II) were recruited 
from three different clinics with similar DOT practices. The three research sites 
were considered to be “typical” DOT clinics and represented diversity being 
located in different areas of the city. We recruited 10 newly diagnosed TB patients 
on the basis of a purposeful sampling strategy, and 11 TB patients, whom had 
interrupted treatment. Patients who attended treatment and patients who had 
interrupted treatment were interviewed about the same themes, and part of the 
validation process involved identifying intersects between findings in the different 
groups. We supplemented the data further by including patients on re-treatment, 
relatives of patients, and health personnel. Observing communication and 
interaction patterns between health workers and patients in the clinics provided 
additional insight. At the end of the study focus group discussions were conducted 
to explore and validate previous findings. The findings are characterized by 
similarities within and between the different groups of participants. I believe that 
the trustworthiness of the study and the internal validity of the findings are 
strengthened by the extensive triangulation within the study.  
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 There are no indications that there has been a selection of particularly 
economically poor participants to the study. The main findings in the study are poverty-
related, but we most likely did not interview the poorest segment of the population. 
According to the local health personnel and the research assistant, the socio-
demographic profile of the participants indicated that many were representing the lower 
middleclass. We saw indications of this during the study as many of the poorest 
residents did not manage to access the health services and interrupted treatment at an 
early stage due to the demand of daily clinic attendance. During the process of tracing 
those whom had interrupted treatment many had died or disappeared, several of them 
leaving to rural areas to secure food through relatives.  
 There may have been a selection of individuals that were in favor of 
biomedical treatment, and recruiting participants from alternative institutions 
might have provided a broader picture of how people perceive and act upon 
symptoms and treatment of TB. Almost all of the participants in the study adhered 
to the biomedical perspective, in the sense that they believed that TB medication 
was important to achieve a cure. However, there were many examples of change- 
or parallel use of different medical systems.   
 I used different strategies to ensure that I explored what I intended to explore, 
and that the data represented issues relevant to the questions posed in the study.  The 
broad themes that were included in the interview guide were included on the basis of a 
thorough literature review and on several sources of theoretical inspiration. 
Acknowledging the complexity and dynamics of the subjects of concern I wanted to 
ensure that participants were exposed to the main themes that the literature had seemed 
to pinpoint as being relevant to the understanding of adherence. The study was therefore 
partly deductive, in the sense that important broad themes were pre-selected for inquiry. 
On the other hand, the reason why all these broad themes were included was to avoid 
limiting the focus to either e.g. “health-beliefs” or “structural barriers” and their separate 
influence on the management of TB. By including all (seemingly) major themes I 
wanted to allow the participants themselves to define the importance of different factors. 
I also wanted to ensure an understanding of how important variables could be 
interrelated and subsequently provide a “thick description” on the subject of concern. To 
ensure a representation of lay experiences and theories I gradually included and explored 
themes as they were emerging from the field. By using open-ended questions and to a 
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certain extent a narrative approach, I sought to enable participants to identify and 
emphasize what they considered important.  
 As described in the method chapter, the number of health personnel interviewed 
in this part of the study is limited and inclusion of more health personnel would have 
ensured a more valid representation of this group’s views and experiences.   
 Another issue regarding the trustworthiness of the data, of particular 
concern working with an interpreter, is critical language awareness as emphasized 
by Willig (2008, p.11). “Language does not simply mirror reality”: Words can 
carry accumulated and particular cultural, social, and political meanings. The same 
phenomenon can be described in different ways and give rise to different 
understandings. Working with an interpreter I was particularly concerned about 
establishing a shared understanding of the content in the research project. We 
thoroughly discussed the research protocol and the aim of the study, in which the 
assistant contributed valuable inputs. The interview guide was translated back and 
forth several times, the last version being a negotiated product between me and the 
research assistant. During this process we discussed and clarified each others 
interpretation of important words and concepts to be used in the study. During the 
interviews and in the process of listening to the taped interviews, I emphasized that 
meaning should have priority over form. This implied that instead of focusing on 
word-by-word translation I encouraged the interpreter to translate in a way that 
gave the right meaning to the statement. Translating the form and meaning of a 
statement in one language into a corresponding form of another language may 
actually change the meaning, and thus reduce the trustworthiness of the data 
(Wallin & Ahlström, 2006). The transcriptions were conducted in a way that was 
as close to a verbatim translation as possible, still taking into account the 
preservation of meaning. The assistant included pauses, emphases in intonation, 
emotional expressions like crying or laughter, observations regarding body-
language, and the use of irony by including “ironic” in brackets. In agreement with 
me (after listening to the taped interviews), parts of the interview that had little 
relevant information were condensed and summarized.    
 In the Norwegian part of the study (paper III & IV), a purposeful sample of study 
participants were recruited through primary health care services and six main hospitals 
in Oslo/Akershus; the region where more than one-third of the TB cases in Norway 
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occurred in the study period. 22 TB patients who originated from either Somalia or 
Ethiopia were recruited for the study. Data from the Norwegian Surveillance System for 
Communicable Diseases (MSIS) show that the number of reported TB cases in 2005 and 
2006 were highest among people who originated from Somalia and Ethiopia (not 
including Norwegian-born) (Winje et al., 2006b; Winje et al., 2007). We thought the 
experiences of these two groups would be of particular interest to health workers and 
policymakers. We also had an interest to include participants originating from the same 
geographical area as the previous study, allowing some type of comparison, for example 
in relation to interpretation of early symptoms. Health personnel in relevant positions in 
a variety of districts/hospitals were contacted by phone for a potential interview. Some 
were recruited by snowball sampling, as participants were asked to identify potential 
participants who could provide relevant information. The final sample consisted of 20 
health personnel; of whom eight were doctors, five were TB coordinators, two were 
community nurses, and five were nurses from home-based services.    
 There are no indications that there has been a selection of patients with certain 
types of experiences in the study. Most of the patients were recruited trough TB 
coordinators, and even though some of the TB coordinators seemed eager to identify 
participants that were satisfied with how the treatment was organized, other TB 
coordinators emphasized the importance of trying to identify patients that they though 
had different experiences. During the data collection period, a total of 10 persons 
originating from Ethiopia and 30 persons originating from Somalia were diagnosed with 
TB in Oslo/Akershus. I ended up interviewing a large proportion of the actual cases: 
Seven out of 10 existing patients from Ethiopia, and 15 out of 30 existing patients from 
Somalia. During the recruitment of health personnel I found that there was a variety of 
views regarding the practice of TB treatment (DOT). Trough snowball sampling I was 
therefore able to recruit health workers that I was told had different/contrary opinions or 
practices. 
 I used various strategies to ensure that I explored what I intended to explore, and 
that the data represented issues relevant to the questions posed in the study. The same 
approach as described in the first part of the study was used to ensure internal validity in 
the Norwegian fieldwork. On the basis of a literature review, experiences from the 
previous study from Ethiopia, and several sources of theoretical inspiration, I decided to 
base the questions on selected broad themes. This time I was more explicit in seeking to 
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explore experiences related to the diagnostic process. To ensure representation of lay 
experiences and theories I gradually included and explored themes as they were 
emerging from the field. By using open-ended questions, and to a larger extent than in 
the first part of the study, using a narrative approach, I sought to enable participants to 
identify and emphasize what they saw as important. After some interviews the semi-
structured interview-guide was replaced with a thematic check list, and the participants, 
to a large extent, set the agenda.  
 Some patients had limited language skills in Norwegian or English, which may 
have caused misunderstandings during interviews. However, I sought to modify this 
weakness by immediate transcription and clarifications through phone-calls or a second 
interview with some of the participants. The transcriptions were verbatim, but I included 
comments in brackets where I suggested explanations to statements that seemed unclear. 
At the end of each transcription I made a summary of the main content, made comments 
related to the atmosphere during the interview, and systematically wrote down issues 
which needed to be clarified. Further comments were added after I had clarified issues 
through phone calls with some of the participants. Pauses, emphases in intonation, 
emotional expressions, and notes regarding observation of body language were included 
in the transcriptions.  
 A weakness of this part of the study is that all of the data from patients is 
based on interviews and retrospective accounts. We have no data on what actually 
took place in the medical encounters that our participants refer to. Participants may 
have recall bias regarding type, severity, and onset of symptoms, or may have 
moral or psychological reasons for attributing delay or other negative experiences 
solely to the health service system. One may therefore question the validity of 
participant’s accounts. Also, the health personnel may have had moral or 
psychological reasons for claiming certain views. The methodology would have 
been strengthened if the context had allowed for the use of observation. However, 
the strength of the study lies in the homogeneity and coherence in the answers 
within and between different groups of patients and health personnel. We found 
that patients’ accounts to a large extent were confirmed by health personnel, and 
there is nothing in the data suggesting that we should distrust their accounts. Data 
about how participants experience the health services should be considered as 
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valid in their own terms, as patients’ experiences are important clinical outcome 
measures (Annandale & Hunt, 1998).  
5.1.3 External validity – transferability 
Transferability means that findings, interpretations and concepts from one study may be 
transferred to another context and be valid in that context. This also implies that the 
findings must be considered interesting and relevant to researchers, policymakers or 
health workers in other settings. Kvale states that “pragmatic validation rests on 
observations and interpretations, with a commitment to act on the interpretations” (Kvale 
1996, p. 248). The pragmatic validity will be especially important in research with an 
indirect motive of change: Without applicability or practical relevance, the knowledge 
obtained will not be of much use. In our search to understand how patients with TB 
perceive and manage their disease we have conducted two different studies. The first 
study context represents a high-endemic, low-income setting while the second study 
context represents a low-endemic, high-income setting. We have decided to focus on 
how patients interpret and act upon symptoms, in interaction with health personnel, in 
two different parts of the world (paper II & III). We have also chosen to focus on how 
patients and health personnel perceive and experience TB treatment, organized as DOT, 
in these same two parts of the world (paper I & IV). In each of the two studies, measures 
have been taken to ensure that the sample would provide data that would be of 
relevance, according to the aim of the study. This has been attended to by the described 
procedure for purposeful sampling, and by including the perspectives of both patients 
and health personnel. We did not aim for a representative sample in an epidemiological 
sense. However, we have observed that the sample does not deviate much from the 
population group as a whole with regards to certain characteristics. Data from SSB  
(2010c) show that few individuals from Somalia are integrated in the labor market. In 
2008, only 45 % of Somali men were employed and only 25 % of the women. Many 
Somali women live alone with children, and struggle with their finances. People from 
Somalia represent the group (together with people from Iraq) that most often only hold 
temporary employment positions (SSB, 2010a). People from Ethiopia are more 
integrated in the labor market, and the differences between sexes are less. In 2005, 54 % 
of all first generation Ethiopian immigrants were employed (SSB, 2007). Compared to 
the overall population, Ethiopians are overrepresented in the hotel- and restaurant 
business (SSB, 2007), which often implies shift work and irregular working conditions.                  
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The sites selected for recruitment of participants have sought to ensure 
“representativeness” in the sense that we have recruited participants within a 
geographical area with a (relatively) high number of TB cases, and from a variety of 
clinics/sites. We should, however, emphasize that the sample of patients from Norway 
was restricted to people who originated from Somalia and Ethiopia. These two groups 
represent heterogeneous cultures, and the findings may not be representative of all 
immigrant TB patients in Norway.  
We have employed qualitative methods to explore the research questions in 
this study. Kvale’s definition of validity includes a focus on the pragmatic value of 
research, or in other words whether studies that are being conducted are reflecting 
variables of interest (Kvale, 1996). This relates to transferability in the sense that 
the meeting between the study and the research community, policymakers or 
health workers will be a test of whether the study reflects methods and findings of 
interest. The study from Ethiopia has received a lot of interest and the preliminary 
findings have been presented at three international conferences and at a variety of 
meetings with relevant stakeholders. The preliminary findings from the study in 
Norway have been presented at two international conferences, and at a yearly 
gathering of TB coordinators in Norway. During this process I have received 
important support, comments and reflections, which have greatly encouraged me 
to continue in the publishing process.   
 The insight produced through each part of the study and the insight 
provided from the study as a whole will possibly represent two different 
dimensions of interest. By exploring views and experiences in a high-endemic, 
low-income setting versus a low-endemic, high-income setting, we may identify 
factors that serve as common challenges and potential solutions. Examples of 
findings that might be transferable across different contexts are found in papers II 
and III. These papers explore how people living with TB in two different parts of 
the world perceive and manage their symptoms. Our findings show that patients, 
independent of context, perceive TB as a serious lung disease associated with 
poverty. We found that participants in both contexts associated TB with a 
persistent cough, but due to its perceived severity people would (often) not suspect 
TB in the absence of symptoms such as weight loss and weakness. Even though 
these interpretations were similar, interpretations and management of symptoms 
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may be modified or changed when one moves from a country where the 
prevalence of TB is high to a country with a low prevalence. Paper III shows that 
patients may perceive themselves as unlikely victims of TB while living in affluent 
parts of the world. Persistent cough may be interpreted as a common cold, and the 
meeting with a health system lacking in awareness of TB may strengthen such an 
interpretation. Our findings related to patients’ and health workers’ experiences of 
TB treatment (DOT) in papers I & IV show that patients in a low-endemic setting 
may experience barriers related to the organization of treatment similar to those 
described in a high-endemic setting. Considering the disparity in available 
resources, this is a surprising finding. However, as illustrated in our study, the 
groups that have the most difficulties adapting to the DOT system share some 
characteristics. For example, paper IV illustrates how patients in Norway, who did 
not have permanent jobs, were particularly vulnerable. This is in line with the 
findings from Ethiopia. These findings should encourage the research community 
to conduct research in other low-endemic settings. Further, it should encourage 
policymakers to reconsider or modify present methods of ensuring treatment 
completion and cure for TB. However, the reception among policymakers – and 
the subsequent pragmatic value of these findings – still remains to be seen.       
5.2  Interpretation and management of symptoms – diagnostic delay   
5.2.1 Addis Ababa, Ethiopia 
In Ethiopia we found that early symptoms of TB were interpreted and acted upon 
according to local explanatory models. Often a cough was not recognized as 
possible TB unless accompanied by serious symptoms like weight loss and 
hemoptysis, similar to findings from other settings (Nair, George, & Chacko, 
1997; Demissie et al., 2002; Storla et al., 2008). Early symptoms of TB were 
categorized as a culturally explained disease (bird) and often attended to by self-
treatment inspired by the popular or the folk sector of the health care system 
(Kleinman, 1980). Even if most people described self-treatment of early symptoms 
as a response to a culturally specific interpretation, implicit economical barriers 
are most likely part of the rationale in which people make their choices. People 
know that going to a health centre will cost money, even the public centers. There 
will be expenses related to transport, diagnostic procedures, as well as an incurred 
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loss of income and opportunity costs caused by time used queuing up in public 
clinics. In line with Becker and Maiman (1975), and Becker (1990), health 
behaviors may be shaped by factors such as availability and accessibility of 
services as well as by the perceived severity of the disease. Stated differently, 
strategies such as self-treatment may (partly) be a function of structural barriers in 
the society at large. 
  In paper II, we explore how stigma associated with TB and public health 
services made many patients, despite the costs, use private health services. Public 
clinics were stigmatized because they were considered to be for the poorest people, 
and patients were reluctant to expose themselves lining up in queues at such 
clinics. According to Goffman, stigma represents an attribute that is perceived as 
deeply discrediting in a social relationship or context (Goffman, 1968, p.13). 
Stigma that is directly associated with living in poverty has been found to 
negatively influence health trough psychological distress. Shame, inferiority, and 
disrespect from others are sources of stress and anxiety, which can reinforce the 
stress associated by being infected by a disease in the context of inadequate 
economic resources (Reutter et al., 2009). In our study (paper II) we found that TB 
carried several stigmas related to the etiology of TB. Circumstantial causes such as 
poverty and sinful behaviour; including the close association with HIV/AIDS, 
made people reluctant to reveal which disease they were suffering from. This was 
illustrated through patients’ continued use of the illness taxonomy bird to explain 
their symptoms, even after being diagnosed with TB. To avoid judgemental talk 
and exclusion by community members, patients protected themselves by 
explaining their symptoms using the more harmless, non-stigmatized illness 
taxonomy bird. The extensive use of bird can therefore be seen as “impression 
management” (Goffman, 1968), or as a strategy intended to enhance acceptance 
and avoid social exclusion. A study in Somalia found that pressure due to 
stigmatisation could lead to two types of concealment; hiding of TB and\or the 
denial of the symptoms and disease (Serkkola, 1998). If hiding or denial of 
symptoms is a common practice, many people may never reach government health 
services because of psychosocial barriers. Stigma has, in different ways and in 
several settings, been associated with diagnostic delay (WHO, 2006; Storla et al., 
2008).  
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 The use of private clinics has another dimension, not explicitly elaborated 
on in paper II. Some participants shared that one of the reasons they preferred 
private clinics was that they could not afford to loose a full day’s work, or even 
risk loosing their jobs, having to queue up in a government clinic. An early study 
from Addis Ababa (Teklu, 1984) supports this claim by reporting that one reason 
for treatment interruptions was that employers or private persons refused to give 
permission for their employees or domestic servants to go to the TB center to 
collect their drugs. A synergistic effect of stigma, lack of permanent employment, 
and lack of rights as an employee, may lead to a long delay period because people, 
due to many reasons, spend time saving money to go to a private clinic.  
 The beliefs and behaviors that constitute different activities in the health care 
system are heavily influenced by social institutions, social roles, interpersonal 
relationships, interaction settings, economic and political constraints, and a number of 
other factors (Kleinman, 1980). We found that both private and public clinics in the 
professional part of the health sector in Ethiopia labeled and managed symptoms 
according to lay explanatory models. In paper II, we describe the repeated visits made by 
patients at the same level of health care without receiving a proper diagnosis, 
particularly in the private sector. Diagnostic delay, due to several visits at the same level 
in the health care system, has been described in several other settings (Storla et al., 
2008). In paper II, we suggest that the practice of repeated consultations, including 
repeated courses of non-specific antibiotics, may be related to financial incentives 
among private practitioners. However, there were many examples of health personnel 
who understood TB within a traditional framework. Independent of cause, classifying 
and managing symptoms by reference to lay explanatory models made this knowledge 
part of the “clinical reality” (Kleinman, 1980), and an important arena for disseminating 
awareness of how to interpret and manage TB according to the perspective on which the 
treatment is based (biomedical) is lost. A study from an English suburban community 
has shown how the biomedical model can be adapted so that it “makes sense” in terms of 
the folk models of illness (Helman, 1978). Regardless of motivation, it can be argued 
that in Addis Ababa such overlapping is inexpedient, because it delays diagnosis and 
affects people’s perceptions and management of symptoms throughout treatment. The 
public health implications are great, as delay in diagnosis increase the period of 
infectivity, and as demonstrated in this context, seriously affects management of 
81 
 
treatment and the severity of the disease. Since health personnel relate to both 
indigenous and bio-medical knowledge, there should be potential for finding rational 
ways of communicating with patients; in which symptom interpretation and subsequent 
treatment makes sense.    
 5.2.2 Oslo/Akershus, Norway 
In the Norwegian study, we found that persistent cough not accompanied by symptoms 
such as weight loss and weakness could be interpreted as inconsistent with TB. Cough 
and fever were often interpreted as harmless symptoms, and were treated in accordance 
with a common cold. Paper III shows that the interpretation and management of 
symptoms can be modified or changed when one moves from a country where the 
prevalence of TB is high to a country where the prevalence is low. Some patients told 
that persistent cough would have raised a suspicion of TB in their home countries, but 
that the new context, Norway, had influenced their interpretation of symptoms. Causal 
associations between poverty/poor nutrition and susceptibility to TB; and a sense of not 
being a likely victim of the disease, could delay the first initiative to seek help. In 
addition, most patients were not aware of the possibility that they could carry a latent 
infection, which increased the sense of not being vulnerable.  
Stigma was raised as a cause of delay by only one patient in the Norwegian 
material. In the meeting with his doctor, this patient was deliberately hiding symptoms 
associated with TB, because he feared the social consequences of receiving such as 
diagnosis. One of the reasons why stigma seems to play a minor role in diagnostic delay 
in Norway may be that the public sector is the main source of health funding (ca 84 per 
cent) (SSB, 2006). Subsequently patients may utilize public services without the risk of 
being stigmatized. In addition, less awareness about TB in the society reduces the risk of 
people associating your symptoms with TB.     
Patients’ health seeking behavior must also be understood in the light of 
structural barriers or enablers within the society at large. Even though TB drugs are free 
in countries that have implemented DOTS, the costs that patients bare before treatment 
are, as discussed earlier, of major importance. Seeking a diagnosis in Norway implies 
costs, but living in a welfare state most likely prevents that people have to balance the 
costs of initiating medical help with costs related to daily needs. Health services in 
Norway are made accessible by a share-cost system which implies that patients only pay 
a share of the costs when they receive treatment by a general practitioner, by a 
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psychologist, a specialist outside of a hospital, for prescriptions of important drugs, and 
for transportation expenses in connection with examination or treatment. A cost-share 
ceiling (NOK 1840 in 2010) ensures that people that have needs that require frequent 
health care visits, do not have to worry about costs beyond the defined ceiling (for the 
rest of the calendar year) (Norwegian Ministry of Labour, 2010). In line with Becker and 
Maiman (1975), and Becker (1990), we may say that even though the perceived 
vulnerability to TB is lower among the participants in Norway, the perceived costs 
(financial, psycho-social) of initiation of health care is also lower; which may serve as a 
cue to action.  
 The beliefs and behaviors that constitute different activities in the health care 
system are heavily influenced by many other factors, such as the interaction with health 
personnel (Kleinman, 1980). We found that health personnel in Norway lacked 
awareness of both atypical and typical symptoms of TB, and the level of suspicion 
seemed to be determined by the epidemiological situation in Norway, and not by the 
epidemiological situation in the patients’ country of origin. Many of the patients that 
suspected TB experienced that they were not taken seriously and consulted with several 
doctors during their search for a diagnosis. As a result, the diagnostic process could 
endure for months, even years, after the first meeting with the health services. These 
findings are supported by a previous study from Norway, based on data from the 
National TB Registry, clinical case notes from hospitals, and referral notes from primary 
health care providers (Farah et al., 2006). This study found a median total delay of 63 
days from the onset of symptoms to the initiation of TB treatment. The delay was 
primarily attributed to doctors not initiating TB specific examinations despite symptoms 
suggesting TB. The authors of this study emphasize the need for awareness of TB in the 
general population and among health personnel in order to reduce diagnostic delay. A 
recent publication on TB screening and follow-up of asylum seekers in Norway 
concluded that the coverage of screening was satisfactory, but fewer suspect cases than 
one would expect were followed up in the community and referred to a specialist. In line 
with Farah et al. (2006) the author points to a limited focus on TB among health workers 
and in the society at large (Harstad et al., 2009).   
5.3  A cross-cultural perspective on diagnostic delay  
Our study shows that patients in both Ethiopia and Norway perceived TB as a severe 
lung disease. Awareness of early symptoms (e.g. persistent cough) seems to be low in 
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both contexts. Or rather, even though people associate TB with persistent cough, cough 
alone is seldom enough to make people act, based on a suspicion of TB. Assessing the 
findings in both studies, what seems to complete lay people’s symptomatic picture of TB 
are symptoms from the lungs (cough, hemopthysis, dyspnoea) combined with symptoms 
suggesting lack of food/poverty (weight loss) and symptoms suggesting severity 
(weakness, tiredness, fever, weight loss). Even though most people are aware of some 
sort of interpersonal transmission, TB is, in both contexts, first of all strongly associated 
with poverty, and subsequently with a disease that affects certain countries or certain 
layers of a population. Thus, people have more knowledge about the sociological causes 
of the disease than the microbiological cause. In the Norwegian study we found that 
many patients had learned about the microbiological perspective through doctors. 
Patients had then integrated the bacteria into already existing explanatory models. The 
bacteria were perceived as the agent that caused infection, and that carried the disease 
between people. However, most participants still saw TB as “circumstantial” in the way 
that living in poverty, exposure to certain elements (cold, wind, dust), or conducting 
sinful behavior were also seen as underlying causes. The absence of such circumstances 
(poverty in particular) made it difficult to understand why they had become vulnerable 
to the disease. In other words, even if patients internalize elements of bio-medical 
medicine it does not necessarily mean that the elements are emphasized or interpreted in 
the same way as within bio-medical medicine.  
  Paper II suggests that lay categorizations of early TB symptoms converge with 
diagnostic practices in parts of the professional sector in Ethiopia. Due to such practices 
the diagnostic process could endure for many months after patients’ first contact with the 
health services. Similarly, in paper III, we show that patients’ interpretations of 
symptoms often are confirmed in the meeting with health personnel in Norway. As in 
Ethiopia, the consequences are that the diagnostic process is prolonged. In paper I, we 
suggest that patients’ long diagnostic trajectory, receiving repeated treatment with non-
specific antibiotics in different parts of the health care system, could be profit motivated. 
The epidemiological situation in Ethiopia should imply high awareness of TB, but as 
illustrated in the material, health personnel also lack awareness or misinterpret early 
symptoms of TB. In Norway, a quantitative study from Oslo/Akershus found diagnostic 
practices somehow similar to those in Ethiopia. The study found that the main reason for 
the long total delay was that doctors did not initiate TB specific tests in patients with 
84 
 
symptoms of TB before treatment with antibiotics had failed (Farah et al., 2006). We 
found that there were no examples of patients draining their resources in the private 
sector, but several patients changed doctors and received subsequent treatments with 
antibiotic. One reason for delaying specific diagnostic tests may be the low prevalence 
of TB in Norway, and one may consider TB to be an unlikely diagnosis.  
In line with Becker, we may conclude that TB is perceived as severe in 
both contexts, while the perceived vulnerability differs greatly. In Norway, the 
effect of perceived low vulnerability is somehow balanced by few socio-economic 
barriers, which may represent a trigger to action at an earlier stage. In Ethiopia 
(even though awareness of early symptoms is low), the epidemiological situation 
implies a perception of vulnerability that is higher. However, social and financial 
barriers in the society at large seem to outweigh the potential that lies in such 
awareness. Health care system delay is, for different reasons, high in both 
contexts, although mostly related to either lack of awareness of TB; of typical or 
atypical symptoms; and poor diagnostic routines or lack of diagnostic tools. 
5.4 The burden of treatment and its consequences 
5.4.1 Addis Ababa, Ethiopia 
In the study from Ethiopia we found that daily clinic-attendance is time-consuming and 
physically demanding, and that the rigid routines at the health clinics reinforce many of 
the emerging problems. Our findings are in concordance with findings from other high-
endemic settings (Munro et al., 2007a). In a country where people often do not possess 
the benefit of having a permanent job, or social security benefits when one gets ill, a 
serious illness like TB may carry consequences such as loss of work or the possibility to 
work as a day laborer. In paper I, we describe how a patient’s loss of job and/or income 
occurs at a point in time where many have drained all their economic sources (diagnostic 
process), but where they need extra money to cover expenses related to daily clinic-
attendance and procurement of protein-rich food. The emphasize on protein-rich food 
made patients feel powerless; knowing that certain type of food would make the TB 
treatment more efficient, and yet not being able to access even basic food items on a 
daily basis. Even though the need of protein-rich food was explained within a traditional 
framework, a good nutritional status and the value of protein-rich food in particular, are 
to some extent supported by the literature. Protein-energy malnutrition and micronutrient 
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deficiencies increase the risk of developing TB, and it has been found that malnourished 
TB patients have a delayed recovery as well as a higher mortality rate compared to well-
nourished TB patients (Gupta, Gupta, Atreja, Verma, & Vishvkarma, 2009).  
Our findings (paper I) suggest that patients who have fewer human or material 
resources available in their environments, such as the very poor, single mothers, and 
working immigrants from rural areas are the most vulnerable to treatment interruption. 
Such groups may interrupt already at early stages of treatment, and many within this 
category may never initiate treatment. The TB case detection rate in Ethiopia is very low 
with only a 28 % detection rate of new smear positive cases and a 40 % detection rate of 
all TB cases (WHO, 2009d). Heavy treatment related burdens, disseminated by TB 
patients to the community, may influence people’s health seeking behavior, and as such 
influence the level of passive case detection. Another patient group that is particularly 
vulnerable to treatment interruption are those whom become impoverished due to illness 
or slow disease progression, and who do not manage to restore their health and social 
status. These patients end up in a vicious circle, where their physical condition 
contributes to income poverty; further dependency; emotional exhaustion; and 
sometimes loss of hope. In paper I we argue that a decision to interrupt treatment may be 
shaped by past struggles and accrued costs, which may seem emotionally, socially or 
financially unbearable at the moment the decision is taken (Christensen-Szalanski & 
Northcraft, 1985).  
Paper I also demonstrates how structural barriers may be compensated for by 
social support mechanisms in the society. Lack of public social security systems pave 
the way for different types of reciprocal arrangements: To help a neighbour in crisis is to 
invest in your own social security. However, at the point someone’s condition is 
interpreted as fatal, community members may reduce their support based on the fact that 
the diseased person will no longer be able to contribute within the reciprocal system. We 
may say that the community’s response towards persons in severe and prolonged life 
crisis seem to move from a “generalised reciprocity” (sharing of resources without strict 
obligation to repay) towards a more “balanced” type of reciprocity (less moral, more 
economic way of sharing resources) (Seymour-Smith, 1986, p.241). A study from 
Somalia (Serkkola, 1988) concluded that a serious disease like TB changes the “normal 
social order”. Attitudes and behavioural patterns were shaped on the basis of values and 
norms rationalizing both avoidance and support, and responsibility for a diseased person 
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was found not to correspond with the traditional loyalty founded on kin. According to 
Coleman (1997, p. 148), stigma may be used to justify exclusion based on fear of having 
to share material resources for prolonged periods of time. Thus, economic exclusion can 
be legitimized by viewing it as a consequence of a moral exclusion, since emotional and 
cognitive distancing is linked with other types of distancing (Reutter et al., 2009). In 
paper II we argue that the professional part of the health care system may counteract 
prolonged use of existing support mechanisms because stigmatizing notions about TB 
are brought back and confirmed within the social reality of lay people.  
 5.4.2 Oslo/Akershus, Norway 
We found in the Norwegian study that a majority of patients experienced DOT as rigid 
and inflexible and felt that they had no power to influence their own situation (paper IV). 
Those who had jobs or that attended school experienced that this lack of flexibility and 
unpredictability in how the treatment was organized had high social costs. Those that did 
not have a permanent job were the most vulnerable (paper IV). Men in particular 
described DOT as humiliating and related this to the powerlessness they felt by having 
to accept a treatment that interfered with their social life and their working life. The 
information/practice of DOT was experienced as authoritarian and lacked transparency, 
in which made several of the participants view DOT as a treatment that were only 
practiced on immigrants from poor countries.  
Only one patient in the material interrupted treatment, which may be due to the 
close monitoring of a relatively small patient group. Most patients had an address or a 
telephone number where they could be traced if they interrupted, making it difficult to 
“disappear” from the system. The only patient in the study who did interrupt treatment, 
claimed she was given up by health personnel due to the unpredictability she caused by 
her frequent change of address. Another explanation for why so few patients seem to 
interrupt their treatment may be that the Norwegian health personnel gave information 
that provided a more concise and logical explanation of the disease and its treatment. 
Patients explained how the information they received from Norwegian health personnel 
made them realize that TB was a “normal disease”; that it was not chronic; that it was 
treatable and that they would not die. The bacteria were perceived as an agent possible to 
fight; that carried less alternative explanations; and subsequently less stigma. Many 
patients felt they avoided “talk” and judgmental attitudes by avoiding the term 
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tuberculosis and instead telling people that they were suffering from an “infectious 
disease” or a “bacterial disease”. This “impression management” was often facilitated by 
the absence of the “classical” signs of TB (as pronounced weight loss and visible 
weakness); since few of the participants in this part of the study suffered from such 
symptoms.  
Another important factor, not elaborated on in the papers from Norway (paper III 
& IV), is that patients tended to believe that the medicine they got in Norway was better 
than what they would receive in their home countries; strengthening the belief in the 
existing bio-medical treatment. While patients in Ethiopia seemed to stay in treatment 
because they feared the (insecure) consequences of interruption (dying), patients in 
Norway seemed motivated to stay on treatment because they knew they would survive. 
Since most patients felt confident that they were not going to die or be chronically ill, 
they did not depend on engaging in vulnerable reciprocal relationships to secure 
economic or other types of support from relatives and friends. Such confidence was, to a 
certain extent, supported by the fact that they were receiving treatment within the frames 
of a welfare state. Not having to expose ones vulnerability, nor depend on others, may 
have reduced felt as well enacted stigma. Thus, the social and financial burden of being 
ill appears to be far less in this context, which may serve as the main reason why people 
complete their treatment regimens.   
5.4.3 Cross cultural perspectives – the burden of DOT  
Findings related to patients’ and health workers’ experiences of TB treatment (DOT) in 
Norway and Ethiopia show that different contexts produce different types of 
experiences. However, there are similarities related to how the organization of treatment 
is experienced, and how DOT affects certain patient groups. In Ethiopia we found that 
those struggling the most to manage treatment were members of vulnerable or 
marginalized groups; the poor; the homeless; single mothers; those employed as day 
labourers; those working in the private sector; those lacking rights as an employee; those 
without social security rights; those having migrated to Addis to get a job or to get TB 
treatment; and those lacking a social support network.  
 Comparing the findings in Ethiopia with the findings in Norway we see parallels. 
One parallel is the rigidity in the system, and a lack of individual adjustments to the 
patients’ social and working life, which cause barriers that make it difficult to 
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simultaneously attend to demands related to treatment and demands related to other 
areas of life. Further, even though the extreme poverty related barriers in Addis Ababa 
are not comparable to the situation for TB patients living in Norway, there is still a 
tendency that the most vulnerable patients are those who have the most difficulty 
adapting to the DOT system. Paper IV shows that patients in Norway who did not have 
permanent jobs were particularly vulnerable. This is in line with the findings from 
Ethiopia. One group of participants in Norway had provisional engagements involving 
shift work or work agreements made on a day-to-day basis. These conditions caused a 
vulnerability that participants sought to compensate for by presenting themselves as 
reliable, flexible shift workers; qualities difficult to assert due to the DOT arrangement. 
Many of those that had been through long diagnostic processes had not been in a 
position where they could claim a sick leave, and due to illness they had gradually 
reduced their number of shifts. This led to an unfortunate economic position both before 
and during the treatment. Others described difficulties receiving money through the 
social services after they had been diagnosed; either because their work was not 
documented or because their previous income was based on work agreements made on a 
daily basis. There were cases where patients had their electricity and telephone closed 
due to inability to pay the bills. Many were troubled because they could no longer afford 
to send money to relatives in their home countries.  
In a study from India, Singh et al. (2002) reported an algorithm that excluded 
mainly poor and disadvantaged patients. This algorithm was based on “suitability 
criteria’s” for DOT, while other groups were considered less suitable. The less suitable 
were socially marginalized groups such as the poor, those not having ration cards, 
members of the lower castes, alcoholics, and abandoned or widowed mothers. Other 
criteria making patients less suitable for DOT were a low level of integration in the city 
(such as patients that had recently moved to Delhi, patients staying in Delhi for a short 
time, or patients being recent migrants to Delhi with their families still living in the 
village), and patients who were daily wage earners, or a contract or factory worker with 
shift duties. It was also important to decide whether patients were difficult to reach or 
not; living in a house difficult to locate or in a house being far from the clinic. The 
migrants from rural areas (i.e. the poorest) were by health personnel described as those 
that could be ‘least trusted’ (Singh et al., 2002). The criteria made to disqualify patients 
in this study serve as a description of the groups that experienced the most problems 
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adapting to DOT in our study as well. These criteria acknowledge the fact that these 
particular groups most likely will struggle to adapt to DOT, and subsequently represent 
patients that might have a poor outcome. The study also serves as an illustration of how 
vulnerability and social inequality erroneously may end up being interpreted and treated 
as recalcitration.  
Patients in both studies reported a series of humiliating experiences being treated 
by DOT (paper I & IV).  However, even though the stories that were told by patients in 
Ethiopia mirrored humiliating experiences, humiliation seldom emerged as an explicit 
notion in the interviews conducted in Ethiopia. There could be different explanations for 
this, but Maslow’s hierarchic theory of needs can represent a possible explanation. 
Maslow introduces a hierarchy of five levels of basic needs: Physiological needs (needs 
of oxygen, food, water etc), safety needs (needs for protection, feeling safe), social needs 
(needs of love, belongingness, friendship), needs for esteem (needs of self-respect, self-
confidence, appreciation, social status, dignity), and needs for self-actualization 
(realization of personal abilities, aims). Beyond these needs, higher levels of needs exist, 
including spiritual needs and needs for understanding (Maslow, 1943). Even though 
Maslow’s theories have been criticized of being linear (Neher, 1991), it is possible that 
individuals who manage their illness in the midst of poverty, hunger and hopelessness, 
are less receptive – or rather – may suppress needs related to self-esteem. Subsequently, 
patients who experience that their physiological and safety needs are covered may 
express social and psychological needs more explicitly. Another explanation may be that 
there are differences in the expectation of autonomy, and that DOT (to some extent) may 
be accepted in one context, while being experienced as humiliating in another context.         
Let us return to the debate between Barnhoorn and Farmer (Barnhoorn & van der 
Gest, 1997; Farmer, 1997), about which factors are most relevant in understanding why 
patients may not complete treatment. The discussion centered on to what degree themes 
like health beliefs are important in understanding non-compliance to TB treatment. 
Farmer argued that these approaches are overemphasized and that studies fail to 
recognize the wider influences on patients’ lives such as poverty, conflict, political 
instability, and racial and gender inequalities. This study shows that Farmers emphasis 
on structural barriers is of major importance in understanding the burden of illness and 
treatment. Structural barriers in the society at large can explain, or at least partially 
explain, why and how people interpret and manage their disease and the treatment in the 
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way they do. However, it is also important to understand the impact of local cultural 
interpretations and practices, in particular when such practices impact on TB patients’ 
ability to manage treatment. An example of this is the importance of understanding the 
use of the illness taxonomy bird; a cultural conception used in both the folk, popular and 
the professional part of the health care system in Ethiopia. Even if bird cannot be 
directly related to treatment interruptions, it is a component that guides beliefs and 
activities among TB patients and health personnel; from symptom recognition and 
management, to diagnostic procedures; all activities of which indirectly affect treatment 
adherence. Yet again, the extensive use of the illness taxonomy bird can be understood 
as poor people’s efforts of preventing further loss of social and economic power.          
Assessing the health worker-patient relationship we might find a dimension that 
somehow corresponds with both Barnhoorn & van der Gest and Farmers’ perspective.  
In a patients’ search for diagnosis and treatment, they depend on health personnel’s 
competence, but also on their ability and will to provide information that might empower 
patients to make informed decisions in their efforts to regain their health. Patients also 
need environments where they feel free to ask questions and gain the knowledge 
necessary to make such decisions. Homedes and Ugalde (1993) draw attention to the 
socio-economic, educational, cultural and linguistic differences between patients and 
health workers and how that complicates the health worker-patient relationship. In Costa 
Rica, they followed 404 consultations where 1023 medications were prescribed, and 
found that only 10 of those consulted asked for clarification about the prescription. 
Homedes and Ugalde claim that patients with low income or low education seldom ask 
for clarification or additional information, and even less frequently question their 
doctors’ practices.  
In the Ethiopian context we found that patients were not provided the information 
they needed to understand their symptoms and their treatment. Similarly, patients did not 
feel free to ask for clarification, or to question diagnostic procedures or treatment 
practices. A variety of causal attributions assigned by the individual or the health 
workers affected the patient’s ability to access, obtain and maintain relevant treatment. 
In line with Barnhoorn & van der Gest, what finally killed the participant that 
interrupted treatment and went for “holy water” (paper II) was his confusion over the 
etiology, symptoms and prognosis of his disease; a confusion that was strengthened in 
the interaction with local health workers. A mixture of cultural and religious 
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interpretations served as a way of disciplining the patient group, so that they would stay 
focused and not become recalcitrant during treatment. By withholding and adjusting 
information a desired power imbalance was preserved, and patients remained dependent, 
vulnerable and powerless. According to Kleinman (1980, p.52) the power to legitimate 
certain interpretations as the “right” or only ‘clinical reality’ is not equally distributed. 
The professional sector is sovereign because social power, to a large extent, depends on 
institutionalization, and while the popular sector is diffused, the professional sector is 
largely institutionalized. Subsequently, the power behind the explanatory models 
provided by health workers in this setting was considerable. 
Counteracting dialogues based on patients’ needs or premises, and hence 
participation in their own health care, was also clearly illustrated in the Norwegian 
material. In Norway there are regulations, like the Patients’ Rights Act (Helse- og 
Omsorgsdepartementet [HOD], 1999), which underline a patient’s right to participate in 
their own health care, including the right to chose between available and medically 
sound methods of examination and treatment. To be able to ensure such rights patients 
should receive information necessary to obtain insight into her/his health condition and 
into the content of care. There are also TB specific guidelines to secure that individually 
adjusted treatment plans are prepared – to facilitate the treatment (DOT). Still, the 
findings illustrate that the information is given in ways that do not actively invite 
patients to take part in decisions about how to organize their treatment. Contrarily, it is 
given in a way that leaves patients with the impression that there is no room for 
negotiation; rather there are strong indications of sanctions towards resistance in any 
form. As argued by Waitzkin (1979), withholding or adjusting information, and 
implying sanctions, may reduce patients’ subjective sense of autonomy and their 
objective power to influence their treatment. As in the Ethiopian context, TB patients in 
Norway remain dependent, vulnerable and powerless.  
A study based on interviews with health professionals involved in TB control in 
various parts of the world found that many interpreted the role of the DOT provider as 
going beyond observing whether patients actually swallowed their drugs. Especially 
those working in high-income settings saw DOT as a continuous process of negotiation, 
in which patients’ individual needs and characteristics were attended to throughout 
treatment (Macq et al., 2003). However, our study illustrates how authoritarian, less 
92 
 
patient friendly models of DOT can be practiced in both high-income and low-income 
contexts. Subsequently, this study serves as an example that one cannot assume that 
DOT implies protection of patient autonomy; not even in contexts where one would 
expect autonomy to be of high value.    
5.4.4 Power structures  
Farmer (1999) argues that an understanding of the experience of illness needs to 
consider the micro level of the individual within the context and influence of 
macro level structures, processes and interactions. In other words, in order to 
understand how people interpret and manage TB in different contexts, we need to 
recognize how larger structural forces limit the patient’s ability to access, maintain 
and complete therapy. Some have claimed that a focus on macro level structures 
(“structural violence”) may lead to few concrete commitments to act (Barnhoorn & 
van der Geest, 1997). Barnhoorn & van der Geest claim that a key question is 
whether one should start by trying to change society’s unjust structures, or whether 
one should try to understand, and change, patterns that reproduce such structures at 
the individual level. There are probably no clear answers to these questions. Still, 
to prevent some of the barriers and burdens faced by TB patients, there is a need to 
raise awareness of how processes and interactions between the individual, the 
community and (representatives of) the health care system, might be shaped by 
wider, less transparent power structures. A useful analytic tool for describing a 
patient’s experience of being ill is the conceptual framework introduced by 
Scheper-Hughes and Lock (1987). This framework allows for an understanding of 
an individual’s body from three perspectives; as subjects and single bodies, as 
social bodies, and as subjects influenced by a body politic. Body politic denotes 
the possible ways an individual and her/his body can be influenced and 
manipulated by political and economical processes. As pointed to by Farmer 
(1997), the risk is that individual behavior, adjusted to structural barriers outside 
the individuals’ control, is interpreted as a product of the subjective or the social 
body. As such, the political body is overseen, and as a result how the political 
body is influencing the social body and social structures. Further, how these social 
structures and social interactions influence the individual and the experience of 
being ill (Scheper-Hughes & Lock, 1987). 
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In an attempt to understand how macro-level structures of domination and 
oppression are reproduced in micro-level interactions between individuals, Waitzkin 
(1979, p.602) uses doctor-patient encounters to illustrate how medicine serves as an 
institution of social control. Social control is referred to as “mechanisms by which 
agencies of the society achieve people’s adherence to norms of appropriate behavior”.  
In line with Trostle (1988) he argues that scientific knowledge is shaped and reinforced 
by social institutions, and that these social institutions are structural expressions of the 
power- imbalance that exists between different social classes. He argues that 
mystification, either through information control or the use of jargon, maintains 
stratification in the relationship between patients and physicians. Instead of sharing 
information with fully informed patients the physician maintains the dominance in the 
interaction, and decreases the patients’ subjective sense of autonomy and objective 
exercise of power. Thus, existing power structures in the society at large are exercised 
and maintained in face-to-face interactions between health personnel and patients. These 
perspectives might help us understand how it is possible to implement and practice 
authoritarian and patient un-friendly treatment systems like DOT, across cultures. As 
exemplified in both contexts of our study, the interaction patterns between patients and 
health care workers are characterized by the power-imbalance that some would say is an 
inherent part of most health worker-patient relationships. However, the restrictions on 
civil rights and autonomy, as well as the associated burdens faced by patients, are 
beyond what one would normally consider as acceptable losses, at least in the western 
world.   
Foucault (1975), points to how a society may respond to an abnormality, like an 
infectious disease, by declaring a “state of emergency” with subsequent restrictions or 
withdrawals of individual rights. In public health discourse, members of the middle class 
have historically been portrayed as possessing the valued qualities of self-denial and 
self-efficacy. Individuals from the working class on the other hand have been pictured as 
dirty, lazy, immoral; and without capacity of resisting their inclinations (Lupton, 1995, 
p.75). Disciplinary measures, including different types of coercive measures, have 
subsequently primarily been directed towards less-privileged and less powerful members 
of society. Public health movements have also become increasingly concerned with 
maintaining the boundaries of populations, preventing those living within the border 
from being contaminated from those coming from the outside. Thus, not only the poor 
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and the working class, but also immigrants have increasingly been portrayed as targets in 
public health discourse and practices (Lupton, 1995, p.38).  
Coker (2000, p.25) suggest that a common thread that runs trough public health 
areas like immunization, mental health and infectious diseases like TB, is that coercion 
always begins with those least able to resist or argue: children, the mentally ill and the 
poor. At the end of the nineteenth century, there was a shift from controlling TB towards 
the control of the behavior of those with TB. There was an increasing use of coercive 
measures, but such measures were not used uniformly, but focused towards the lower 
classes. In 1904, a physician in Denver, called Henry Sewall said: “TB is a respectable 
disease if you have money, but without it, it is a mean low-down business” (Coker, 
2000, p. 40). Coker draws parallels between the increasing use of coercive measures in 
the end of the nineteenth century and the use of coercive measures in the 1980 and early 
1990 in New York City. New York City was the first to implement DOT, and public 
health policy allowed health officials to confine those that were assumed to represent a 
danger to society. Even if this is a context known for its strong focus on autonomy, such 
measures did not seem to lead to any protests. As in the previous century, those that 
were involved were poor, homeless, uneducated immigrants; groups without power.  
The papers from Ethiopia (I & II) suggest that impoverished, vulnerable patients 
may hesitate to approach the health personnel with questions or requests of any kind; the 
power-imbalance being evident and often intentionally maintained by health workers. In 
the papers from Norway (III & IV) we found that vulnerable patients, often with an 
unclear residence permit or poor language skills, felt that the distance between 
themselves and those in charge of their treatment was insurmountable. Even if patients 
in both contexts were exposed to coercive measures, in which decisions lacked 
consistency and transparency, and which imposed heavy burdens, few participants 
argued or resisted in any way. The study shows how participants in both contexts lack 
advocates or interest in layers of the population with political or economical power. As 
one of the participants in the Norwegian study remarked; “if the treatment I receive had 
been given to an influential Norwegian we would have read about it in the newspaper”.   
Trostle (1988, p.1300), argues that medical compliance is better understood if 
viewed as an ideology; “a system of shared beliefs that legitimize certain norms and 
values at the same time as they claim to be based on empirical truths”. Such ideologies 
facilitate transformation of power into authority and hence legitimate control. As pointed 
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to by Hurtig et al., a treatment system like DOT has the effect that focus is placed on 
patients’ failures while, at the same time, one is “masking the failures of the system to 
enable patients to comply” (Hurtig et al., 1999, p.558). By focusing on patients’ 
behavior, even coercive measures, which assumingly are addressing the problem (patient 
behavior), may be legitimized. A question to be asked then, is whether such ideologies; 
with its authoritarian, uniform approach would have been announced and widely 
implemented if TB was distributed equally between social classes. How would any 
wealthy layer in any population respond to a request of renouncing rights related to job 
security, food security, and physical, emotional or social wellbeing? Power is not 
equally distributed between classes, and neither is the power to resist (Lupton, 1995). A 
typical TB patient is poor and black, with little power to exercise her or his autonomy in 
the meeting with social institutions that are structural expressions of the power-
imbalance that exists between different social classes. As discussed in paper IV, DOT, as 
one among many knowledge practices, entails an intervention into individual lives that 
are already infused with knowledge practices, and individuals may respond within a 
continuum of appropriation to resistance. Poor people and minority groups may be 
accustomed to subordinating themselves to authorities, facilitating self-disciplining and 
subsequent control. Another dimension that may explain lack of resistance is articulated 
by Lupton (1995, p.46). She argues that the discourse and practices of public health, for 
a long time, have carried with them moralistic and discriminatory meanings disguised 
under a utilitarian logic. During the Reformation the prevalent opinion was that sin and 
immorality were predisposing causes of illness, and such moral undertones can be 
argued to influence the way we handle diseases today (Coker, 2000, p.34). When 
diseases seem difficult to control and medicine appears to be ineffective in treating it, 
ideas of blame that can be traced back to medieval notions of sin and punishment, purity 
and contagion, may evolve. In line with Coker (2000), she shows how definitions of 
groups being “dirty” and “contagious”; in need of extra surveillance, for centuries have 
corresponded with the poor, the working class and immigrants (Lupton, 1995, p.46). 
With the emphasis DOT has placed on the fault of the individual, there is a risk that such 
notions will be used to develop certain knowledge practices with the aim that individuals 
internalize and discipline themselves according to this knowledge. Health workers may 
be withholding and adjusting information, partly to preserve the power imbalance; partly 
to facilitate the treatment, and partly to discipline. By the use of subtle threats of 
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punishment by authorities like the police or even God; cross culturally exemplified in 
this study (paper II & IV), the purpose of the treatment gets blurred.  
It has been argued that a practice that carries major consequences for patients’ 
autonomy and civil rights is shifting its emphasis from prevention of drug resistance to 
that of policing treatment compliance (Coker, 2000, p.11). Foucault (1975) argues that 
one of the characteristics of disciplinary societies is that all means of correction aim at 
creating a subject who obeys without question, and in order to achieve this goal secrecy 
and control over possible means of punishments is needed. The less control patients have 
over the disease, its cause and its possible treatment, the easier it is to establish a 
relationship of domination in which individuals habitually obey. Our study suggests that 
what our participants had in common was not culture, but TB and powerlessness.  
5.5  Ethical questions related to DOT  
DOT has been debated from an ethical and human rights perspective. It has been 
claimed that there has been too little focus on whether the implementation of DOT has 
been user-friendly, and culturally-sensitive enough, and whether or not enforced daily 
clinic-based treatments are ethically justifiable (Porter & Ogden, 1999; Lienhardt & 
Ogden, 2004). Universal DOT has been challenged as an unethical intrusion of patients’ 
autonomy, and as a violation of constitutional claims implying that the least restrictive 
means are to be used (Hurtig et al., 1999). Questions has been raised addressing power-
imbalances between health care workers and the TB infected (Porter & Ogden, 1997; 
Hurtig et al., 1999); It has been argued that the discourse of DOT is one of domination 
and control (Coker, 2000; Ogden, 1999), while others have argued that a “marginal 
intrusion” on patients autonomy, represented by DOT, is justified by the public health 
benefits that can be achieved (Bayer, Dubler, & Landesman, 1993). It has been claimed 
that TB control efforts that ignore socio-economic conditions or that require programs 
that affects patient autonomy in vulnerable populations, may aggravate already existing 
inequities and inequalities (Verma et al., 2004).   
During the last few years the IUATLD and the WHO have made attempts to 
address some of the ethical issues within TB control. In 2004, IUATLD appointed an 
Ethics Advisory group to review clinical trials, scientific programmes and policies. This 
group has produced policies and operational guidelines based on the Helsinki 
Declaration (Fanning, 2008). In 2008, the WHO’s Ethics and Health Team of the 
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Department of Ethics, Equity, Trade and Human Rights and the Stop TB Department 
established a WHO Task Force on Addressing Ethical Issues in TB Care and Control 
Programmes. A WHO document entitled: ”Ethical guidance for TB Care and Control 
Programmes” is meant to be published within 2010 (WHO, 2009f) and to guide 
stakeholders in implementing TB control programs in an ethical manner. 
5.5.1 Ethical frameworks addressing public health interventions  
There are several frameworks articulated by ethicist’s used to assess the justification of 
public health interventions such as DOT. These frameworks include a loose set of moral 
considerations and they to a great extent overlap (Childress et al., 2002; Kass, 2001; 
Upshur, 2002; Bensimon, Ross, & Upshur, 2007). Childress et al. (2002), point to five 
different principles that need to be weighed when considering ethical concerns of public 
health interventions:  
• Effectiveness (infringing on one or more moral considerations should be based 
on public scientific evidence that the proposed intervention will do more good 
than harm)  
• Proportionality (benefits of any proposed intervention outweigh any negative 
features and effects; such as infringement of patient autonomy)  
• Necessity (any intervention that raises moral concern, should not go beyond what 
is necessary to achieve the goal; e.g. provision of incentives versus coercive 
measures)  
• Least infringement (measures implemented should seek to minimize any moral  
infringements)  
• Public justification (public health agents that implement practices or policies that 
infringe one or several moral considerations have the responsibility to provide 
solid, transparent explanations and justifications acceptable to the public).  
The principles are intended to help decide whether public health measures legitimize 
overriding values such as individual liberty and justice, in specific cases. Each principle 
may conflict with each other, and each of the principles may have to yield in certain 
situations (Childress et al., 2002). The principles have a dynamic and negotiated nature, 
which facilitates their use in different cultural contexts. As underlined by Childress et 
al., even though the general moral considerations that are reflected in the principles find 
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support in various societies and cultures, it is impossible to determine their weights in 
advance. In some cultures, values such as individual liberty might be valued as much 
more important than in other cultures. Whenever conflicts arise over concrete public 
health measures, the most important thing to recognize is the need to balance such 
general moral considerations in light of the particular context. Upshur (2002) includes 
the principle of reciprocity in a discussion on relevant ethical principles in public health: 
If burdens are imposed on a person in order to comply with public health requests, the 
community should “pay back” by ensuring that burdens like use of time or income are 
minimized or compensated for. Addressing the principle of reciprocity could help when 
balancing moral considerations where conflicts arise.    
A central ethical issue in TB control has been balancing patients’ rights and 
autonomy with the protection of the greater public health (Verma et al., 2004). In a 
critical review of the evidence, ethics and effectiveness in the management of TB, 
Verma et al. base their discussion on what is considered the primary consideration in 
many of the ethics framework for public health; the principle of effectiveness and the 
principle of least restrictive means. They refer to Volmink and Garner’s (2001) 
systematic review which provides no evidence that DOT improves cure or treatment 
completions rates, and argue that lack of solid evidence, combined with neglect of use of 
least restrictive means, are particularly problematic when vulnerable segments of the 
population are targeted. Verma et al. refer to Kass who states:  
“As a rule of thumb, the greater the burden posed by a [public health] program, – 
for example in terms of costs, constraints on liberty, or targeting particular, 
already vulnerable segments of the population – the stronger the evidence must 
be to demonstrate that the program will achieve its goals” (Kass, 2001, p.1776-
82).   
Even though different moral considerations may be weighed differently in different 
contexts, we assume that WHO’s global implementation of DOT (and the forthcoming 
ethical guidelines) are grounded in general moral principles. In the following discussion, 
I seek to illustrate how different aspects of the ethics of TB treatment needs to be 
questioned on the basis of two concerns: First, the preservation of dignity in interactions 
with the health services, and second, the moral and human rights argument to ensure 
access to treatment by patients as well as remaining healthy after treatment is completed.        
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I use the concept “autonomy” and “respect for people’s autonomy” in line with 
the understanding put forward by Beauchamp and Childress (2001). They argue that to 
respect an autonomous person is, “at a minimum, to acknowledge that person’s right to 
hold views, and to take actions based on personal values and beliefs” (2001, p.63). This 
implies that respect for people’s autonomy involves acknowledging peoples decision-
making rights, but also to help people build up or maintain their capacities to make 
autonomous choices. Disrespect for people’s autonomy involves “attitudes and actions 
that ignore, insult, or demean others’ rights of autonomy” (2001, p.63). Beauchamp and 
Childress (2001) underline that hardly any person, or any action, will at any stage or 
situation be fully autonomous, and for an action to qualify as autonomous, it requires 
“only a substantial degree of understanding and freedom from constraints, and not a full 
understanding or a complete absence of influence” (2001, p.59). Appropriate criteria of 
“substantial autonomy” will have to be addressed within specific contexts (Beauchamp 
& and Childress, 2001, p.60).     
5.5.2 How do our findings add to the discussion?  
We have found that burdens, in terms of indirect and direct costs, and constraints on 
liberty and autonomy, are affecting vulnerable segments of the population. In Ethiopia 
(paper I) we found that those who were the most vulnerable, such as the very poor, 
single mothers, and working immigrants from rural areas, were the ones that struggled 
the most to live up to the demands of daily clinic attendance. Some of these patients – 
representing groups that DOT was designed to attend to – were forced to interrupt 
treatment, and lost access to further treatment and follow-up. In Norway (paper IV) we 
found the same tendency; the most vulnerable patients, such as those without permanent 
jobs, were those that had most difficulties in adapting to DOT. In both contexts we have 
provided examples of how vulnerable patients are deprived of the possibility to 
participate in their own health care due to the power-imbalance in the patient-health 
worker interaction. We have suggested that such power-imbalance is reinforced because 
of the characteristics of the patient group; being poor, illiterate, or having an immigrant 
status. Other studies have also documented how vulnerable patients may experience new 
and insurmountable barriers in relation to organization of treatment (DOT) (Munro et al., 
2007a). Viewed against a lack of evidence that DOT improves cure or treatment 
completion rates, we can question to what degree the principle of effectiveness, and the 
related principles of proportionality and necessity are being addressed. It is difficult to 
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see that DOT is doing more good than harm when patients that initiate treatment risk 
being excluded from further treatment and follow-up because they cannot adapt to the 
system (paper I). It is difficult to see that potential benefits of DOT outweigh any 
negative features and effects if patients don’t have the opportunity to optimize their 
health while undergoing treatment (paper I). It is difficult to see that DOT outweighs any 
negative features if patients do not manage to hold on to their jobs or social positions 
while on treatment (paper I & IV).   
Even though there is a lack of evidence of the effectiveness of DOT, standardized 
DOT has been widely implemented without considering least restrictive means. This 
also applies for the two different contexts in our study. Least restrictive means imply 
that one would implement efforts according to a continuum where self management 
(potentially with some sort of support) where the least restrictive means, and where 
detention in a health care setting would represent the other end of the spectrum of 
restriction (Verma, Upshur, Rea, & Benatar, 2004). Or as argued by Coker (2000, 
p.118); least restrictive means imply that “people must be allowed to fail before being 
condemned for that failure”. Doyal (2001) has argued that violation of patient autonomy 
can only be justified if every effort has been made to optimize the success of treatment 
without such violation. Our material shows that even in a low-endemic, high-income 
context like Norway, efforts are not being made to optimize the success of treatment 
without such a violation. On the contrary, patients that clearly express their will to 
initiate and adhere to TB treatment are forced into a treatment regimen without being 
allowed to display their willingness to comply and subsequently retain their autonomy 
throughout treatment (Coker, 2000). Based on our study, it is difficult to see how 
standardized DOT in any way can be reconciled with the principle of least restrictive 
means, since it imposes a coercive treatment regimen on patients that initially – and over 
time – clearly have verbalized and demonstrated their wish to comply (paper IV).       
It has, however, been argued that because DOT is standardized, health workers’ 
initial treatment decisions are not violating another ethical principle; the principle of 
justice: By emphasizing equal treatment for all, acts of discrimination may be prevented 
(Dubler, Bayer, Landesman, & White, 1992). Another argument has been that it is 
difficult for health workers to predict who will comply with treatment, and basing 
selection on socio-demographic variables may lead to discrimination (Iseman, Cohn, & 
Sbarbaro, 1993). Both these arguments were used to legitimize standardized DOT 
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among health personnel in Norway (paper IV). However, even though DOT is 
standardized we found that health authorities still use their professional power to decide 
whether an individual is within the bounds of the orderly and the normal, and 
subsequently whether or not to be treated by DOT. Furthermore, evaluation practices 
conducted by those in power lacked transparency and appeared arbitrary (paper IV), 
which may reinforce vulnerable patients’ feelings of humiliation and disempowerment. 
As argued by Childress et al. (2002), public health agents that implement practices or 
policies that infringe on one, or several moral considerations, have the responsibility to 
provide solid and transparent explanations which are acceptable and understandable to 
those involved.   
Doyal (2001, p.213) underlines that any coercion used in persuading patients to 
submit to DOT must be balanced with help to “develop the self-respect and self-control 
necessary for them to optimize their own health in the future”. Our study indicates that 
the practice of DOT does not encourage such empowerment. In Ethiopia (paper II), we 
found that patients were not provided with the knowledge necessary to make sense of 
their own disease and treatment, so that they could ensure future healing and avoid re-
infection. Furthermore, the treatment was not adjusted in a way that made it possible to 
attend to basic needs. This could cause further impoverishment and disempowerment 
(paper I). In Norway (paper IV) we found that the practice of DOT had consequences for 
patients’ working lives, school attendance, and social lives – and served as a barrier to 
vulnerable patients’ efforts at societal integration.  
In both contexts we found that health personnel lacked respect and sensitivity in 
their meetings with patients. Health workers seemed to loose sight of the individual 
patient and their lives in their effort to perform one main task; DOT. Emotional distance, 
combined with lack of continuity, and minimal time use, prevented patients from 
participating in their own treatment – and could serve as a source of continuous 
humiliation. The use of unskilled or poorly trained health workers served as another 
cause of why patients where exposed to undignified and autonomy reducing practices 
(paper I & IV). As argued by Porter and Ogden (1999), the danger in implementing a 
target driven program is that health workers may be more focused on achieving these 
targets than in caring for the patient and their future health and lives. Within this 
potential conflict also lies the potential abuse of power. Porter and Ogden (1997), argue 
that health interventions may embody power-imbalances between the receivers and 
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deliverers of the intervention, in which e.g. the health workers are the ones that decide 
when, and how the intervention is going to take place. In their discussion they refer to 
Hall (1992), who argues that even if people give away some degree of autonomy in 
exchange for a membership in a community, parts of the individual autonomy will still 
remain. Hall continues by questioning to what extent this part of the autonomy is 
attended to within public health measures. A practice where patients comply with DOT 
but still experience being punished for being delayed in collecting the medicines (paper 
I) is an example of how such residual autonomy is left out of the equation. A practice 
where patients are denied storing their own medication, even if this implies daily delays 
to work due to unpredictable home based services (paper IV), is another example. DOT 
is based on the ideology that all TB patients are potential defaulters, and within that 
assumption lays the potential for condemnation. One might argue that treating everyone 
the same is just, but a uniform program that violates patients’ autonomy, and that 
humiliates patients, might first of all confirm that TB patients are poor and powerless, 
and potentially to be blamed for their own condition. On the basis of our study it seems 
legitimate to ask whether neglect of care and dignity in the services is legitimized and 
facilitated by the receivers of DOT representing a group without power.  
A related question is whether the disregard of the heavy burdens imposed on 
vulnerable patients are neglected due to similar power-structures. The principle of 
reciprocity emphasizes that when persons experience a loss of autonomy to protect the 
community, the community should “pay back” by ensuring that burdens like use of time 
or income is compensated for (Upshur, 2002). It is difficult to see that any efforts to 
compensate for burdens are made when patients are told to walk long distances to access 
daily treatment no matter how ill they are (paper I). It is difficult to see that efforts to 
compensate for burdens are made when rigidity in the systems makes it impossible to 
attend to daily work or social activities (paper I & IV). This study has illustrated that the 
principle of reciprocity is attended to, to a surprisingly little extent. Surprisingly – 
because reciprocity should not only be considered as “pay back”, but also an assurance 
of adherence, and subsequently an element of effectiveness. This study provides, 
disturbingly, many examples of practices that are not ethically sound, and that do not 
legitimize systematic infringements on not only patients’ autonomy, but basic human 
rights.  
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5.6 Future challenges  
The intertwined problems of delay in seeking treatment and interruption of treatment 
among individuals with TB are illustrated throughout our study. Patients face burdens, 
barriers and enablers at different stages of illness and treatment, which are dependent on 
or reinforced by individual, cultural, social, economic and political factors. Some of 
these burdens and barriers, faced by TB patients, may not be relieved until society’s 
unjust structures are changed. However, there are processes and interactions between the 
individual and various parts of the health care system that might, if modified or changed, 
reduce some of the burdens and limit some of the barriers patients face in their search for 
health.  
5.6.1 Ensuring early diagnosis   
Exploring the causal attributions to TB, made by people in different contexts, will 
facilitate a better understanding of health seeking behavior in all stages of the disease. 
The causal attributions will not only affect patients’ priorities and strategies, but also 
affect how they psychologically and socially cope with the disease. Waisbord (2007) 
relates that lessons drawn from anti-stigma interventions in health programs show the 
need of questioning dominant beliefs about diseases, and the need to provide supportive 
environments where people feel free to express themselves and their disease. Since the 
social stigma that is attached to TB seems to represent a barrier in all stages of the 
disease, questioning dominant beliefs in all parts of the health care system may be an 
important step in creating an environment where patients are encouraged to seek help.  
Many studies have emphasized that when one seeks to change knowledge and 
practices, building on local beliefs and practices are a more promising course of action 
than only relying on providing biomedical information that replaces the existing 
knowledge and practices (Vecchiato, 1997; Waisbord, 2007). This study illustrates the 
importance of identifying primary or substitute motives behind different practices, since 
domination, power and exploitation can represent parts of what at first glance can be 
interpreted as “indigenous knowledge” and “local practices”. Within the same line of 
argumentation, it is important to realize that overlapping explanatory models can be 
inexpedient and have serious emotional, social and economical consequences for 
patients.  
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Health seeking behaviors are often described as governed by factors that patients do not 
control (Farmer, 1999). To increase such control, patients need to understand their 
disease, including the logic connection between TB’s etiology and its treatment. Patients 
need to know how TB is transmitted; how early symptoms can be manifested; how the 
disease may develop; how it can be prevented, and how it can be cured. Even though 
there are multiple causes of TB, which may correspond with lay explanatory models 
(such as poverty), the causal concepts that are being addressed trough diagnostic 
procedures and treatment in the professional part of the health care system, should be 
made available to patients.  
Regardless of the kind of knowledge an individual possess, knowledge in itself 
will never enable people to overcome the structural and socio-economic barriers that 
restrain and complicate health seeking behavior. However, increased knowledge may 
limit the risk of resources being drained from patients due to repeated visits at the same 
level in the health care system. The findings from Ethiopia are one of many examples 
that the private sector needs to be formally involved in TB treatment if TB detection 
rates are to be increased and infectious cases are to be diagnosed as early as possible. 
This is in line with WHO’s Stop TB Strategy (WHO, 2009c), which encourages the 
engagement of all types of care providers. Special attention should be given to improve 
TB detection, referral or treatment in sectors where financial incentives may reinforce 
methods of diagnosis and treatment that are not in accordance with national strategies.     
 Even if the private sector becomes further involved in TB diagnosis and 
treatment this might not represent the only solution. People may still end up using a lot 
of time and resources in their search for a diagnosis among the variety of available 
services within the health care system. Measures strengthening and improving the public 
sector in a way that makes it more competitive with the private sector might represent a 
more sustainable solution. To achieve this, public services must be made more user-
friendly. Several studies have shown that unfriendly, disrespectful and poorly motivated 
health personnel discourage patients from using public health care services (Storla et al., 
2008). Health personnel need to be trained in how to communicate and interact with 
patients in a way that preserves dignity and enhances autonomy. Exploring dominant 
beliefs among health workers may promote non-judgmental and supportive treatment 
environments. To avoid stigma and time-use associated with queuing up in public 
clinics, more flexible opening hours is one adjustment that could change health seeking 
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patterns within communities. At the same time one might have to invest in providing 
working conditions or incentives that make public clinics attractive for health workers. 
By making public TB clinics more accessible, money used for diagnosis and treatment in 
private clinics can be reallocated to poverty related needs that may occur as a 
consequence of becoming ill with TB.  
Independent of which health sector a patient seeks treatment in, awareness and 
proper management of early symptoms have potential for improvement in both high- 
endemic end low-endemic settings. In low-endemic settings doctors need to be trained to 
adjust their level of suspicion to the migration history of the patient. In high-endemic 
settings one should be aware that health personnel may understand and practice TB 
treatment within a traditional framework, and that there might be a need for further 
training within the perspective on which current TB services are based.  
As acknowledged in the WHO’s Stop TB strategy (WHO, 2009c) health 
personnel in low-income settings need access to reliable diagnostic tools. In settings 
with high rates of HIV/TB co-infections, health personnel can be prevented from making 
the right diagnosis and prescribing the right treatment due to limited access to tools like 
mycobacterial culture. Besides causing diagnostic delay, lack of diagnostic tools might 
complicate the understanding of TB’s etiology, as when health workers do not relate to 
why patients fail to respond to treatment. As demonstrated in this study, lack of such 
tools may pave the way for – or reinforce – explanations that correspond with 
stigmatizing explanatory models.   
5.6.2 Ensuring treatment and a lasting cure    
TB control efforts can derive from a microscopic view or a telescopic view of the 
disease; efforts can aim at the microbiological or the socio-economic causes. To be able 
to ensure that people with TB access and complete treatment, and remain healthy, there 
is a need to acknowledge and respond to both these perspectives. In the late nineteenth 
century and the early twentieth century there was a clear understanding of the 
association between TB and poverty, and public health measures had an advocacy 
approach that focused on improving living conditions among the poor. Scientific 
advances, such as the discovery of the tubercle bacillus and the discovery of antibiotics, 
caused a shift from a holistic, advocacy approach towards an individualistic, bio-medical 
106 
 
approach (Gandy & Zumla, 2002). This shift disguised – and has continued to disguise – 
the societal factors that make people vulnerable to exposure to TB and vulnerable to 
develop active TB. These are the same societal conditions which produce barriers in 
accessing, obtaining and maintaining treatment (Farmer, 1997). A precondition to 
managing TB must be to include the conditions that predispose for the disease, and at the 
same time seek to adjust the treatment so that the inequalities that do predispose for TB 
are not reinforced in the meeting with the health services. As illustrated in this study 
(paper II & IV), poor and otherwise vulnerable people experience a series of interacting 
crises that accumulate over time, and which affect their possibility to remain under 
treatment. A rigid, inflexible practice of DOT reinforces such crises and DOT per se can 
add to the chain of structural barriers that patients have to overcome to get cured. The 
WHO’s Stop TB strategy (WHO, 2009c) recognizes the importance of addressing the 
needs of poor and vulnerable populations. However, a uniform, target driven approach, 
with little focus on the individual patient, may prevent such efforts. Our study show that 
a variety of social and economic costs and other burdens change and interplay over time. 
This can create a type of vulnerability that will not be identified without services that 
place the focus on the individual patient. To ensure that TB patients get cured – and 
remains healthy – one must address the complexity of causes, and the coexisting and 
interacting crises that follows a TB diagnosis; through programs that have a more 
holistic and process oriented approach.  
Besides widening health disparities, burdens associated with treatment may 
negatively influence existing rationalities and health seeking patters within communities. 
Studies have found that people’s health seeking behaviors are influenced by strict TB 
control measures. A study from Vietnam found that private practitioners were preferred 
because they offered flexible and less authoritarian approaches, including non-
supervised treatment (Lönnroth, Tran, Thuong, Quy, & Diwan, 2001). Similarly, a study 
from India found that TB patients resisted strict TB control programs by choosing 
private practitioners (Fochsen, Deshpande, & Thorson, 2006). A study from Vietnam 
found self-treatment as a means of avoiding the control exerted by the national TB 
program (Johansson & Winkvist, 2002). Flexibility and options in the way the treatment 
is provided, such as choice of own treatment supporter, may help to find manageable 
solutions for completing treatment. Reminders, such as daily telephone calls, or text 
messages, combined with pill dispensers and continuity in the follow-up may represent 
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good solutions in low-endemic/high-income settings. In high-endemic/low-income 
settings different types of community based DOT, or self-treatment combined with 
available forms of reminders and close follow-up, represent possible solutions. To 
ensure sensitivity and avoid humiliating experiences, all treatment supporters/DOT 
providers, independent of formal status, should receive adequate training. Continuity 
among treatment supporters may allow patients to display their willingness to comply 
and subsequently retain their autonomy throughout treatment (Coker, 2000). As 
illustrated in our study, health workers (or others) that base their approach on distrust are 
likely to have a paternalistic attitude, which will not encourage mutual involvement in 
treatment.    
A holistic and more comprehensive approach to TB control would include 
measures such as securing income and access to food while on treatment. In a study 
from Haiti, Farmer et al. found that when supplemental food and income were provided, 
mortality rates and cure rates, but also factors such as weight gain and ability to return to 
work, significantly improved (Farmer, Robin, Ramilus, & Klim, 1991). A study from 
Kenya found that HIV patients that were enrolled in a food program while on treatment 
self-reported better adherence, less side effects, a greater ability to satisfy increased 
appetite, weight gain, recovery of physical strength and increased possibility to resume 
work. These improvements were found to trigger increased support from family and 
community members (Byron, Gillespie, & Nangami, 2008). Making food or income 
support an integral part of TB treatment can therefore be an important step in 
strengthening already existing support systems. This action could be the first step in 
acknowledging that treatment with antibiotics addresses only the proximate cause of TB 
– and not the more distant links in the causal chain (Ho, 2004). Furthermore, making 
food or income support an integral part of TB treatment can be the first step in 
acknowledging and addressing the ethical principle of reciprocity. If individuals are 
required to sacrifice their self-determination for the sake of the wider community, one 
must seek to minimize burdens by addressing psycho-social, physical or economic costs. 
Even if access to food and other basic needs are more precarious in high-endemic/low-
income countries, our study shows that rigid DOT programs have high costs for 
vulnerable patients also in low-endemic/high-income settings. Standardized, target 
driven programs that do not seek to help patients in coping with treatment related 
burdens may increase the vulnerability among groups already being marginalized, and 
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short term benefits may not be sustainable. Furthermore, programs that use autonomy 
reducing strategies fail to empower people so that they will gain more influence on their 
future health and lives. Even though the WHO’s Stop TB strategy (WHO, 2009c) 
recognizes the empowerment of patients and communities as important components in 
TB control, the results from our study are not encouraging.  
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6.   Conclusion In conclusion, this thesis suggests that: 
• To understand how people interpret and manage symptoms, causal attributions to 
TB needs to be explored in the light of cultural, social and economic factors in 
the society at large.  
• Patients’ management of TB and its treatment should be understood by viewing 
the individual as a whole, in which decisions and preferences derive from a wider 
social context. 
• To better understand barriers to long-term treatment adherence, one needs to 
relate that interruption of treatment can be shaped by past struggles and accrued 
costs.     
• Interventions to ensure early diagnosis and treatment completion should 
acknowledge the intertwined problems of delay in seeking treatment and 
interruption of treatment.  
• Cross-cultural similarities in the practice of DOT suggest that monitoring and 
other treatment practices should be viewed in the light of power-structures in the 
society at large, including the micro-level interactions between actors involved.  
• Cross-cultural similarities in the practice of DOT show that one cannot assume 
that the implementation of DOT – in any context – implies protection of patient 
autonomy.  
• Use of unskilled and poorly trained health personnel is one of the causes why 
patients are exposed to undignified and autonomy reducing practices. Health 
personnel need to be trained in how to communicate and interact with patients in 
a way that preserve dignity and enhance autonomy.  
• Programs that violate individual autonomy fail to empower people to gain more 
influence on their future health and lives. Even though the WHO recognizes 
empowerment of patients and communities as important components in TB 
control, this study shows that such empowerment is far from achieved.   
• Even though the WHO’s Stop TB Strategy has recommended implementation of 
“community based DOT” in national TB control programs, uniform and 
authoritarian versions of DOT are still put into practice.  
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• Inequalities that predispose individuals for TB may be reinforced in the health 
services. Low-income and vulnerable TB patients may experience a series of 
interacting crisis that may accumulate over time, and which affect their 
possibility to remain under treatment. A rigid, inflexible practice of DOT 
reinforces such crises and DOT per se adds to the chain of structural barriers that 
patients have to overcome to get cured.    There should be efforts to: 
• Create supportive environments where people feel free to express themselves and 
their concerns about the disease. To ensure such environments one needs to 
question dominant beliefs and attitudes in the health care system and within 
communities.  
• Raise awareness among health professionals about typical and atypical symptoms 
of TB and to increase health professionals understanding of patients’ own 
interpretation of symptoms. In low-endemic settings doctors need to be trained to 
adjust their level of suspicion to the migration history of the patient. In high-
endemic settings health personnel might need further training within the 
biomedical perspective.    
• Increase awareness among patients on how TB is transmitted, how early 
symptoms can be manifested, how TB can progress, how TB can prevented, and 
how TB can be cured.    
• Strengthen and improve the public sector in a way that makes it more user-
friendly. Investments should be provided to attract qualified health workers.  
• Ensure a holistic and context-sensitive approach to TB control that includes 
identifying and building on existing support mechanisms in the society.    
• Avoid disempowering and humiliating practices by organizing treatment in ways 
that secure continuity and promote concordance models of communication. 
• Create structures and decision-making processes where informed patients are 
able to express their views and negotiate their needs throughout treatment. 
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• Create TB programs that focus on processes that individuals undergo throughout 
the course of the disease. A process oriented approach might help health workers 
stay connected to the individual patient and the promotion of health in a wider 
sense.  
• Establish ethical guidelines to enhance patient autonomy, empowerment and 
dignity within all TB control measures.   
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7. Future research 
Our study suggests that there is need for research that: 
• Explores how people understand and experience TB and its treatment in different 
contexts. Examining local understanding and management of symptoms may be 
of particular value in understanding management of TB in different phases of the 
disease.  
• Explores health care seeking patterns within local communities – with the aim of 
illuminating bottlenecks or cultural, social or economic barriers that may be 
prevented or modified in order to ensure early diagnosis.   
• Examines a wide range of preceding, interacting, and contextual factors that may 
influence long-term medication adherence. Mapping time-specific and context 
specific burdens, barriers and facilitators may help develop strategies that may 
build on and strengthen already existing social support mechanisms.  
• Explores how health personnel understand and manage symptoms of TB and 
where such understanding converges or dissociate with lay explanatory models. 
• Explores how policymakers and health personnel understand DOT and on which 
grounds they implement and practice different variants of DOT.  
• Compares different types of organizing treatment in various social and economic 
contexts. Intervention packages which include a mixture of measures, such as 
strengthening the competence among health personnel, and securing of 
livelihood and food during treatment, should be assessed by both quantitative and 
qualitative methods. More studies from low-endemic countries are needed. 
• Examines the effect of the implementation of ethical guidelines in clinic-based 
TB treatment and in wider TB control efforts.     
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Appendix A 
 
Interview guide for follow-up group  
 
Interview number --------------------- 
Date of interview -------------------- 
Patients first visit to clinic -------------- 
 
First interview  
Demographic background 
Gender ------------ 
Age ------ 
Education---------- 
Civil status-------  
Permanent home-address/homeless-------- 
Occupation---------------- 
 
Symptom understanding, understanding of own vulnerability/severity, and 
acting (ca two weeks after diagnosis) 
 
Can you tell me about the period you felt the first signs of being ill? 
Possible probes: 
What kind of complaints did you have when you decided to go to the TB  
clinic for the first time? 
Can you remember how long you waited before you sought medical help?  
What did you think you were suffering from?  
Why do you think you got this disease? 
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You have now started with treatment, do you feel better?  
Do you think you are ill now? Why, why not? 
Do you think the medicines you receive will cure your illness? Why, why not? 
 
Interaction with the clinic and the health personnel 
Was the TB-clinic your first choice when you sought help?  
Why? If not, where did you go first? (take account) 
Did you discuss your choice with anybody? If yes, who? If no, why not?  
Can you tell me what happened when you came to the clinic for the first time?  
Possible probes:   
Did anybody tell you that you were suffering from TB?  If yes, when/ who? If no, what 
were you told you were suffering from? 
How did you react? 
Were you told how to get cured? 
Did they tell you for how long you had to take medicines? 
Did you understand why? 
Were you satisfied with the information that you got?  
Did you ask questions? If no, why not?  
Can you tell me what issues you would have liked to talked about? 
 
After the first meeting with the clinic, how did you feel about going back?  
During these 2 weeks at the clinic, have you often talked to the same persons? 
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Social support (family, spouse, neighborhood, community) 
After the first visit at the clinic, did you know that you had TB? If no, did you think you 
were suffering from something else? 
Did you tell anybody? If yes, who? If no, why not? 
Possible probes: 
If yes; how did this person(s) react?  
If yes; did your family/spouse support you to go through the medical treatment?  
Why, why not? Did they suggest other alternatives? 
If no; how do you think these persons would have reacted? 
If no; do you plan to tell your family, spouse, and friends? Why, why not? 
 
Can you take the decision about treatment on your own? If not, who can?   
Do people in your community talk about this disease? What do they say?  
Why do you think some people with TB don’t talk about their disease? 
 
Structural/socio-economic barriers 
Were do you collect your medicine? When? 
Does the health worker observe you when you swallow the medicine?  
If yes, how do you feel about that?  
How does this arrangement affect your daily life? (Work, family-life) 
Is it difficult for you to collect your medicines? If yes, in what way?  
In your opinion, how could this treatment arrangement (DOT) been improved? 
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Second interview 
Illness experience, understanding of own vulnerability/severity, and acting 
(ca two months after diagnosis)   
 
You have now been on treatment for about 2 months. How do you feel? 
Possible probes: 
Do you think you are ill now? Why, why not? 
How long do you think it will take before you get well?  
Have you experienced any good changes in the way you feel?  
Do you think this is due to the tablets? If no, what do you think is the reason? 
Have you experienced any bad changes in the way you feel (side-effects)?  
Do you think this is due to the tablets? If no, what do you think is the reason? 
What kind of problems has this disease created for you? 
Have you tried any other treatment in this period? Why, why not? 
 
Interaction with the health personnel  
Can you tell me something about your experiences while going to the clinic this last 
month?  
Possible probes: 
Can you remember any situations that made you feel good at the clinic? 
Can you remember any situation that made you feel uncomfortable? 
Are you often talking to the same persons when collecting medicines?  
Is there any person at the clinic that makes you feel good? Why?  
Can you tell me what you usually talk about with the health worker? 
What would you have liked to talk about? 
Do you feel that you now know more about the disease you are suffering from? 
Are there things you still feel insecure about? 
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Have you asked about these issues? If yes, did things become clearer? If no, why not?  
During the last weeks, have you ever considered not to go to the health centre?  
 
Social support (family, spouse, neighborhood, community) 
Alternative 1: In the first interview you told me that you had not told your family/spouse 
about you being ill? Have you told them now? If yes, how did they react? If no, how 
does this affect your daily life?  
Alternative 2: In the first interview you said that you had told your family/spouse about 
your condition. Has anything changed?   
Possible probes: 
Have any of your family members or friends suggested another treatment? 
Do you have someone that support and encourage you to continue the treatment? 
Have you told your neighbors/friends that you have TB? If no, why not? If yes, how did 
they respond? 
 
Have you got to know any others in the community with the same disease? 
Do you think that having TB is different for a woman compared to a man?  
Do you think there are any groups in your community that face more difficulties having 
TB than others? Who? Why?  
Have you experienced that people think that TB is a disease to be ashamed of? 
 
Structural/socio-economic barriers 
Can you tell me how this treatment arrangement (DOT) affects your daily life?  
Possible probes:  
Is it difficult for you to collect medicines?  
Has anything changed (to the better or worse) since last time we talked? 
Has it affected your economy in any way? 
In your opinion, how could the arrangements of collecting medicines been improved? 
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Third interview  
 
Illness experience, understanding of vulnerability/severity, and acting (after 
about five months on treatment) 
You have now been on treatment for about 5 months. How do you feel? 
Possible probes: 
Do you think you are ill now? Why, why not? 
What do you think would have happened if you stopped taking medicines? 
Are you still experiencing the good changes you mentioned last time? 
Are you still experiencing the bad changes you mentioned last time (side-effects)? 
Do you still think this is due to the medicines (or other mentioned reasons)? 
Can you tell me how this disease affects your daily life at this point? 
How do you feel about going to the clinic every day?  
 
Interaction with the health personnel  
Tell me about your experiences going to the clinic these two last months? Has anything 
changed? 
Possible probes: 
Can you remember any situation that made you feel good? (At the clinic) 
Can you remember any situation that made you feel uncomfortable? 
Have you got to know any of the nurses or doctors in particular? 
Do you talk to many different health workers? How do you feel about this? 
Is there anyone in particular you like to talk to? Why? 
 
Have you experienced that different people tell you different things about your condition 
or treatment? 
Are there still issues that you feel insecure about? 
Do you find it easier or more difficult to ask questions now? 
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Can you tell me some good things about coming to the health centre? 
Can you tell me some bad things about coming to the health centre? 
 
Social support 
Alternative 1: You told me earlier that you still had not told some family members about 
your disease? Have you told them now? If yes; how did they respond? If no, how do you 
hide it? 
Alternative 2: You told me earlier that you had told your family/spouse about you being 
ill. Have you experienced any changes in your relation to them?  
Possible probes: 
Do you still feel that they support you in going for treatment? 
Have any of your relatives suggested that you should stop the treatment?  
 
How is your relation with your neighbors/friends at this point? 
Have you got to know any others in the community with the same disease?   
Have you experienced that people with TB hide their symptoms from others? Do you 
know why? 
Would be easier to have this disease if people in the community knew more about it?  
 
Structural/socio-economic barriers  
Can you tell me how this arrangement (DOT) affects your daily life? (Work, family-life)  
Possible probes: 
Is it difficult for you to collect your medicines? 
Has anything changed to the better or worse since last time we talked? (Economy, 
support)   
Since we last talked, have you considered stop going to the clinic for tablets? 
If yes, why? If, no; do you think you will face any problems coming here for another 3 
months?  
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Appendix B 
 
Interview guide for patients who had interrupted treatment 
 
Interview number---------- 
Date of interview---------- 
First visit to clinic------------- 
Periods of interruptions in treatment--------  
Last visit to clinic-------------- 
Demographic background 
Gender ------------ 
Age ------ 
Education ---------- 
Civil status -------  
Permanent home-address/homeless -------- 
Occupation ---------------- 
 
Symptom understanding, understanding of vulnerability/severity, and acting   
Can you tell me about the period you felt the first signs of being ill? 
Possible probes: 
What did you think you were suffering from? (Type/name, signs) 
How did you think you had got these complaints? (Cause, transmission) 
What made you chose to go to the TB-clinic? 
Did you try other treatment methods first? Why, why not? 
If yes, are you still using this treatment? 
How did you feel about taking the tablets? 
133 
 
Did you think this medicine would cure your illness? 
Did you experience any good changes in the way you felt physically? 
Did you experience any bad changes in the way you felt physically (Side-effects)? 
When you stopped going to the clinic, how did you feel at that point? (Cured? Feeling 
well?) 
Did you consider that you could become ill again? Why, why not? 
Did you continue or enter another type of treatment?  
Do you think you are suffering from TB now? Why, why not? 
 
Social support     
Did you discuss how to get well with anybody?  
Did you take the decision about going to the TB clinic on your own? 
Did anybody support you in going to the TB-clinic the first time? (Who? Why/why not?) 
When did you start thinking about not going for your medication anymore?  
Can you remember what you were thinking?  
Did you take the decision about not going for treatment anymore alone? (If, no who did 
you discuss it with?) 
Can you tell me why you (and others) decided that this was the best thing to do?  
Did people in your neighbourhood know that you were suffering from TB at this point?  
How? Why, why not? 
What do people in your community say about this disease? Do you agree?   
Do you think that having TB is different for a woman compared to a man? 
Do you think there are any specific groups in your community that face more difficulties 
having TB than others? Who? Why?   
Have you experienced that people think that TB is a disease to be ashamed of?  
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Interaction with the clinic and the health personnel 
Was the TB-clinic your first choice when you sought help? If not, where did you go 
first? (take account of history)  
How did you experience the first meeting with this (public) clinic?  
Possible probes: 
Who received you? What did they tell you?  
Did you understand that you were suffering from TB? 
If yes, how did you react? If no, did you get the impression that you were suffering from 
something else? 
Did the doctor/nurse tell you how to get cured? 
Did the doctor/nurse tell you how long you had to take medicines? 
Did you understand why? 
 
Do you remember how you felt after your first meeting with the clinic?  
How did you feel about going back? 
During the period when you went to the clinic, did you often talk to the same persons? 
What did you usually talk about with the health worker? 
Were there issues you would have liked to talk more about?  
Did you learn more about TB after you started going to the clinic? 
Did you feel that you could ask questions about the issues you were insecure about?  
From your experience, can you tell me something good about going to the TB-clinic? 
(Can you remember a situation that made you feel good?) 
From your experience, can you tell me something bad about going to the TB- clinic? 
(Can you remember a situation that made you feel uncomfortable?) 
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Structural/socio-economic barriers 
In the period you went to the clinic, can you tell me how having TB affected your daily 
life? (Work, family-life) 
Did anything of importance change? (Relation to spouse, relatives, work etc.)  
Possible probes: 
Was it in any way difficult for you to collect your medicines? Why, why not?   
Did it affect your economy in any way? 
Did any good or bad changes occur when you stopped going for treatment?  
What would have made it easier for you to continue to take medicines? 
 
Did anyone from the clinic try to contact you when you did not come for treatment the 
first time? When, how, by whom? 
How did the health personnel react when you interrupted the treatment?  
Did anyone try to contact you when you dropped out from treatment? When, how, who?  
In your opinion, how could the arrangement of collecting medicines been improved? 
What would you have done to make sure that all the patients came to the clinic and 
fulfilled their treatment?  
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Appendix C 
Thematic interview guide - health personnel, Ethiopia 
Local perceptions/explanations of the cause of TB (e.g. bird) 
Local perceptions/management of symptoms 
Local perceptions/explanation of prognosis  
Local perceptions of bird (etiology) 
Local perceptions of the connection between bird and TB (samba) 
Local perceptions of the connection between TB and HIV/AIDS  
Local perceptions of the concept of “restart” (megershet) 
Health workers own perceptions 
Diagnostic /treatment procedures when patients present with bird 
Diagnostic/treatment procedures when patients are suspected of having TB  
Use of culture tests (treatment, re-treatment) 
Diagnostic/treatment procedures when patients are suspected of having HIV 
Common side effects/information about side-effects/handling of side-effects 
Information to TB patients (when, about what, by whom, follow-up?)  
Protein food and healing 
Sexual intercourse and healing  
Others factors influencing healing? (religious factors) 
Reasons for diagnostic delay (any vulnerable groups?) 
Use of private clinics (reasons) 
Reasons for treatment interruption (vulnerable groups?) 
Main questions asked by patients regarding their disease/treatment  
Main problems faced by patients during treatment (according to experience)  
Stigma/exclusion in the community/support mechanisms (vulnerable groups?) 
Suggestion for improvements (DOT) 
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Appendix D 
 
Interview guide for TB patients – Norway  
 
Interview number---------- 
Date of interview---------- 
Interpreter-------------- 
Type of TB/stage of treatment--------- 
 
Demographic background 
Gender ------------ 
Age ------ 
Education ---------- 
Civil status -------  
Permanent home-address/homeless -------- 
Occupation ---------------- 
 
Symptom understanding/understanding of vulnerability/severity and acting   
Can you tell me about the period you felt the first signs of being ill? 
Possible probes: 
What types of signs/complaints did you have when you decided to see a doctor (or 
others)?  
Can you remember how long you waited until you sought medical help? 
Where did you go? Why?  
Did you try other treatment methods first (e.g. cough medicine) 
What did you think you were suffering from? (Type/name of disease, signs) 
How did you think you had got these complaints? (Cause, transmission) 
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You are currently under treatment, how do you feel? (Or, you have now completed 
treatment, how do you feel?)  
Do you still think you have TB?  
Have you experienced any side-effects (bad changes)? 
Do you think the medicines you take will cure you? Why, why not, when?  
 
Interaction with health personnel/experiences related to diagnostic process  
Can you tell me what happened the first time you came to the doctor/hospital/emergency 
room?  
Possible probes:  
What kind of diseases was mentioned/considered by the health worker? 
How did you react? 
If TB was diagnosed/considered, did you talk about the length of treatment? 
Were you satisfied with the information you got? 
Were you satisfied with the tests/diagnostic procedures that were initiated?  
Did you ask questions? If no, why not? 
 
Can you tell me what happened after the first visit to the doctor/hospital/emergency 
room? (Diagnostic procedures, final diagnosis, hospital stay)  
If admitted to hospital: Can you tell me about your experiences during the hospital 
admission? (isolation)  
 
Information/understanding of disease and treatment 
Can you tell me about the planning meeting that took place at the hospital? (planning of 
treatment, DOT) 
Possible probes:  
How did you feel during this meeting? 
Did you ask questions? Why, why not? 
Did you manage to convey what was important for you? 
139 
 
Can you tell me what you knew about TB and its treatment before you got ill? 
(cause/treatment/prognosis) 
Can you tell me what you know about TB and the treatment now?  
Are you satisfied with the information that you have got? Why, why not?  
  
Social support  
How did you react when you received the TB diagnosis? 
Did you tell anyone? If yes, who? If no, why not? 
Possible probes: 
If yes, how did this person(s) respond?  
If no, why not? How do you think they would have reacted?  
If no, do you plan on telling people (friends, neighbors) later on?  
 
Have people around you changed in any way after you got TB? How? 
What kind of support do you feel that you need? 
What kind of support do you experience that you get?  
Possible probes: 
Have you had any negative experiences related to the fact that you have TB?  
Have you had any positive experiences related to the fact that you have TB? 
  
Perceptions/experiences with the treatment (DOT) 
Can you tell me about your experiences with the treatment you received at home (DOT)? 
Possible probes: 
How did the plan (treatment plan) that was made at the planning meeting work?  
Have the plan been evaluated/adjusted?  
Do you feel that you have received enough information about the disease and the 
organization of treatment?  
Are there still issues that are unclear?   
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Have the organization of treatment (DOT) affected your life in any way? (socially, 
practically, economically)? 
Possible probes: 
Where do you get your medication (at home, at home-based services) 
At what point during the day? Every day? 
How long time do you use on a daily basis?     
What has been good, not so good? (information, continuity etc)  
Can you tell me about a situation where you felt good?  
Can you tell me about a situation you felt uncomfortable?  
 
Why do you think health personnel want to se that you take your medication? 
Can you say anything about how your experience of being observed while taking the 
medication?   
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 Appendix E 
 
Thematic guide - health personnel in Norway  
  
 TB treatment – system level 
Present work, experience with TB related work (type, length, responsibility)  
Cooperation between primary health care services, hospitals, TB coordinators (float? 
problems?)  
TB coordinators role/position (important, redundant, accepted?)  
Intention behind DOT(S)? Foundation of the implementation (regulation, law, binding, 
guiding?)  
DOT - a coercive measure? (as perceived by present health worker, others, why, why 
not?) 
Patient groups being treated under DOT (pulmonary, extra-pulmonary, preventive 
treatment, selection?). Why these groups?  
Changes in TB control after the implementation of DOTS in Norway in 2003 (what 
changes, why, how?) 
Elements of TB control in Norway which could be improved (what works well, less 
well, DOT in particular) 
Experiences with the home based services (quality of services) 
Other potential ways of organizing DOT? (why, why not) 
 
TB treatment – individual level 
Experiences in relation to how TB patients relate to their disease (cause, treatment, 
prognosis, stigma) 
Experiences in relation to how relatives relate to TB (how do patients relate to the 
relatives)  
Experiences in relation to how TB patients relate to DOT (any differences related to sex, 
age, country of origin, education level etc?) 
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Experience of barriers/burdens faced by TB patients (due to the organization of 
treatment) 
Role of TB coordinators, others, to prevent/modify potential barriers 
Information that patients need (disease, treatment, DOT) 
How, when, by whom are information given? Information needs covered? (why, why 
not) 
Follow-up during treatment. Continuity? Follow-up talks? (primary nurse, primary 
hospital doctor? ) 
Practice of DOT throughout treatment (flexibility, choice of DOT provider, assessment 
over time, use of pill-dispenser)  
Standardized DOT versus DOT based on personal needs (pros, cons) 
DOT in the intensive phase, DOT all throughout treatment (pros, cons) 
Essential elements needed to secure a well functioning treatment system (all parties) 
 
Ethical concerns  
Any ethical dilemma’s due to the implementation/practice of DOT? (patients’ autonomy, 
self-esteem, dignity, burdens) 
Example for discussion: Some of the patients have claimed that it would have been more 
debate about DOT if the treatment (to a further extent) had involved ethnic Norwegian. 
Do you agree?  
Problems/ethical challenges related to equal treatment (no prior assessment)                                                
Problems/ethical challenges related to flexible, individually adjusted DOT       
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Errata 
In paper III (Experiences of being diagnosed with tuberculosis among immigrants in 
Norway – Factors associated with diagnostic delay: A qualitative study), page 2, in the 
paragraph “Participants and data collection”, line 8: “….highest incidence rates in 2005 
and 2006 were found among people from Somalia and Ethiopia”, should be corrected to 
“…the number of reported TB cases in 2005 and 2006 were highest among people who 
originated from Somalia and Ethiopia.”   
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Abstract
Background: Non-adherence to tuberculosis (TB) treatment is an important barrier for TB
control programs because incomplete treatment may result in prolonged infectiousness, drug
resistance, relapse, and death. The aim of the present study is to explore enablers and barriers in
the management of TB treatment during the first five months of treatment in Addis Ababa, Ethiopia.
Methods: Qualitative study which included 50 in-depth interviews and two focus groups with TB
patients, their relatives and health personnel.
Results: We found that loss of employment or the possibility to work led to a chain of interrelated
barriers for most TB patients. Daily treatment was time-consuming and physically demanding, and
rigid routines at health clinics reinforced many of the emerging problems. Patients with limited
access to financial or practical help from relatives or friends experienced that the total costs of
attending treatment exceeded their available resources. This was a barrier to adherence already
during early stages of treatment. A large group of patients still managed to continue treatment,
mainly because relatives or community members provided food, encouragement and sometimes
money for transport. Lack of income over time, combined with daily accumulating costs and other
struggles, made patients vulnerable to interruption during later stages of treatment. Patients who
were poor due to illness or slow progression, and who did not manage to restore their health and
social status, were particularly vulnerable to non-adherence. Such patients lost access to essential
financial and practical support over time, often because relatives and friends were financially and
socially exhausted by supporting them.
Conclusion: Patients' ability to manage TB treatment is a product of dynamic processes, in which
social and economic costs and other burdens change and interplay over time. Interventions to
facilitate adherence to TB treatment needs to address both time-specific and local factors.
Background
Tuberculosis (TB) is a major public health challenge, with
an estimated 8.8 million new cases and 1.7 million deaths
in 2003 [1]. 27% of these cases and 31% of the deaths
occur in Africa, where case rates continue to rise. The situ-
ation in Africa has been attributed to the HIV epidemic
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and poorly organized TB control programs [1,2]. Treat-
ment of TB requires access to appropriate health care, but
patients may find it difficult to adhere to the intended
treatment even if such services are available. Studies from
both low- and high-income countries show that between
20% and 50% of patients with TB do not complete treat-
ment regimes [3,4]. Incomplete treatment may result in
prolonged infectiousness, drug resistance, relapse, and
death [5]. Improvement in treatment outcomes requires a
better understanding of the barriers and enablers patients
experience during TB treatment. Quantitative and qualita-
tive studies from countries in Asia and Africa point to bar-
riers related to availability and accessibility [6-8], and
direct and indirect costs related to treatment [9-12].
Inconvenient routines in health care systems [13-15] and
interaction with health personnel may also act as barriers
[13,16-18].
In Ethiopia, where there is an increasing incidence of new
infectious TB cases [19], quantitative studies from rural
areas found that between 6.7% and 20% of patients inter-
rupted treatment and that long distances to the health
facilities, poor awareness about the disease and treatment
length, side effects and lack of family support are impor-
tant factors [20-23]. An early case control study from
Addis Ababa found that "social problems" and "feeling of
improvement" were major causes of treatment interrup-
tion [24]. These studies found that most patients inter-
rupted treatment in the third or fourth month.
Few studies have used qualitative methods to explore
patients' experiences during different phases of treatment,
and to the authors' knowledge the studies on diagnostic
delay and treatment interruption in Ethiopia have not
been explored further in qualitative research.
WHO has emphasized that an important research area is
identifying time points in the treatment that are of impor-
tance for different types of adherence strategy [25]. The
aim of the present study is to explore enablers and barriers
in the management of TB treatment during the first five
months of treatment in Addis Ababa, Ethiopia.
Methods
We used qualitative methods to explore enablers and bar-
riers in the management of TB treatment. We found that
in-depth interviews conducted during different stages of
treatment were the most appropriate method for explor-
ing how context-specific enablers and barriers interact
over time. We used focus group discussions for further
exploration and validation of information from the in-
depth interviews. The study comprised a follow-up study
with three individual in-depth interviews of 10 newly-
diagnosed TB patients, in addition to one single individ-
ual interview with 11 TB patients who had interrupted
treatment. We also interviewed two TB patients who were
on re-treatment, four relatives, five health care staff, and
conducted focus group discussions involving 11 TB
patients currently undergoing treatment.
Study setting
Data was collected over a six-month period in Addis
Ababa, the capital of Ethiopia, in 2001–2002. At this time,
Addis Ababa had about 95% coverage of directly observed
treatment, short course (DOTS) in existing governmental
health facilities [26]. TB treatment involved daily attend-
ance for two months (the intensive phase), followed by a
period of six months during which medicines were col-
lected once or twice a month (the continuation phase). At
the time of the study, HIV counselling and testing was not
routinely carried out for TB patients. Anecdotal reports
and clinical observations suggested a high rate of co-infec-
tions, and according to the Ethiopian Ministry of Health
AIDS patients occupied about 42% of existing hospital
beds [19,27]. The number of TB patients not completing
their full course of treatment was difficult to estimate, as
only a proportion of smear-positive patients were evalu-
ated for their outcome [26].
Study sites
Participants were recruited from three sites: (i) Woreda 23
Health Centre, a centre for TB diagnosis and treatment
located about two kilometres from the ALERT (All African
Leprosy and Rehabilitation Training Centre) hospital; (ii)
St Peter's TB Specialized Hospital Outpatient Service,
which offered diagnostic and treatment services and was
located in the Kolfe area; (iii) and Kebele 16 Health Post,
which provided TB treatment but was without diagnostic
facilities (patients were diagnosed at Woreda 23 Health
Centre). This health post was located in a slum area close
to the ALERT hospital and training centre. (A Kebele is
part of a Woreda and is the smallest administrative unit in
Ethiopia.) These research sites where chosen based on
advice from local researchers at Armauer Hansen's
Research Institute (AHRI) and from WHO's TB/Leprosy
advisor at the Ministry of Health in Ethiopia. The sites
were considered to be "typical" DOT (directly observed
treatment) clinics, but they were also chosen because they
represented diversity being located in different areas of
town. The three sites had similar routines related to daily
TB treatment (DOT).
Participants and data collection
The study included both TB patients who were attending
TB treatment and TB patients who had interrupted TB
treatment. Newly diagnosed TB patients ("new cases")
were approached by means of an invitation letter distrib-
uted by health personnel at Woreda 23 Health Clinic. A
purposeful sample of 10 patients; five men and five
women aged 18 to 67 years, participated in the prospec-
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tive part of the study. Two patients declined to participate
because they were too ill. Participants' characteristics are
displayed in Table 1. There were difficulties with tracing
patients who had interrupted treatment, due to lack of, or
incorrect, addresses. St Peter's TB Specialized Hospital
Outpatient Service and Kebele 16 Health Post were there-
fore included for the purpose of recruiting patients who
had interrupted treatment. We traced 11 patients that had
been on treatment for at least two weeks, and had inter-
rupted treatment for more than six consecutive weeks at
the time of contact. All eleven patients agreed to partici-
pate in the study. The group consisted of six men and five
women, aged 20 to 60 years. Participants' characteristics
are displayed in Table 1. The National Tuberculosis and
Leprosy Control Program (NTLCP) restricts its definition
of defaulters to patients who have attended treatment for
at least four weeks and have been absent for at least eight
consecutive weeks or for a cumulative period of 12 weeks.
All of our participating patients do thus not meet the for-
mal definition of a defaulter. Focus group participants
were recruited by the first author and the research assist-
ant from all three clinics.
We developed an interview guide that covered general
beliefs about TB and TB treatment, as well as time-specific
factors that could affect the management of treatment.
The guide was inspired by Becker's [28] review of models
and strategies to find consistent predictors of adherence.
Becker suggests that certain health beliefs, together with
the psychological and other perceived costs of the recom-
mended action, the interaction between patients and
health service deliverers, and other types of social influ-
ence, are important dimensions for understanding adher-
ence.
Ethics
Informed oral or written consent was sought in all cases.
De-identification and confidentiality were ensured by
using numbers and fictitious names to describe and iden-
tify patients. Ethical approval for the study was obtained
from the Regional Committee for Medical Research Ethics
in Norway and the National Ethical Clearance Committee
in Ethiopia.
Individual in-depth interviews
The first author (MS) conducted face-to-face, tape-
recorded, qualitative, in-depth interviews. The questions
and answers were translated from English to Amharic and
vice versa by a local research assistant/interpreter. All
interviews took place at locations chosen by the patients.
The interviews lasted from two to three hours. Questions
in the interview guide were open-ended, and emerging
themes and hypotheses from earlier interviews were
explored in subsequent interviews. 10 TB patients were
interviewed three times over a period of five months. The
first in-depth interview was conducted two weeks after
diagnosis, the second interview two months later and the
third interview five months into treatment. All patients,
except one who died, participated in all three interviews.
A single individual in-depth interview was conducted
with each of the 11 patients who had interrupted treat-
ment. Other groups of informants, like relatives of
patients that died after treatment interruption, and
patients on re-treatment, were also interviewed. In-depth
interviews were additionally conducted with two nurses
and one doctor from Woreda 23 Health Centre, one nurse
from Kebele 16 Health Post and one nurse from St Peter's
TB Specialized Hospital Outpatient Service. These individ-
uals were recruited because they were managing TB
patients on a full-time basis. Participants' characteristics
are displayed in Table 2.
Focus groups
Two focus group discussions with TB patients who were
undergoing TB treatment were arranged after the in-depth
interviews were completed. Patients with different educa-
tional backgrounds were chosen [29], yet with adjust-
ments to personal features and the group composition as
a whole. One group consisted of five female TB patients,
the other of six male TB patients. Participants' characteris-
tics are displayed in Table 3. The focus group discussions
lasted for two hours, and were moderated by the research
assistant, who was trained in focus group interview prin-
ciples and techniques. The first author introduced pre-
Table 1: Characteristics of 10 patients undergoing treatment and 
11 patients who had interrupted treatment who were 
interviewed individually
Characteristic Undergoing 
(n = 10)
Interrupted 
(n = 11)
No. No.
Gender
Male 5 5
Female 5 6
Age
< 25 3 2
26–35 6 6
> 36 1 3
Education
Partly illiterate/illiterate 1 4
1–6 years 3 3
7–10 years 1 2
11–13 years 5 2
Occupation
Daily labourer* 2 3
Civil servant 2 1
Private sector 3 4
Other 3 3
* Person who is not employed on a permanent basis, but who may 
meet at a regular point every day to compete with others to be hired 
for the day.
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selected topics related to common, discrepant or particu-
larly interesting findings from the in-depth interviews for
further validation. Notes were taken, and the discussions
were tape-recorded.
Analysis
Use of an interpreter during interviewing creates a poten-
tial source of misunderstanding. We actively sought to
prevent errors by continuously discussing and negotiating
the content of key words, broader concepts and units of
meaning. The first author and the research assistant/inter-
preter thoroughly discussed and clarified the content of
each tape-recorded interview. Clarifying notes were added
and main themes and issues to be explored in subsequent
interviews or focus groups were systematically written
down (conceptual maps). A "memo" (notes on each par-
ticipant, including main content of the interview) was
made enabling the second and third author to read about
each of the participants that were interviewed and quoted
in the manuscript. The research assistant translated and
transcribed verbatim each interview and the discussions
in the focus groups. All transcriptions were manually
coded within a defined coding frame. The coding frame
was developed on the basis of Becker's theories [28], and
was informed by themes and issues emerging from the
material. Data concerning factors that affected patients'
management of TB treatment was used for systematic text
condensation, according to the principles of Giorgi's [30]
phenomenological analysis, modified by Malterud [31].
The analysis followed these steps: (i) reading all the mate-
rial to get an overall impression; (ii) identifying units of
meaning that represent different factors that influence the
management of TB treatment, and coding for these; (iii)
condensing and summarizing the content of each of the
coded groups; (iv) integrating the insights from the con-
densed meaning units into generalized descriptions that
reflect apparently significant factors. The analysis was
summarized and accounted for in an analysis document
that all authors commented on.
Results
We found that loss of employment or the possibility to
work led to a chain of interrelated barriers for most TB
patients. Daily treatment was time consuming and physi-
cally demanding, and rigid routines at health clinics rein-
forced many of the emerging problems. Patients with
limited access to financial or practical help from relatives
or friends experienced that the total costs of attending
treatment exceeded their available resources. This was a
barrier to adherence already during early stages of treat-
ment. A large group of patients still managed to continue
treatment, mainly because relatives or community mem-
bers provided food, encouragement and sometimes
money for transport. Lack of income over time, combined
with daily accumulating costs and other struggles, made
patients vulnerable to interruption during later stages of
treatment. Patients who were poor due to illness or slow
progression, and who did not manage to restore their
health and social status, were particularly vulnerable to
non-adherence. Such patients lost access to essential
financial and practical support over time, often because
relatives and friends were financially and socially
exhausted by supporting them. These findings are
grouped into main themes and examined in further detail
below.
Loss of income
The majority of patients in the study experienced loss of
employment or the opportunity to work as one of their
main problems during treatment. Patients reported losing
their job when their TB diagnosis was known, or because
they were too ill to continue working, or were unable to
find daily work because of the time consuming treatment
arrangements. Three patients were housewives, but the
Table 3: Characteristics of 11 patients who were undergoing 
treatment and who were interviewed in focus groups
Characteristic No.
Gender
Male 6
Female 5
Age
< 25 4
26–35 4
> 36 3
Education
Partly illiterate/illiterate 2
1–6 years 3
7–10 years 4
11–13 years 2
Occupation
Daily labourer 3
Civil servant 3
Private sector 2
Other 3
Table 2: Characteristics of 5 health personnel and 6 other 
participants who were interviewed individually
Characteristic Health personnel 
(n = 5)
Others 
(n = 6)
No. No.
Gender
Male 3
Female 2
Education
Nurse 4
Medical doctor 1
Relatives of patients 4
Patients on re-treatment 2
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household finances were still affected because their hus-
bands lost income and risked their jobs escorting them to
the clinic. One of the husbands explained:
"I tried to explain for them that I was the only one working in
our family, so I couldn't go every morning ... because in that
way I would lose my job and me and my wife would die of hun-
ger. I work in the private sector and it is difficult to get permis-
sion every day." (Participant 24, prospective group.)
Patients who worked in the private sector and "daily
labourers" (a person who is not employed on a perma-
nent basis, but who may meet at a regular point every day
to compete with others to be hired for the day) were most
affected. Also health personnel identified these groups as
particularly vulnerable:
"People who are daily labourers or work in the private sector
they can't get any kind of [sick] leave and they face more prob-
lems. Many of them interrupt treatment because they don't
want to lose their jobs. They rather live for a while, with money
and their jobs, to eat and then die." (Participant 27, male
nurse.)
Being ill and without access to any health care benefits
often resulted in a loss of income from one day to the
next. Patients' situations were aggravated because loss of
income coincided with additional expenses. More than
half of all the patients had been treated at private clinics
before entering conventional TB treatment, paid for from
savings or money borrowed from relatives or community
members. Daily attendance at a clinic caused high trans-
portation costs, and those that could not afford transpor-
tation incurred opportunity costs due to extensive time
use. In addition, most patients believed that they had to
eat expensive protein food like meat, milk and eggs to get
cured. A daily labourer offered an illustration of how the
struggle to obtain "good food" increased his already pro-
nounced personal crisis caused by loss of income:
"How can I get this food [good food], it is impossible to get this.
I don't have a job. [...] "I'm even considering committing sui-
cide. [...] I have lost all hope ... totally. I am the one that sup-
port me and now I can't support myself. I can't work, and then
it is hard for me to survive." (Participant 10, male patient, pro-
spective group.)
Loss of income combined with additional costs made TB
patients' particularly vulnerable during the first period of
treatment (the intensive phase). Two patients in the pro-
spective group continuously considered interrupting
treatment due to a lack of money for food and transporta-
tion to the clinic.
Hunger
Impoverishment due to loss of income caused unpredict-
ability and emotional stress in relation to daily access to
food. Many participants described feeling chronically
hungry, suffering the slow starvation of people who eat a
little bit every day but whose hunger is never fully satis-
fied. A young male patient, who lived with his single, TB
inflicted mother, was too ill to continue working as a daily
labourer. He related how lack of food made him lose his
motivation to follow the treatment:
"Q. During the last weeks, have you ever considered not to go
to the health centre?"
"Yes, I thought about that many times ... on and off. Especially
when I lack food I feel like not coming. [...] My only motivation
is to get food ... food ... it is food that is motivating me [...] to
get food, any kinds of food ... at the right time ... and to have a
person that can help you get that food." (Participant 8, male
patient, prospective group.)
Chronic hunger induced a feeling of hopelessness among
patients. Irregular and insecure access to food over time
made many lose their hope of recovering and avoiding
death.
Taking medicines on an empty stomach
Gastritis was the most common side effect, and was
reported by nearly all intensive-phase patients. The symp-
toms were described as a burning or gnawing pain in the
abdomen. A few patients explained that they pretended to
swallow the medicines, saving them until they could take
them with food or milk. A female focus group participant
explained:
"I knew that I would feel the pain if I swallowed the tablets
immediately [at the clinic]. Therefore I pretended swallowing
the tablets. I took the tablets, hiding them. Then I swallowed
the tablets later ... with milk ... at home." (Female focus group
participant, focus group one.)
Patients attributed side effects, such as gastritis, nausea,
and vomiting, to taking strong medicines on an empty
stomach. These side effects had a large psychological
impact: Since most patients considered access to food,
and particularly food with a high content of protein, as
extremely important to healing, symptoms as gastritis
served as a continuous reminder of their poverty and what
they considered to be poor healing conditions.
Physical demands
Most patients complained that the first two months of
treatment were physically exhausting. This was particu-
larly the case for the many patients who were at advanced
stages of the disease at the time they started treatment.
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Patients attending treatment at Kebele 16 Health Post had
shorter walking distances than those attending the other
clinics. This was a tremendous advantage for the many
who could not afford transportation. Most patients from
the other two clinics reported using one to two hours each
way. A patient with advanced symptoms, and who was
also suffering from various side effects, described her daily
walk to the clinic:
"Q. Do you always walk or do you take any kind of transport?"
P. "I walk, I don't have any money for transport."
"Q. Is it hard?"
P. "Yes, it is a bit far. I use almost two hours and I vomit on the
way." (Participant 5, female patient, prospective group.)
Once at the clinic, patients often waited an hour or more
to get their medication. This delay was mainly caused by
intensive-phase patients being told to attend at the same
time in the morning. This time-consuming system was
described as humiliating by some of the patients.
Rigid routines and health staff attitudes
The three clinics in the study practised DOT without tak-
ing into consideration that many patients were not physi-
cally able to come to the clinic. Many patients told how
they had begged to be hospitalized, but due to a lack of
hospital beds this option was out of the question for
many. One patient died on the 59th day of treatment,
having been refused medical attendance before the 60th
day, in accordance with clinic routines. Her husband
described how they had struggled to make health person-
nel understand that she was far too ill to walk to the clinic:
"We went to the clinic to ask if the nurse could give her the
medicines, at least once in seven days, telling him that our
house was far away [...] and explaining them that she was too
weak to go to the clinic every day ... she couldn't walk at that
time. The nurse didn't understand, rather he threatened her
saying he would demand her to come and collect the medicines
no matter how ill she was." (Participant 24, prospective group.)
In a few cases, relatives were allowed to collect the medi-
cines on behalf of very ill patients. This, however, put the
relatives' jobs in jeopardy, as they had to queue at the
clinic every day. In most cases, the patients were escorted
to the clinic by relatives. This incurred transportation and
opportunity costs for two persons, often within the same
household. The clinics allowed no exceptions for family-
or cultural events, and were highly inflexible as regards
patients trying to combine daily treatment with work-
related activities. Only one patient in the prospective
group managed to hold on to his job. He explained the
repeated difficulties he faced trying to balance the
demands of work with the treatment arrangements:
"Once I came late and I met the bad nurse ... and he was angry
about it. He told me to sit and wait for him until he got back
from town, just to give me my medicines. After he warned me
not to come late anymore and then he gave me the medicines.
He said, 'next time you will be given the injections even later
and you will be very late for your work'." (Participant 6, male
patient, prospective group.)
Some nurses were more flexible than others, but there
were examples from all three clinics of patients who were
threatened, humiliated or treated angrily by staff for not
adhering to the implicit rules of the system. At one of the
clinics, two patients reported that they had been denied
access after a period of interruption.
Dynamics of social support
The support of family and community members was
extremely important during the intensive phase of treat-
ment, because this to a large extent compensated for loss
of income. Even though TB caused fear and stigmatiza-
tion, people shared resources in a time of crisis, and recip-
rocal arrangements provided most TB patients with some
food. Many received physical support in walking to the
clinic, and some received money for transportation. A
male patient who lost his job as a car washer explained
how the contributions of relatives and community mem-
bers helped him:
"Even if I can't get good food I try to get as much food as possi-
ble. People who visit me bring me food ... neighbours and rela-
tives." (Participant 9, male patient, prospective group.)
Many patients experienced changes in the level of support
as the treatment program progressed. A male patient, who
lost his job as a temporary teacher, moved to live with rel-
atives in a rural area after completing the intensive phase.
His friends and grandmother no longer had the means to
help him:
"She [grandmother] couldn't afford to help me anymore. She
couldn't help me because of her shortage. They are all fed up
[...] I have moved, walked from place to place ... and there is
no food. In the rural area, even if my father is poor, I at least
managed to get milk from the neighbourhood." (Participant 1,
male patient, prospective group.)
Many patients faced difficult situations after completing
the intensive phase of treatment, as the levels of support
dropped. Both patients and health personnel reported
that the causes of the changes in support levels were
closely related to practical and symbolic changes in treat-
ment at this stage.
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Crisis precipitated due to completion of the intensive 
phase
Based on a synthesis of the various sources of data we
found completion of the first phase of treatment to pre-
cipitate changes, often critically affecting existing support
mechanisms: First, patients were expected to stop going
for treatment on a daily basis, and were not expected to
need money for transport or help with walking to the clin-
ics. These changes reduced the attention focused on their
difficulties, and their needs therefore became less visible.
Second, it was expected that the health status of patients
who had finished the streptomycin injections, which were
considered the "main" medicine, should improve signifi-
cantly. Third, physical improvement was associated with
the expectation that patients would start to work again.
Fourth, the foods provided from the community were
expected to make a physical difference in patients. There
is a strong association between TB and HIV/AIDS, and
patients with a "curable disease" are expected to gain
weight and strength within a certain period of time.
Patients with prolonged disease (intermittent symptoms
or no weight gain) may be treated as having an incurable
disease (AIDS or a "chronic" type of TB), a condition that
carries additional stigma.
Six out of 10 patients in the prospective group, all still
financially dependent on others, experienced increasing
problems in mobilizing enough help in the period
between the second and fifth months. Some gradually
received less food, others were told to leave the house
because they were no longer able to contribute with the
rent. The experience of one patient, who still displayed
symptoms as skinniness and weakness during the contin-
uation phase, is illuminating. He reported how his rela-
tionship with his brother and sister-in-law became
increasingly tense because he could no longer pay his
share of the food and rent. He was told to leave in his fifth
month of treatment:
"People will get bored of you. Earlier they supported me when
they had money, or with some food, but they don't do that much
more. I can't ask for help all the time. (Crying) It is at home ...
they have asked me to leave their house now." (Participant 10,
male patient, prospective group.)
Relatives and community members may start to interpret
the slow recuperation process negatively, as indicating
eventual death, or they may assume that the patient will
not mange to re-establish his or her income. The basis of
reciprocity is taken away both when a patient become
totally dependent either permanently or for a prolonged
period of time, and when people think that the patient is
dying. When health personnel were asked about their
experiences related to treatment interruption, they all
mentioned patients leaving to live with relatives in rural
areas as one of the main causes. This was seen as a conse-
quence of patient-relative relationships being financially
or emotionally exhausted in the later stages of treatment.
Interplay of factors
Attending TB treatment brought with it various struggles
to meet the physical, psychological and financial costs of
treatment. Interviews with patients who had interrupted
treatment also demonstrated the interplay of such factors.
Five patients interrupted during the intensive phase of
treatment, two of them with only a few days left. Six
patients interrupted between the third and sixth months
of the continuation phase. Only one patient pointed to a
single factor as the cause of treatment interruption. This
patient was denied a sufficient ration of medicine to ena-
ble her to travel to the place where her son just had been
murdered. The causes of interruption were different, but
interrelated. They often operated over time and were most
often related to financial constraints. Three examples that
illustrate identifiable patterns in treatment interruption
are presented below.
Case one
A single mother, a working immigrant from a rural area,
used to beg outside one particular church before and after
morning mass. She had a small but regular income from
regular church visitors. Due to DOT, which takes up the
morning hours, she couldn't do that anymore, and her
only source of income was dramatically reduced. As a
result, she was unable to pay for the room she rented, and
she and her baby ended up on the street. She turned to the
health personnel, telling them that she was starving and
that she needed to take the medicines with her to her
mother in the countryside. Her request was denied, and
she decided to leave without the medicines after two
weeks of treatment:
"I didn't intend to interrupt the medicines at that time, but I
was too poor to keep on taking the medication. I was told to eat
eggs, meat and to drink milk, but the truth was ... I didn't even
have injera [Ethiopian pancake]. I went to the countryside
because I was forced to go there." (Participant 19, female
patient, retrospective group.)
This case illustrates how poor patients without rights to
paid sick leave or access to financial support from family
and friends experience acute and unbearable financial cri-
ses during early stages of treatment.
Case two
A male TB patient interrupted treatment shortly before
completing the intensive phase. During treatment, he
made intensive efforts to find daily work, but his physical
condition and the time-consuming system made this dif-
ficult. He often had no money for transport, and he felt
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weak and tired from having to walk four kilometres twice
a day. Sometimes he was late for treatment, which made
the health personnel angry. After about a month and a
half, he experienced that the friends who had helped him
the most became more reluctant to support him with
money. At the same time his relatives, all living in a rural
area, invited him to a funeral. He asked the health person-
nel to be allowed to attend, but this request was denied.
He decided to leave, interrupting treatment. When asked
why he interrupted, he gave several reasons:
"P. I didn't finish the treatment because I had to work to get
food and I was told to eat anything possible for the medication
and for the disease ... otherwise the medicines can't work ...
and to get food I had to work. The other thing was that I didn't
have money for transport to come to the clinic and I couldn't
walk always because I would be too late by the time I arrived at
the clinic. [...] I felt weak by walking to the clinic everyday, and
the insult of health personnel discouraged me.
Q. Would you say this whole situation made you go to your rel-
atives?
P. I went there because I was obliged to go there. (Pause) But I
was not motivated to come on foot to the hospital anymore."
(Participant 13, male patient, retrospective group.)
This case illustrates the situation where a patient ends up
in a vicious circle, where the demands of treatment
become more and more difficult to handle. A funeral or a
sick relative then represents a breaking point; a legitimate
way out of daily and accumulating struggles.
Case three
A young girl interrupted treatment after four and a half
months. At the time she started the medication, she was
too ill to walk to the clinic, and her mother collected the
medicines every day on her behalf. The time the mother
spent on daily attendance and nursing her daughter made
it impossible for her to work, and both mother and
daughter became totally dependent on food provided by
their neighbours. After two months of daily treatment, the
community members expected them to manage on their
own again. However, re-establishing herself as a beggar
and laundry washer proved difficult for the mother, and
as she was the only breadwinner, she became unable to
feed all her children. Desperation and hunger made the
sick girl break with the established social norms of the
community by begging in her own neighbourhood. This
led to unbearable fights with her mother:
"I started with the treatment, but after a while I felt so hungry
and the shortage of food at home ... and because I felt like men-
tally disturbed taking the medication ... made it impossible for
me to continue. On top of that my mother treated me so badly
at home. To overcome the shortage of food at home I started to
beg food and money from the neighbourhood. This begging
thing made my mother really mad. She said I was humiliating
her. We had some really big fights and after that I escaped from
home." (Participant 21, female patient, retrospective group.)
This case illustrates how prolonged illness may affect rela-
tions with relatives and community members. Weeks or
months of involuntary dependency force patients into
humiliating situations, while relatives and friends may
suffer from social or financial exhaustion.
Discussion
What does this study add to previous knowledge?
This study suggests that patients' management of treat-
ment is a product of dynamic processes and that patient's
behaviours respond to the complex patterns of socio-eco-
nomic and psychological factors during the course of
treatment.
The effect of time per se on adherence behaviour is
described by Christensen-Szalanski and Northcraft [32].
They point to the importance of understanding patients'
temporal perception of costs and benefits, and how tem-
poral perceptions may be influenced by delayed benefits
and accrued costs. We found that most patients experience
a chain of interrelated barriers during the intensive phase
of treatment. This chain is often activated by loss of
income and followed by lack of money for transport;
extensive time use; daily physical demands; food insecu-
rity; side effects and hunger. Rigid routines related to daily
attendance exacerbate many of these problems. TB
patients loosing their jobs and the opportunity to work
has been reported both in other parts of Ethiopia and in
other countries [6,12-14,33,34]. A study from Addis
Ababa [35] reported walking distances up to two hours
and found that the distances from patients' homes to the
health centres contributed to diagnostic delay. The author
underlines that the same factor may seriously affect TB
patients' ability to attend daily treatment.
We found that barriers in the intensive phase are managed
by most patients, albeit in different degrees, partly deter-
mined by the extent of financial and practical support
from family and neighbours. The protective effects of fam-
ily support have been found in other studies [6,10,33,36].
One study indicates that initially strong family support
became weaker during treatment [14]. Our study suggests
that patients who have fewer human or material resources
available in their environments, such as the very poor, sin-
gle mothers, and working immigrants from rural areas, do
not benefit from such protective factors. Some of these
patients may be forced to change their strategy and, as
related in this study, forced to move in with relatives in
BMC Public Health 2008, 8:11 http://www.biomedcentral.com/1471-2458/8/11
Page 9 of 11
(page number not for citation purposes)
other areas due to acute financial crisis that arise even dur-
ing the early stages of treatment.
We found that a decision to interrupt TB treatment may be
taken in response to social obligations, such as attending
a funeral. A study from Addis Ababa [24] found illness of
relatives and attendance at funerals to be two of the most
frequently cited reasons for treatment interruption. Even
if such decisions are triggered by strong social norms, they
may be shaped by past struggles and accrued costs, which
may seem unbearable at the moment the decision is
taken. Hungry patients who lack the strength or motiva-
tion to continue treatment have also been found else-
where [37]. Previous studies from Ethiopia have found
that most patients interrupt in their third or fourth month
of treatment [22-24]. One study [23] found lack of family
support to be one of the major causes of interruption, and
this is supported by the findings in this study: Many
patients ended up in a vicious circle, where poverty and
possible co-infections (HIV) led to slow recovery, and
where slow recovery contributed to income poverty and
further dependency. These barriers manifested themselves
at a time when psychological and other costs had accumu-
lated, and enablers like family and community support
were decreasing. This study shows that illness-induced
poverty over time threatens the sustainability of house-
hold finances, as well as the social relations that serve as
the basis of the household's continued existence as a
social unit.
Our findings suggest that it is important that the health
care system is aware of the dynamics of social support
mechanisms. In Ethiopia there seems to be a change dur-
ing treatment from a "generalised" to a more "balanced"
type of reciprocity. This movement seems to be consistent
with symbolic and practical changes related to comple-
tion of the first stage of treatment (the intensive phase),
but may also be a product of increasing HIV/TB co-infec-
tion rates. In people's experiences, patients with pro-
longed diseases or intermittent symptoms often die, and
social support may therefore now be withdrawn earlier
than before.
Validity and transferability
The trustworthiness of the study and validity of our find-
ings is strengthened by the extensive triangulation within
the study. We interviewed different groups of patients,
health professionals and patients' relatives. The same
themes were investigated from both a prospective and a
retrospective angle, by means of different methods. Our
findings are characterized by similarities within and
between different groups of respondents and we believe
this strengthen the internal validity of our study.
The sample size is limited and restricted to one geograph-
ical area, and instead of proposing that the findings are
transferable to other contexts, we suggest using the con-
cept of "extrapolation" [38] to describe the usefulness of
our study. Patterns of findings presented in a broad con-
textual frame enable us to be aware of potential similari-
ties in similar contexts, in particular how variables may
interrelate at time-specific points in treatment and how
certain identifiable patterns may create barriers in relation
to the management of treatment.
TB control managers and others may argue that by not
strictly following NTLCP's operational definition of a
defaulter the findings will be less applicable. We believe
the implications are few since the strict definition is
mainly used to separate between defaulters who re-enters
treatment being smear positive again, and patients that
may recommence treatment to finish the initial regimen.
An important implication though may be increasing
awareness of patients that may "default" due to poverty
related barriers early in treatment (< 4 weeks), but that are
not registered as defaulters. The criteria used for defining
defaulters may result in relatively low overall rates of
default, also pointed to in another study from Ethiopia
[23].
Implications for practice
To our knowledge there are few major changes in how the
DOT services are organized in Addis Ababa. One change
that has been made is the establishment of a formal col-
laboration between services related to TB and services
related to HIV/AIDS [39]. However, a recent study exam-
ining the acceptability of HIV testing among TB patients,
conclude that the acceptability is low, and that it poses a
challenge to the scale-up of TB/HIV collaborative efforts
[40]. The findings in the present study may help to predict
treatment interruption during the early stages of treat-
ment, based on patients' socioeconomic and environmen-
tal conditions. Some of the barriers patients experience
during the intensive phase could easily be solved with
more flexible approaches, such as more flexible hours for
attendance and greater flexibility related to participation
in important cultural and family-related events. A primary
nurse-patient system, where patients are followed up by
the same nurse, would help health personnel to identify
each patient's resources and constraints. More individual
approaches will make it easier to establish relations based
on trust, and will facilitate flexible adjustments by means
of follow-up talks throughout treatment.
We believe that TB programs need to address nutrition. As
recognized by many patients, without food medical treat-
ment is in vain. Providing one glass of milk or a small
meal at the clinic could have a positive influence on both
case detection rates and treatment completion. By ensur-
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ing access to some nutritious food, patients may gain
weight and recover faster, probably the best way to fight
stigma and to strengthen social support mechanisms dur-
ing later stages of treatment. Initiating a dialogue with
labour organizations to help prevent TB patients losing
their job is another important step.
Still, many patients will experience difficulties related to
daily attendance. Further decentralization of TB-related
health care, use of mobile clinics, the provision of trans-
port money and permitting some of the poorest or most
ill patients to take tablets home for self-treatment may be
means to increase adherence. A recent review of rand-
omized controlled trials, comparing DOT with self-
administration of therapy, provides no evidence that the
routine use of DOT in low- and middle income countries
improves cure or treatment completion in people with
tuberculosis [5]. Several authors have advocated a shift in
perspective, where patients' socioeconomic environ-
ments, their well-being's and their dignity are included in
future strategies [2,41,42]. Strategies based on self-treat-
ment can be strengthened by support and supervision by
an identified relative or neighbour, or through other
social structures. Several TB control programmes that
leave the choice of DOT supervisor to the patient have
been shown to be successful [43-45].
In order to enable patients to get well, one need to make
an assessment of what formal and informal sources of
support exist, what structures are missing, and how differ-
ent contributors can fill the gap [2]. In Ethiopia, the
involvement of social support structures beyond relatives
seems to be important. One useful structure could be the
edir, a community based body with social responsibility
(mainly for arranging funerals) for those living within a
defined community (Kebele). The edir could become
involved through the appointment of persons to be in
charge of supporting TB patients who are unable to attend
treatment on a daily basis. Social support structures could
also be established based on the model of the successful
"TB clubs", which are small groups of patients who live
near each other, implemented in some rural parts of Ethi-
opia. These clubs, which collaborate with health workers
and key persons in the community, have become an inte-
gral part of the tuberculosis program by referring sus-
pected cases, promote treatment adherence and trace
patients who interrupt [33,46]. Existing community
mechanisms can be strengthened by involving the com-
munities and creating a climate of awareness and shared
responsibility for solving major health issues. By involv-
ing the communities, more flexible arrangements can be
facilitated, the treatment burden can be reduced, and a
better balance can be ensured between control measures
and enabling measures.
Conclusion
Patients' ability to manage TB treatment is a product of
dynamic processes, in which various social and economic
costs and other burdens change and interplay over time.
Interventions to facilitate adherence to TB treatment need
to address both time-specific and local factors.
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